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Abstract 
Processing bodies (p-bodies) are cytoplasmic messenger ribonucleoprotein granules con-
taining components of the mRNA degradation machinery, that form during stress condi-
tions in the budding yeast Saccharomyces cerevisiae. P-bodies are conserved in eukaryotes 
and are related to other mRNP granules such as stress granules and neuronal granules. 
mRNP granules and their components self-assemble through a process of liquid-liquid 
phase separation, facilitated by protein-protein interaction by low complexity regions. Er-
rors in this assembly process can cause a build-up of aggregated protein and have been 
implicated in the pathology of human neurodegenerative diseases such as amyotrophic 
lateral sclerosis. The exact role of p-bodies in normal cellular function is not known, but p-
bodies are induced in conditions of stress, and can store mRNA that later re-enters trans-
lation, leading to the theory that they are sites of mRNA storage. A contrasting theory 
suggests them as sites of mRNA decay, due to the presence of deadenylation, decapping 
and exonuclease complexes within p-bodies. In this work, time-lapse fluorescence micros-
copy, using optimised high brightness, low photobleaching fluorescent protein fusions, was 
used to allow long term imaging of p-body localisation throughout the cell cycle of S. 
cerevisiae. Imaging was combined with microfluidic dissection of mother and daughter 
cells, to track single mother cells over their entire replicative lifespan (RLS) while continuing 
to monitor p body localisation. P-bodies were found to be localised in proximity to multiple 
different organelles with changes to localisation occurring through the cell cycle. Advanced 
replicative aged altered the profile of p-body localisation causing p-bodies to localise 
heavily to the mitochondria. P-bodies were also found to be inherited by daughter cells in 
a process dependent on the mRNA transport machinery and the p-body protein Dcp1. 
This inheritance was multigenerational with a single p-body moving between multiple 
daughter cells and was not lost in cells of advanced replicative age. 
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2.1 Foreword 
Through all the advances in modern medicine over the past century, we now live longer 
and more prosperous lives that we ever have before. The advent of germ theory, modern 
hygiene standards and powerful interventions such as antibiotics, have made the infectious 
diseases of the past largely insignificant to mortality statistics in the developed world. But 
with this newfound longevity previously unrecognised ailments have arisen, caused in part 
by our own body’s lack or preparedness for life beyond historical limits. The most widely 
publicised of these conditions are the cancers, diseased of uncontrolled cellular prolifera-
tion triggered by the build-up of genetic mutations and therefore exacerbated in their 
prevalence by virtue of our lengthening lifespans. Large amounts of research investment 
have gone into understanding the mechanisms of cancer development and pathogenesis 
over the last few decades. This has led to a significant reduction in the morbidity and 
mortality caused by cancers, due to successful interventions and early screening pro-
grammes.  
While cancers affect all parts of the body, the recent shift in media and academic attention 
has been towards the brain, with projects such as the BRAIN initiative in the US and the 
Human Brain Project in Europe hoping to significantly advance our understanding of the 
human brain. What, one might ask, is the point of living to our 100s, curing our various 
physical maladies along the way, only to lose our identities long before that due to neuro-
degeneration of the brain? Understanding the pathology of neurodegenerative diseases, 
such as Alzheimer’s and Parkinson’s disease, is therefore integral to the improvement of 
quality of life in an ever ageing population.  
As well as the focus on this new avenue of research, the age-linked conditions, neuro-
degenerative diseases of the general population also benefit from the new-found attention 
due to their reported similarities at the molecular level. For example, many neurodegen-
erative diseases, both age-related and not, show an increase in the prevalence of aberrant 
protein aggregation. mRNP granules are a key element. These granules are made up of 
various combinations of mRNA binding and other proteins, as well as ribonucleic acids, 
and have been found to be over-represented in diseased cells in conditions such as Amy-
otrophic Lateral Sclerosis (ALS). One possible model of disease pathology involves the 
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sequestration of mRNA and proteins within these granules leading to changes in gene 
expression and cellular function that ultimately lead to the death of the cell. mRNP granules 
have also been implicated in a range of cancers, highlighting their potential as agents of 
disease.  
Although clearly an important factor in a range of statistically important diseases, the struc-
ture and function of mRNP granules has only recently started to become clearer, and much 
still remains unexplained. Here, I describe new aspects of the dynamics of mRNP granules 
in the yeast S. cerevisiae. 
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2.2 The mRNA life cycle in yeast 
The creation and utilisation of mRNA plays a fundamental role in the central dogma of 
molecular biology, in which DNA is transcribed to mRNA which is subsequently translated 
into proteins.  
2.2.1 Transcription and nuclear processing of mRNA 
In eukaryotes, mRNA is created in the nucleus in a process called transcription, in which 
RNA polymerase II catalyses the polymerisation of ribonucleotides complementary to the 
sequence of DNA being transcribed to create a single stranded RNA molecule. This process 
is facilitated by proteins known as transcription factors. Once sequence transcription is 
complete, the RNA undergoes a series nuclear processing events (T. I. Lee & Young, 2000).  
A 5’ cap consisting of a 7’methylguanosine is added at the 5’ end of the mRNA molecule, 
which stabilises the mRNA and prevents exonuclease degradation. The capping process 
occurs while transcriptional elongation is still taking place and involves 3 steps. The ex-
posed triphosphate of the first nucleotide in the RNA sequence is hydrolysed by RNA tri-
phosphatase and a guanosine monophosphate nucleotide derived form GTP is fused to 
the exposed phosphate through a 5’-5’ triphosphate bond by mRNA guanylyl transferase. 
Finally, the N7 position nitrogen of the guanosine nucleotide is methylated by mRNA (gua-
nine-N7-)-methyltransferase (Fong, 2001). Non-coding regions of the RNA, called introns, 
are removed in a process called splicing carried out by a ribonucleoprotein complex known 
as the spliceosome. The spliceosome contains catalytically active RNA that recognises in-
tronic sequences within the mRNA and catalyses their removal. As with 5’ capping this 
Figure 1: The central dogma of molecular biology, DNA is transcribed to mRNA which is 
translated into protein. 
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process happens co-transcriptionally, while the mRNA is still attached to RNA polymerase 
2 (Görnemann et al., 2011). 
Once transcription of the sequence is complete, a poly-A tail, consisting solely of adeno-
sine nucleotides is attached completing the maturation of the mRNA. Almost all coding 
mRNAs in yeast contain a poly-A tail comprising on average 70 poly-adenosines at the 3’ 
end of the sequence. Poly-A polymerases add these adenosine monophosphate nucleo-
tides after mRNA has been cleaved at the 3’ end in a processes that is instigated by the cis 
regulatory elements in the DNA sequence (Ares & Proudfoot, 2005; Bentley, 1999). 
mRNA is exported from the nucleus where it can be recognised by components of the 
mRNA translation machinery and translated to produce proteins. The export process is 
controlled by the nuclear pore complex (NPC) made up of nucleoporin proteins that form 
a channel in the nuclear membrane (C. Smith et al., 2015a). To facilitate mRNA export, 
mRNAs combine with export factors to form ribonucleoproteins that then translocate 
across the NPC into the cytoplasm. These mRNPs can be remodelled to regulate direc-
tionality and nuclear export rate (C. Smith et al., 2015b). 
2.2.2 Localisation of mRNA 
Translation can occur freely in the cytoplasm or can be localised to specific areas of the 
cytoplasm or compartmentalised in specific organelles. The advantage of limiting transla-
tion to localised positions within the cell are numerous; for example, localised translation 
can be used to introduce polarity and facilitate polarised cell growth. It could also be used 
to facilitate asymmetric cell division as in budding yeast. Other examples of localised trans-
lation include production of protein involved in neuronal processes and daughter cell spe-
cific transcription inhibition (Niessing et al., 2018).  
To achieve localised translation, mRNAs must be transported to the required destination 
by an mRNA transport system or linked to an existing organelle transport system by adapt-
ers. In budding yeast, examples of both mechanisms have been observed. Direct transport 
of mRNA in yeast is facilitated by myosin motor proteins, specifically Myo4 which translo-
cates along actin filaments (Bohl, 2000; Rodriguez et al., 2006). The best-known example 
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of this process is that of the Ash1 mRNA which encodes a transcription inhibitor that 
Figure 2: The main processes involved in transcription. A - The elongation of the mRNA 
transcript by RNA polymerase II. B – Addition of the 5’ methyl guanosine cap. C – Splicing 
of introns in the mRNA. D cleavage of the 3’ region and addition of a Poly-A tail.  Reproduced 
under Creative commons licence, see Appendix for details. 
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prevents mating type switching when present. Ash1 is trafficked to the tip of the emerging 
bud during cell division and prevents mating type switching in the daughter cell by local-
ised translation, while the mother cell retains the ability to switch mating types (Bobola et 
al., 1996). ASH1 mRNA has several localisation elements contained in both the coding re-
gion and 3’ untranslated region (Bohl, 2000). These regions are recognised by the mRNA 
binding protein She2 in the nucleus, with a relatively low affinity that is enhanced by the 
addition of a second protein, She3, upon nuclear export. She3 binds both She2 and the 
mRNA to stabilise the interaction and increase its specificity (Edelmann et al., 2017; Marisa 
Müller et al., 2011). She3 also binds constitutively to the myosin motor protein Myo4. To-
gether the 3 proteins form a messenger ribonucleoprotein complex capable of transport 
along actin filaments (Bohl, 2000; M. Müller et al., 2007).  
She2 has also been shown to bind to the membrane of the endoplasmic reticulum, specif-
ically the cortical ER which in yeast is transported to the bud tip. The observation that 
cortical ER transport is dependent on the Myo4/She3 complex revealed an associated role 
in mRNA transport (Genz et al., 2013; Schmid et al., 2006). Multiple mRNAs have been 
shown to be co-transported with the cortical ER into the budding daughter cell with all 
these mRNAs capable of being bound by She2 (Fundakowski et al., 2012). Although the 
specific mechanism of ER binding by She2 is not known the association with the ER has 
been shown to be specific to the ER and no other organelle membranes (Genz et al., 2013). 
In order to prevent translation of mRNA during transportation, the She2/She3/Myo4 mRNP 
is complexed with translation inhibitors such as the p-body component Dhh1 (Zhang et al., 
2017). Release on inhibition by the local environment at the destination then allows trans-
lation initiation to take place. 
Translation can also occur on the outer membrane of the ER. Translation on ER membranes 
mainly produces membrane proteins or those destined for secretion (Shao & Hegde, 2011). 
Translation begins in the cytoplasm, after which the emergence of a targeting domain on 
the extending amino-acid sequence triggers a pause in translation and relocation of the 
ribosome to the ER membrane. The ribosome is bound by a membrane complex called 
the translocon and insertion of membrane proteins then occurs co-translationally. 
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2.2.3 Translation of mRNA 
Translation of mRNA to produce proteins is a multistep process. The major conserved 
proteins in eukaryotic translation are outlined below. Translation begins with initiation, the 
formation of 80S ribosomes capable of elongating amino acid sequences, via the joining 
of a 48S initiation complex to a 60S ribosomal subunit (Jackson et al., 2010). The 5’ cap of 
the mRNA is initially bound by the cytoplasmic cap binding complex, composed of initia-
tion factors 4E, 4G and 4A. The cap binding complex works to unwind secondary structures 
in the 5’ region of the mRNA and create a circular mRNA structure through binding to the 
poly-A binding protein associated with the 3’ poly-A region. The cap-binding complex 
associated mRNA is then bound by the 43S pre-initiation complex of the 40S ribosome 
and ternary complex of eIF2-GTP Met-tRNAmet to form a 48S initiation complex before 
scanning the mRNA to identify a start codon. 
Figure 3: mRNA is transported through the cell by the "locasome" complex, made up of 
She2, She3 and Myo4 as well as translational repressors. She2 and She3 proteins link the 
mRNA to the actin cytoskeleton via the class V myosin motor protein Myo4. mRNAs are 
transported from mother to daughter cells to enable bud localised translation. 
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Upon recognition of the start codon at the P-site of the 40S ribosome, the GTP bound to 
Figure 4: The initiation of Eukaryotic translation. The mRNA 5’ cap is initially bound by the 
cap binding complex eIF4F, followed by mRNA circularisation by Pab1 binding to the cap 
complex and poly-A tail. The 48S complex associated bind to the cap complex and scans the 
mRNA for the start codon, after which the 60S subunit binds to form an elongation competent 
80S ribosome. 
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eIF2 is hydrolysed to GDP, releasing it, along with the other initiation factors (Dever et al., 
2016; Wilson et al., 2000). 
To begin elongation of the peptide, the A site of the ribosome is populated with a eEF1A-
GTP-aminoacyl-tRNA complementary to that of the mRNA sequence, and the eEF1A-GTP 
is hydrolysed to eEF1A-GDP. A peptide bond is formed between the two amino acids and 
movement of the ribosome shifts acceptor ends of these tRNAs into the E and P sites 
respectively. Hydrolysis of eEF2-GTP provides the energy for movement of the anticodon 
ends into the same sites. The E site tRNA is released and a new eIF1A-GTP-aminoacyl-
tRNA populates the A site to begin the process again. Eventually a stop (or nonsense) 
codon is reached and translation termination is initiated (Dever et al., 2016). 
Once the A site of the ribosome is populated with a stop codon, eRF1, a functional tRNA 
mimic binds the ribosome along with eRF3-GTP. Hydrolysis of the GTP of eRF3-GTP causes 
its dissociation and accelerates peptide release from the ribosome (Eyler et al., 2013). The 
ATPase Rli1 then binds eRF1 and catalyses the hydrolysis of the peptide-tRNA bond to 
release the nascent polypeptide. Further hydrolysis by Rli1 releases the 60S subunit from 
the mRNA and further ribosome associated proteins promote the dissociated of the 40S 
unit. This release process is known as recycling and these ribosomal subunits can then re-
enter translation using the same or new mRNAs. 
2.2.4 mRNA Decay in Yeast 
A key stage in the control of gene expression in Saccharomyces cerevisiae, as in other 
eukaryotic cells, is the turnover of cytoplasmic mRNA. mRNA may be subject to decay due 
to regulatory processes influencing the decay of particular mRNA species, or due to quality 
control mechanisms identifying aberrant sequences and targeting them for decay. The 
multiple pathways for mRNA decay in yeast have been elucidated in numerous studies and 
proteins and mechanisms involved in mRNA degradation have been identified. In yeast, 
two general mRNA decay pathways are present and act on cytoplasmic mRNA. Both path-
ways begin with the process of deadenylation, in which the 3’ poly(A) tail of the mRNA is 
shortened or removed by a deadenylation complex consisting of Pan2/Pan3 (Brown & 
Sachs, 1998) or Ccr4/Not/Pop2 (M Tucker et al., 2001). Following deadenylation, mRNA can 
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undergo either 3’ to 5’ exonuclease degradation by the exosome (J. S. J. Anderson & 
Parker, 1998) or decapping by the decapping complex consisting of Dcp1/Dcp2 followed 
by 5’ – 3’ exonuclease degradation by Xrn1 (Travis Dunckley & Parker, 1999; Hsu & Stevens, 
1993; Kenna et al., 1993; D Muhlrad et al., 1995; Denise Muhlrad & Parker, 1994; E. Van Dijk 
et al., 2002). The exosome is also capable of endonuclease activity, although the mapping 
of endonuclease sites in S. cerevisiae to mRNA sequences showed that very few are 
Figure 5: Elongation (top) and termina-
tion (bottom) of eukaryotic translation. 
Elongation - A polypeptide is produced 
by a recurring process of aminoacyl-
tRNA binding to the ribosome A site, fol-
lowed by peptide bond formation to the 
existing peptide. The mRNA is translo-
cated through the ribosome to move the 
tRNA between sites, allowing release of 
the tRNA from the E site and ingress of 
a new aminoacyl-tRNA. Termination – 
release factor 1 mimics aminoacyl-tRNA, 
binding to the A site with a correspond-
ing stop codon. Hydrolysis of GTP facili-
tates peptide release and Rli1 catalyses 
dissociation of the ribosomal subunits. 
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degraded in this way (Parker, 2012).  
Decapping followed by degradation by Xrn1 is thought to be the major pathway for mRNA 
degradation in yeast due to both observations of mutant strains and direct measurement 
of degradation rates. Mutations in the 5’-3’ exonuclease or decapping factors show signif-
icant changed in mRNA decay rates compared with mutants in the 3’-5’ pathway (Beelman 
et al., 1996; X. He & Moore, 2005) indicating that the decapping pathway may influence 
the degradation of a greater volume of mRNA. Mutations in the decapping proteins also 
cause severe growth restrictions and are lethal in some strains of yeast (Beelman et al., 
1996; Travis Dunckley & Parker, 1999; Giaever et al., 2002). Computation modelling of the 
degradation pathways also implied that deadenylation had the largest influence on mRNA 
levels and changing the rate of deadenylation had a larger effect on levels than changing 
the activity of the 3’-5’ exonuclease pathway (Cao & Parker, 2001). 
For the non-standard degradation of mRNA, for example in cases of aberrant mRNA se-
quences, yeast also possess quality control mechanisms capable of acting independently 
of the usual degradation pathways that allow specific targeting and degradation of these 
mRNAs. These pathways can act by bypassing the usual restriction of deadenylation 
through deadenylation-independent decapping, such as in nonsense-mediated decay, or 
through rapid 3’-5’ exonuclease (non-stop decay) or endonuclease cleavage (no-go de-
cay) of the mRNA (Doma & Parker, 2006, 2007; D Muhlrad et al., 1994; Van Hoof et al., 
2002).  
As deadenylation, decapping and Xrn1 degradation factors have been shown to accumu-
late in cytoplasmic p-bodies, this pathway is explored further below. 
 Deadenylation 
Deadenylation is the process of removing adenine nucleobases from the 3’ UTR of an 
mRNA. This process is carried out by 3’ – 5’ exonucleases known as deadenylases with the 
Ccr4/Pop2/Not1 complex being the major yeast deadenylase (M Tucker et al., 2001). Ccr4 
has been shown to be the catalytically active subunit of this complex (Goldstrohm et al., 
2007) with Pop2 promoting Ccr4 activity, but still retaining an exonuclease activity, demon-
strated in vitro, that may be active under certain conditions (Thore et al., 2003; Viswanathan 
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et al., 2004). The Not proteins may function in adapting the complex to different mRNAs, 
as mutations in these proteins can affect the deadenylation of specific subsets of mRNA 
(Morgan Tucker et al., 2002). A secondary deadenylase complex consisting of Pan2, the 
catalytic subunit, and Pan3, thought to bind the poly-A tail region via a zinc finger domain 
(Schäfer et al., 2014) is also present in yeast. This complex is promoted by the poly-A bind-
ing protein, Pab1 (Boeck et al., 1996), which also inhibits Ccr4 activity, and may be respon-
sible for the initial shortening of exposed poly-A tails bound to Pab1, as deletion mutants 
of Pan2 lead to longer poly-A tails (Brown & Sachs, 1998). A partial redundancy exists 
between these 2 deadenylase complexes, as deletion of either does not lead to fatal phe-
notypes, but growth defects in which growth rate is limited. Pan2 can continue past its 
initial 25 nucleotide region in a Ccr4 deletion mutant but arrests at around 20-25 remaining 
adenine nucleotides. No further deadenylases are known and none are likely to exist given 
Figure 6: Simplified progression of mRNA decay in budding yeast and eukaryotes. The 
Pan2/Pan3 complex is responsible for initial deadenylation, followed by continued dead-
enylation by the Ccr4/Not1 complex. Decapping proteins Dcp1 and Dcp2 catalyse the re-
moval of the 5’ mRNA cap, in a process enhanced by Edc3. Finally, Xrn1 exonuclease activity 
degraded the exposed 5’ mRNA in a 5’ – 3’ direction. 
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that a double deletion of Ccr4 and Pan2 results in the loss of deadenylation activity (M 
Tucker et al., 2001). 
Regulation of deadenylation rate has been shown to occur via three general mechanisms. 
First, as previously mentioned, the binding of Pab1 to mRNA promotes Pan2 activity as 
Pab1 plays an important part in translation initiation through the binding of eiF4G. There 
is therefore an intrinsic link between translation and degradation. Many of the mutations 
and events in translation that affect degradation could be explained by changes in the 
binding of Pab1 to the Poly-A tail, causing a decrease in Pan2 activity and an increase in 
Ccr4 activity leading to a greater overall rate of deadenylation (Parker, 2012). Second, 
translation termination also impacts deadenylation rates, possibly through the direct inter-
action of eRF3 with Pab1 (Cosson et al., 2002) as inhibiting this interaction leads to changes 
in deadenylation (Kobayashi et al., 2004). Deadenylation can also be influenced by external 
environmental factors, although current knowledge in this area is limited. Deadenylation 
reduces in response to stress (Hilgers et al., 2006), most likely to compensate for the con-
current inhibition of translation initiation and maintain required mRNA levels. Although 
translation initiation complexes and other mRNPs can be packaged in cytoplasmic granules 
(see below) during stress events, and Ccr4 has been shown to localise to one such granule, 
the p-body, this process is not necessary for the general reduction in deadenylase activity. 
Cycloheximide treatment, which inhibits granule formation, has no effect on the inhibition 
of deadenylation during stress. Deadenylation can also be influenced by the kinases Pkh1 
and Pkh2, which are also regulators of p-body formation (G. Luo et al., 2011). These kinases 
are activated by sphingolipids, important signalling molecules, that can also influence p-
body formation (Cowart et al., 2010). Finally, deadenylation can be influenced by the mRNA 
structure. The sequence of mRNA can influence its secondary structure by creating stem 
loops and other structures that can inhibit or enhance the binding of mRNA binding pro-
teins such as Pab1. Deadenylation is particularly susceptible to 3’ UTR structures that recruit 
other mRNA binding proteins. Puf5, a member of the Puf family of 3’ UTR binding proteins, 
has been shown to recruit the Ccr4 deadenylase complex through the direct biding of 
Pop2 (Goldstrohm et al., 2006, 2007). Other mRNA binding proteins such as the helicase 
Dhh1 also influence Ccr4 recruitment, and it has recently been shown that transcripts 
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bound by Ccr4/Dhh1 (Dhh1 again being a p-body component) during normal growth are 
subject to regulation during starvation (J. E. Miller et al., 2017). 
To summarise, deadenylation is a two-stage process in which the Pan2/Pan3 complex first 
shortens the initial nucleotides and then has its activity is promoted by the presence of 
Pab1, introducing a point of regulation. The Ccr4/Not complex removes the remaining 
poly-A nucleotides not bound by Pab1 triggering either the decapping process or 3’-5’ 
degradation by the exosome. Multiple factors affect Ccr4/Not complex binding to the 
mRNA, and sequence specific features can regulation the specific decay rates of individual 
mRNAs. This process can be globally regulated by environmental factors with some envi-
ronmental factors such as nutrient starvation having specific effects on distinct mRNA pop-
ulations. 
 Decapping 
Active eukaryotic mRNAs feature a 5’ structure called the cap, a methylated guanine nu-
cleotide that is linked to the 5’ end of the mRNA by its own 5’ carbon. This unique structure 
stabilises the mRNA, preventing 5’-3’ exonuclease activity. For complete degradation of 
mRNA via the 5’-3’ pathway this 5’ cap must therefore be removed to allow access to the 
exonuclease Xrn1. The process of removing this 5’ cap, known as decapping, involves the 
hydrolysis of the cap structure, leaving an exposed 5’ monophosphate that is targeted by 
Xrn1. In yeast decapping is performed by the decapping complex, made up of the catalytic 
pyrophosphatase Dcp2 (E. Van Dijk et al., 2002) and the decapping promotor subunit Dcp1 
(Deshmukh et al., 2008; She et al., 2004). The first 300 amino acids of Dcp2 are responsible 
for the hydrolysis of the phosphate bond (Travis Dunckley & Parker, 1999), and fold into a 
2 domain structure which closes into a more active structure when associated with Dcp1 
(Deshmukh et al., 2008; Floor et al., 2010; She et al., 2008). Dcp2 also features binding sites 
for other activators of decapping such as the Edc3 (Harigaya et al., 2010). 
Regulatory functions of decapping fall into three categories, the catalytic action of Dcp2, 
the removal of the cap-binding complex eIF4F to allow access to the cap and the recruit-
ment of the decapping complex to the cap.  
In vitro observations showed that Edc3 and Pat1 directly bind to and enhance Dcp2 
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catalysis (Harigaya et al., 2010; Nissan et al., 2010), Edc1 and its paralog Edc2 bind instead 
to Dcp1, and have been shown in vitro to enhance Dcp2’s catalytic activity in this complex 
(Borja et al., 2011). During log phase, stress free growth, the catalytic activity of Dcp2 is not 
rate limiting for decapping, as demonstrated by the lack of decapping-deficient pheno-
types in Edc1/2/3 deletion mutants (T Dunckley et al., 2001; Kshirsagar & Parker, 2004). 
Other mutations affecting Dcp2 catalysis give similar phenotypes showing little loss of 
decapping activity, including Pat1 C-terminal domain deletion (Nissan et al., 2010; 
Pilkington & Parker, 2008) and mutations in Dcp1 and Dcp2 themselves (Steiger et al., 2003; 
Tharun & Parker, 1999). 
Further regulatory proteins can increase the rate of decapping by promoting the binding 
of the decapping complex to the 5’ cap or recruiting additional enhances of decapping. 
Protein interaction studies have identified 2 major groups of proteins that interact to form 
decapping complexes. One complex binds to the 3’ end of deadenylated mRNAs in vitro 
and consists of Pat1, the sub complex of Lsm1-7 and the Xrn1 exonuclease (Chowdhury et 
al., 2007). This complex is important in maintaining the order to degradation, ensuring that 
decapping enhancement occurs only after deadenylation by binding to oligoadenylated 
rather than polyadenylated mRNA. It also preferentially activates the decapping and 5’-3’ 
degradation pathway, as a Pat1 or Lsm1 deletion causes exonuclease activity at the 3’ end 
of the mRNA indicative of exosome activity (W. He & Parker, 2001)). The Dcp1/Dcp2 com-
plex can also recruit or be recruited by additional proteins including Edc3, Scd6 and Dhh1 
(Parker, 2012). Several of the proteins involved in these complexes, including Lsm4 and 
Edc3 contain low complexity domains that can lead to aggregation of these mRNP com-
plexes into larger structures such as p-bodies. 
Given the need to remove the cap-binding complex before decapping can occur, transla-
tion initiation can be thought of as being in competition with decapping, with the fate of 
the mRNA factors determining access of the respective proteins (McCarthy, 1998; C. Vilela 
et al., 2000). The observation that a decrease in translation initiation rate, achieved through 
various means, lead to an modulation of the decapping rate support this theory 
(LaGrandeur & Parker, 1999; Linz et al., 1997; D Muhlrad et al., 1995; Schwartz & Parker, 
1999; Cristina Vilela et al., 1999) although this relationship is complex (McCarthy, 1998; 
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Ramirez et al., 2002). The proteins regulating this competition are diverse in function and 
many are also involved in the formation of, or localise to, cytoplasmic p-bodies during 
cellular stress (Nissan & Parker, 2008). Enhancers of decapping in yeast are summarised in 
table x. For enhancers that work by inhibiting translation, the exact mechanism that leads 
to an increase in decapping rate is not clear. It could be a simple matter of increasing the 
time available for the dissociation of the cap binding complex or may be a more complex 
remodelling of the mRNP (Parker, 2012). This set of proteins would be classed under the 
final category of ‘removing the 5’ cap binding complex’. Further evidence that the cap 
binding complex is the key inhibitor of decapping comes from studies of mutants with 
aberrant copies of its constituent proteins, in which mRNA stability is significantly reduced 
(Linz et al., 1997; McCarthy, 1998; Ramirez et al., 2002; Schwartz & Parker, 1999, 2000; C. 
Vilela et al., 2000; Cristina Vilela et al., 1999). 
In the 5’-3’ pathway, the initiation of decapping is triggered by the completion of dead-
enylation. As the poly-A tail is reduced it loses the ability to bind to Pab1 but increases its 
affinity for the Pat1/Lsm complex as demonstrated by the in vitro studies of Pat1/Lsm and 
Pab1 poly-A binding (Chowdhury et al., 2007; Sachs et al., 1987). This reliance on Pab1 is 
supported by the observation that decapping and deadenylation are uncoupled in Pab1 
deletion mutants (Caponigro & Parker, 1995). 
Individual mRNAs can show different rates of decapping. In the same way that mRNA 
sequence can influence the rate of deadenylation, mRNA sequence can recruit additional 
proteins to either increase or decrease the rate of decapping. Many sequence features that 
influence the rate of decapping have concurrent effects on the rate of deadenylation 
(Caponigro et al., 1993; D Muhlrad et al., 1995; D Muhlrad & Parker, 1992; Olivas & Parker, 
2000), pointing towards a general model in which translating mRNPs are remodelled into 
repressed and then decaying mRNPs through the exchange of translation initiation factors 
for decay factors. mRNA features that reduce translation will have an opposite effect on 
decapping. In early work studying the decay rates of both stable and unstable mRNA, 
features that were found to inhibit translation such as poor AUG context (LaGrandeur & 
Parker, 1999) in the case of the MFA2 mRNA enhance mRNA instability and cause faster 
decay rates. 
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Once exposed by the decapping process, the 5’ monophosphate can be recognised by 
the Xrn1 exonuclease, beginning a process of rapid 5’-3’ exonuclease degradation (Kenna 
et al., 1993; Stevens & Poole, 1995; E. L. Van Dijk et al., 2011). 
2.3 Processing bodies 
Processing Bodies (p-bodies) are non-membranous cellular compartments, part of a family 
of similar bodies/granules known as mRNP granules, consisting of an aggregated mixture 
of mRNA and proteins, some conserved and others variable depending on the state of the 
cell. Similar mRNP granules are present in a variety of organisms and hold different roles 
for cellular development and survival, these include Stress Granules (P. Anderson & 
Kedersha, 2008) Germ Granules (Gallo et al., 2008) and Neuronal Granules (Kiebler & 
Bassell, 2006). The structure, composition and function of p-bodies has been studied in 
both human cell lines as well as multiple model organisms such as the yeast Saccharomyces 
cerevisiae. 
2.3.1 Discovery 
P-bodies were originally observed as cytoplasmic foci of mRNA decay and decapping pro-
teins, identified by fluorescent protein fusions and immunofluorescence experiments ini-
tially in mammalian cells (Kedersha et al., 2005) and subsequently in yeast and other eu-
karyotes (U Sheth & Parker, 2003). Fluorescence microscopy represents an invaluable tool 
for the study of p-bodies given the difficulty of purifying or reproducing them in vitro. The 
highly conserved XRN1 exonuclease was shown to form discrete foci in mouse fibroblasts 
(Bashkirov et al., 1997) while both Dcp1 and Dcp2 decapping proteins were found to exhibit 
similar localisations in HEK293 cells (E. Van Dijk et al., 2002). The inclusion of both exonu-
clease and decapping factors led to the initial idea that these foci were sites of mRNA 
decay. Further studies of yeast identified a wider range of proteins involved in decapping 
and mRNA decay that also localised to cytoplasmic foci, as well as co-localising these pro-
teins to confirm they form a single compartment (J. R. Buchan et al., 2011). The term Pro-
cessing Bodies was coined as a name to describe these foci, indicating their role in mRNA 
processing. Genetic studies also showed that deletion mutants of the identified constituent 
proteins caused various effects on PB size and number (summarised in Table X)(U Sheth 
& Parker, 2003). 
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Around the same time as the discovery of p-bodies, a closely related mRNP known as a 
stress granule was also identified and has been shown to be conserved in a similar range 
of model organisms and cell lines (P. Anderson et al., 2015; Nover et al., 1989). Stress gran-
ules are not constitutive components of cells and instead are induced by a range of cellular 
stresses including heat shock, starvation and other translation inhibiting factors (J. R. 
Buchan et al., 2011). Although initially proposed to be formed from existing p-bodies, fur-
ther work has highlighted key distinctions between the composition and function of these 
two mRNPs. For simplicities sake this section focuses only on p-bodies, but their relation-
ship with stress granules should be kept in mind given their various similarities which are 
highlighted throughout. 
Figure 7: Simplified representation of a processing body, a liquid droplet made up of mRNA 
and mRNA binding proteins. The processing body is a phase separated liquid droplet that 
assembles due to multiple intermolecular interactions, Van der Waals forces and hydrogen 
bonds between mRNA and mRNA binding proteins. These interactions lead to increased 
density separating the body from the cytoplasm. 
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2.3.2 Structure and Composition 
Studies using electron microscopy to investigate the ultrastructure of stress granules and 
p-bodies found that they are often closely associated with one another in HeLa cells. How-
ever, the two mRNPs have distinct, non-overlapping structures, with p-bodies showing a 
fibrillar ultrastructure compared with a fibrillo-granular stress granule ultrastructure 
(Souquere et al., 2009). These results point to distinct functions for SGs and p-bodies that 
are backed up by their differing protein composition. 
There are also differences between the p-bodies observed in mammalian cells and in the 
budding yeast Saccharomyces cerevisiae, in which a large number of studies have been 
conducted. Mammalian p-bodies are constitutive components of most cells but vary in 
number and composition depending on the cell type. In contrast, yeast p-bodies have 
been observed to form only under certain conditions, similar to SGs, such as starvation or 
caloric restriction (Decker & Parker, 2012). Mammalian p-bodies disassemble during mitosis 
in a similar fashion to some other organelles and reform in G1, whereas in yeast, p-bodies 
can be present throughout mitosis if the inducing conditions remain in place (Garmendia-
Torres et al., 2014; Yang, 2004). The composition of yeast p-bodies has been extensively 
documented since their initial discovery. With further immunofluorescence experiments 
and fluorescent protein fusions, a wide range of proteins have been observed to localise 
to p-bodies, some constitutively while others only during certain stresses.  
In yeast, the components of p-bodies fall in to 3 general groups. A core group of proteins 
are conserved in p-bodies across organisms in which the decapping and deadenylation 
factors are heavily enriched, with the decapping complex proteins Dcp1 and Dcp2 forming 
core constituents and the enhancer of decapping Edc3 having a role in their formation and 
regulation(Franks & Lykke-Andersen, 2008). CCR4 and other components of the CCR4-
NOT deadenylation complex have also be shown to localise to p-bodies in both yeast and 
other organisms (Doma & Parker, 2007). Secondly a number of mRNA-binding, transla-
tion-repressing proteins have been observed to localise to p-bodies such as the repressor 
of translation initiation SCD6. Interestingly, while SCD6 binds to eIF4G to repress translation 
initiation, and eIF4G appears to localise to both p-bodies and SGs in yeast (Brengues & 
Parker, 2007; Frydryskova et al., 2016), no other translation initiation factors are found in 
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yeast p-bodies. Finally, yeast p-bodies contain a currently unknown group of mRNAs, alt-
hough some mRNAs have been individually identified to localise to p-bodies (Aizer et al., 
2014). mRNA is a requisite component of p-bodies, and when translation is blocked exper-
imentally using cycloheximide) leading to a reduction in mRNA abundance, p-bodies dis-
assemble, presumably into smaller mRNP complexes. More recently, a study of human p-
bodies, in which a sorting method similar to fluorescence associated cell sorting (FACS) 
was used to purify p-bodies, the mRNA content of p-bodies in human cells was obtained 
through mRNA sequencing (Hubstenberger et al., 2017). This study showed that almost 1/3 
of coding mRNA transcripts could be found within the constitutive p-bodies of the human 
cell line, mainly made up of highly abundant but poorly translated sequences. As well as 
this it was also found that another 1/3 of coding mRNAs, and the majority of non-coding 
mRNAs were significantly excluded from p-bodies indicating that mRNA entry into p-bod-
ies was a specific rather than a global phenomenon. This study also discovered a number 
of new protein components of human p-bodies via mass-spectrometry based analysis of 
the purified bodies. Many of these fell into the traditional categories of mRNA repression 
and decay, but some new components were identified including a number of myosin pro-
teins of which one example was shown to localise to p-bodies in vivo. A full list of the yeast 
PB components as derived from the Saccharomyces Genome Database can be found in  
in the Appendix. 
How mRNAs are targeted to PBs has not been fully elucidated but recent work in yeast 
shows that it may be linked to transcription. Linking the transcriptional promotor of an 
mRNA, known to localise to PBs during glucose restriction, to a reporter mRNA results in 
its targeting to p-bodies during that stress. Elements of the promoter known as Heat-shock 
elements (HSEs) were important in limiting localisation and chimeric promotors containing 
HSEs were able to replicate the observed effects. mRNAs may therefore be co-transcrip-
tionally loaded with proteins that direct their localisation to p-bodies upon glucose stress. 
The timing of transcription was also shown to influence localisation, as translation was up-
regulated, and focus formation downregulated when transcription was started during 
stress, rather than before (Zid & O’Shea, 2014). 
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2.3.3 Assembly and regulation 
Although PB regulation appears to vary between organisms, with yeast p-bodies being 
stress-induced and metazoan p-bodies always present, the proteins involved in the regu-
lation of size and abundance appear to be conserved across species. Assembly of p-bodies 
depends on the concentrations of their constituent proteins (Franks & Lykke-Andersen, 
2008; Y. Luo et al., 2018), with low complexity region of Edc3 and Lsm4 being particularly 
important in yeast p-bodies (Decker et al., 2007; Reijns et al., 2008). These regions of low 
complexity have been shown to be involved in both protein-protein interaction and RNA 
binding and are thought to contribute to a process of liquid-liquid phase separation (LLPS), 
in which non-membranous aggregates of proteins become phase separated into a dense 
inner core and aqueous outer layer(Schutz et al., 2017). A complex of Dcp1/Dcp2, mRNA 
and Edc3 has been shown to undergo LLPS in vitro. 
The idea of p-body proteins undergoing LLPS is consistent with previous observations of 
p-bodies in various organisms. Firstly, the conservation of proteins with low complexity 
regions capable of forming a high number of protein or RNA interactions indicates a re-
quirement for this type of protein for the formation of these granules. The appearance of 
p-bodies, as spherical, non-membranous, structures is also consistent with a granule that 
is held together by the surface tension of multiple intermolecular interactions (Kroschwald 
et al., 2015). P-bodies have been shown to undergo fusion events with other p-bodies, and 
similar docking events with the related mRNPs stress granules (J. R. Buchan et al., 2008). 
Further support is provided by the observations that many p-body protein interactions 
appear to show redundancy and can be compensated by overexpression of other factors, 
indicating a non-specific regulation of assembly (Rao & Parker, 2017). Together with the in 
vitro evidence, this provides a strong argument that p-bodies assemble sporadically due 
to LLPS, and that regulation is likely to occur by increasing or decreasing the intermolecular 
interactions necessary for this process. 
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Multiple p body associated proteins have also been shown to be susceptible to aberrant 
protein aggregation when the normal mRNA surveillance mechanisms are disrupted. In a 
study of the composition of wild type protein aggregates and those formed in mutants of 
the mRNA surveillance pathways, multiple p-body components were identified (Jamar et 
al., 2018). Two major p-body components, Dhh1 and Xrn1, were found to commonly form 
protein aggregates in wild type cells, and Dhh1, a regulator of p-body assembly and dis-
assembly (J. R. Buchan et al., 2008; Mugler et al., 2016) also aggregated in NMD, NSD and 
NGD mutants. The p-body components Pat1, Ccr4 and Dcp2 were also shown to form 
protein aggregates in cells deficient in NSD, NMD and MD respectively. This propensity to 
form aggregates can be seen as both advantageous, in the formation of phase separated 
p-bodies, and potentially dangerous, as uncontrolled aggregation can lead to cellular 
damage. 
Yeast p-bodies differ from mammalian p-bodies in their regulation during the cell cycle. 
While mammalian p-bodies appear to be dissolved during mitosis (Yang, 2004), yeast p-
bodies are maintained, and trafficked into the emerging bud in a unidirectional manner 
that appears to confer a selective advantage on the daughter cells, at least under condi-
tions of caloric restriction (Garmendia-Torres et al., 2014). Outside of mitosis regulation of 
p-bodies appears similar across species, with increases in their numbers under conditions 
that generally inhibit translation such as oxidative stress and starvation. In yeast, Dcp2 is 
Figure 8: Conditions inducing processing body formation. Conditions of cellular stress cause 
inhibition of protein kinase A signalling, which may link them to processing body assembly. 
Pat1, a processing body scaffolding protein is phosphorylated by PKA and a subsequent 
reduction in phosphorylation of Pat1 allows processing body assembly. 
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phosphorylated in response to stress which causes its localisation to p-bodies while also 
stabilising a set of mRNAs encoding ribosomal proteins (Yoon et al., 2010). Mammalian 
DCP1a is also phosphorylated in response to stress, affecting its p-body localisation, as is 
human DCP1a during cellular differentiation (Chiang et al., 2013; Rzeczkowski et al., 2011). 
2.3.4 Function 
The function of p-bodies has been much debated in the decades since their discovery. 
While the initial evidence pointed towards a clear role as hubs of mRNA degradation, fur-
ther investigation has cast doubt on that role, and a more general function in mRNA stor-
age and regulation of translation has taken shape. 
The initially observed composition of P-bodies was the main driver of the theory that p-
bodies were sites of cytoplasmic mRNA degradation. This was backed up by the observa-
tion that the inhibition of 5’ – 3’ mRNA decay by removal of the Xrn1 exonuclease caused 
a build-up of p-bodies that were also larger than wild type p-bodies and were thought to 
contain mRNAs stalled in degradation (U Sheth & Parker, 2003) and in human cells were 
shown to be enriched in polyA mRNA (Cougot et al., 2004). It was also found that mRNA 
decay intermediates localised to p-bodies in Xrn1-deficient yeast strains (U Sheth & Parker, 
2003) supporting the theory of degradation occurring in p-bodies. The inhibition of trans-
lation, through the stabilisation of mRNA complexes using cycloheximide, caused a marked 
decrease in p-bodies. This supported their role in mRNA decay, as a reduction in available 
mRNA, due to mRNA becoming trapped on in polysomes rather than available for binding, 
would likely reduce the size of p-bodies reliant on mRNA for their formation. The lack of 
translation initiation factor in p-bodies also points to a role outside general storage of 
mRNAs, unlike SGs where translation factors are found during stress conditions and mRNAs 
are thought to be stored ready to re-enter translation (Brengues et al., 2005). 
Further studies presented a contrasting role for p-bodies, focused on the storage rather 
than degradation of mRNA. mRNA localised to p-bodies was shown to be able to re-enter 
translation after amino-acid starvation-induced p-body accumulation was removed, while 
mRNA’s entering p-bodies were not immediately degraded (Aizer et al., 2014). The mRNA-
Seq study mentioned earlier (Hubstenberger et al., 2017) also found a lack of mRNA decay 
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intermediates in p-bodies, while a study using a new imaging technique to image mRNA 
decay as it occurs showed a lack of mRNA degradation events in p-bodies (Horvathova et 
al., 2017). It has also been shown that the inhibition of PB formation by removal of core 
formation regulator DDX6 (human, Ddh1 in yeast) has little effect on RNA stability for p-
body localised transcripts (Hubstenberger et al., 2017), and that nonsense-mediated mRNA 
decay does not require p-bodies to occur (Stalder & Mühlemann, 2009). An alternative 
approach to mRNA degradation analysis identified both stabilisation and degradation of 
mRNAs that were localised to p-bodies on glucose starvation in yeast (Wang et al., 2018). 
The structure of p-bodies could also be an influencing factor in their function. Recent stud-
ies into LLPS showed that enzyme activity of the core PB component Dcp2 is reduced in 
an in vitro model of LLPS, as is the activity of RNAse A. This could imply that the dense 
liquid droplet core of the PB reduces the activity of decay factors enough for them to 
function as storage sites and protect their mRNA components from decay, either for stor-
age or possible for mRNA transport. 
Overall the true function of p-bodies still remains unclear. There is a large body of evidence 
supporting the fact that they are site of mRNA decay, but more recently work has begun 
to question this, and a role in mRNA storage has also emerged. Given that the initial work 
on PB function, as well as some of the later work supporting its role in decay, was per-
formed in yeast whereas the bulk of the evidence for storage comes from metazoan stud-
ies, it could be that p-bodies have taken on divergent roles, with yeast p-bodies only func-
tioning as storage sites during cellular stress and functioning as sites of decay under normal 
conditions. This is supported by the findings that highly expressed mRNA accumulate in 
yeast p-bodies during various stresses (Lavut & Raveh, 2012) and that p-bodies are re-
quired for long-term survival of stationary phase yeast cells (Ramachandran et al., 2011), 
while also not contradicting the earlier studies of p-bodies that indicate their role in mRNA 
decay. Further work is clearly required to elucidate the full function of p-bodies. 
2.3.5 Transport within the cell 
To date, no functions have been reported that relate p-bodies to the transport of mRNA 
or proteins. However, multiple lines of evidence point towards this as a possibility. In both 
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mammals and unicellular organisms, association of p-bodies with the cytoskeleton has 
been reported.  
In mammalian cells, p-bodies have been shown to move along microtubules in a direc-
tional manner and change microtubule tracks implying association with motor proteins. It 
was suggested that this association with microtubules could be facilitated by binding to 
organelles such as mitochondria, which are known to move on microtubules; although the 
adaptor proteins or cellular motors involved were not identified (Aizer & Shav-Tal, 2008). 
Microscopic observation of fluorescently tagged p-bodies showed both spatially confined 
movement and linear translocation across small regions of the cell. Various p-body com-
ponents have also been shown to co-localise and bind to the class V myosin motor Myosin 
Va in mammalian cells, and siRNA knockdown of Myosin Va inhibits p-body assembly. 
Overexpression of Myosin Va tails also limits the movement of p-bodies in vivo (Lindsay & 
McCaffrey, 2011). Recently, Nesprin-1 has been identified as a link between p-bodies and 
microtubules and expression of the Nesprin-1 microtubule binding region disrupts p-body 
transport on microtubules (Rajgor et al., 2014). 
In plants, p-body motion appears to be actin, rather than microtubule based. P-bodies 
were observed to translocate along actin filaments, with movement inhibited by the over-
expression of myosin XI tails. Myosin XI was shown to bind to the p-body component 
atDCP1, and the Dcp1 myosin interaction was conserved across species, with Yeast Myo2 
binding yeast Dcp1, and Mouse MyoVa binding both yeast and human Dcp1 homologues 
(Alexandra Steffens et al., 2014).  
Less work has been undertaken in budding yeast, although all current evidence supports 
an actin-based mechanism of movement. Myo2 was found in a sucrose gradient fraction 
containing multiple p-body components as well as multiple mRNAs (Chang et al., 2008). 
Myo2 showed partial co-localisation with p-bodies in live cell imaging and a temperature 
sensitive Myo2 protein appeared to inhibit p-body disassembly. A study of a related mRNP 
containing RNase mitochondrial RNA processing factor (MRP) and Xrn1 showed a prefer-
ential localisation in the daughters of budding yeast cells (Gill et al., 2006) which was de-
pendent on the mRNA transport machinery or “locasome” of She2/She3/Myo4. Further 
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work using live cell observation of the p-body marker Edc3 in a microfluidic device showed 
that p-bodies are directionally trafficked into emerging buds, lingering at the bud site be-
fore budding begins. This deliberate inheritance was again dependent on the locasome 
machinery and a drop in velocity of p-bodies during budding was also inhibited by this 
loss of the locasome. The inheritance of the p-body was also shown to confer a selective 
advantage on the daughter cell, whereby cells inheriting a p-bodies reached a larger size 
before budding, although this study was carried out in conditions of dietary restriction. 
2.4 Replicative ageing in budding yeast 
Ageing is the continuing change and development of an organism over time, and on a 
cellular level takes the form of an eventual breakdown in key maintenance systems leading 
to the eventual death of the cell, and the organism.  In budding yeast, ageing is described 
in terms of replicative or chronological ageing. Replicative ageing refers to the breakdown 
in cellular function as a mother cell spawns an increasing number of daughter cells, 
whereas daughters are “reset” in terms of age and capable of producing daughter cells of 
their own. Chronological ageing is the process in which yeast cells deteriorate when not 
dividing, under conditions such as starvation. Replicative ageing in yeast represents an 
attractive model for eukaryotic ageing research, as the mother and daughter cell relation-
ship is easily defined, simplifying the tracking of inherited molecules and damaged pro-
teins. The genetic tractability of budding yeast and its ease of growth, short cell cy-
cle/lifespan and well-developed toolkit of laboratory techniques mean that it has featured 
heavily in ageing research over the past 30 years. 
2.4.1 Conserved mechanisms of extended lifespan 
Using budding yeast as a model for research into eukaryotic ageing processes would make 
little sense unless these mechanisms were conserved in general amongst eukaryotes. Re-
search to date has identified a number of genetic and environmental factors that impact 
RLS in yeast, with these effects being conserved in higher eukaryotes, (Wasko & Kaeberlein, 
2014). A recent high-throughput study of replicative lifespan (RLS) extension in S. cerevisiae 
identified a large number of deletion mutants capable of extending lifespan, and confirmed 
a previous observation that lifespan-influencing genes in the nematode worm 
Introduction 
 
40 
 
 
Caenorhabditis elegans were 5 times more likely to influence lifespan in yeast, implying a 
high degree of conservation in ageing pathways (McCormick et al., 2015; E. D. Smith et al., 
2008). These longer-lived mutants are not necessarily fitter than the wild type strains, in 
fact in most cases they appear to have reduced fitness in a competitive environment, due 
to the gene deletion having an impact on systems vital for normal cell growth (Kyryakov 
et al., 2016). Whether or not interventions against these identified targets in humans could 
yield lifespan extensions remains to be seen, but the conservation of pathways across spe-
cies and the biologically uncompetitive environment that we now inhabit suggest potential 
interventions may be possible (C. He et al., 2018). The factors affecting replicative lifespan 
in budding yeast can roughly be split into physical-environmental and genetic, with signif-
icant crosstalk between the two, in that genetic modifications to the pathways sensing the 
environment may yield similar lifespan extensions in response to changes in the environ-
ment itself. Many of these factors were initially identified in budding yeast and the main 
areas of past and existing research are discussed here. 
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Figure 9: Cell cycle progression (upper) and measures of ageing (lower) in budding yeast.  
The yeast cell cycle follows a defined morphological pattern, as shown above. Replicative 
lifespan is the ageing process due to repeated cell divisions. Chronological ageing is the 
ageing process due to extended non-replicative survival. 
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2.4.2 Sirtuins and ERCs 
The first group of proteins found to extend lifespan in yeast were the Sirtuins. Sirtuins are 
a group of protein deacetylases that deacetylate their targets in response to signalling 
pathways. For example, the namesake of the group, Sir2, deacetylates histones to silence 
certain genetic loci (Finkel et al., 2009).  Only Sir2 is highly conserved across species, having 
homologues in bacteria, yeast, flies, worms and mammals (Brachmann et al., 1995). Over-
expression of Sir2 robustly extends replicative lifespan in budding yeast, and a null mutant 
significantly reduced RLS, an effect which has been replicated in chronological lifespan 
studies from worms and flies (Kaeberlein et al., 1999; Brian K Kennedy et al., 1997; Rogina 
& Helfand, 2004; Tissenbaum & Guarente, 2001). This lifespan-extending effect is thought 
to be due to the activity of Sir2 in promoting genomic stability via chromatin silencing, 
preventing extensive recombination of DNA and limiting global transcription levels (Dang 
et al., 2009). As yeast mother cells age, reduced levels of Sir2 caused increased histone 
acetylation, opening up chromatin and causing increased levels of recombination and a 
global rise in transcription rate that may lead to an aberrant proteome (Dang et al., 2009).  
A further function of Sir2 is to limit recombination at the yeast rDNA locus which encodes 
rRNA. This locus is highly repetitive and therefore subject to increased levels of recombi-
nation compared to the rest of the yeast genome (Kaeberlein et al., 1999; Lindstrom et al., 
2011). Recombination in this locus can cause the excision of so called extrachromosomal 
rDNA circles (ERCs), circular regions of DNA that can accumulate in the nucleus of mother 
cells (Ganley & Kobayashi, 2014). The impact of ERCs on replicative ageing is highly de-
bated (C. He et al., 2018), but a large body of evidence shows a strong correlation between 
the accumulation of ERCs and the shortening of RLS. Live cell imaging of fluorescently 
tagged ERC DNA (using a DNA binding protein fused to a fluorescent protein) showed 
that ERCs are preferentially retained in mother cells during the asymmetric cell division in 
budding yeast (Denoth-Lippuner et al., 2014) in a process dependent on the SAGA com-
plex that facilitated anchoring to nuclear pore complexes (NPCs) (Denoth-Lippuner et al., 
2014). Only ERCs that are bound to NPCs appear to be retained in the mother cell, in an 
NPC Cap structure, while unbound ERC can be inherited with limited efficiency. Another 
study suggested that the true reason for this asymmetric segregation was not necessarily 
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an active mechanism, but a passive one, in which ERCs bound or unbound to NPCs are 
prevented from moving into the daughter nucleus due to the geometry of the bud neck 
and limited timespan of mitosis (Gehlen et al., 2011). This passive mechanism might also 
explain how cytoplasmic structures are partitioned asymmetrically, in cases were their ac-
tive transport to the daughter cell has not been selected for throughout evolution in a kind 
of “default” segregation to the mother cell. The observation that other centromere-lacking 
DNA constructs such as plasmids are also retained in the mother cell seems to support this 
idea, as they may lack the sequence or epigenetic features required for NPC binding. Fur-
ther support comes from a study demonstrating that a relaxing of the diffusion barrier, 
caused by mild heat shock, can allow a more symmetrical partitioning of ERCs, extends 
lifespan of mother cells (Baldi et al., 2017) and is reliant on changes in the activity of protein 
kinase A (PKA) and target of rapamycin (TOR) signalling pathways, which have also been 
shown to influence lifespan (see below). 
The number of ERCs can be influenced by lifespan-extending genetic changes as well as 
environmental factors. For example, deletion of the Fob1 gene, involved in DNA replication 
of rDNA regions, extends replicative lifespan and appears to reduce recombination in the 
rDNA locus, thereby reducing ERCs (Defossez et al., 1999). rDNA instability can also be 
decreased through dietary restriction (DR) in yeast, or by inhibiting the downstream sig-
nalling target or DR, TOR (Ha & Huh, 2011; Riesen & Morgan, 2009). Taken together it is 
clear that at least in yeast, ERCs play some role in the progression of replicative ageing.  
2.4.3 Asymmetric inheritance of protein aggregates 
ERCs are not the only features that are asymmetrically inherited in yeast. Protein aggre-
gates made up of misfolded proteins, co-ordinated by chaperones such as Hsp104 also 
appear to be selectively retained within mother cells. This observation is of particular im-
portance to research on human neurodegenerative diseases, as many of these diseases 
are characterised by aberrant protein aggregation and subsequent cell death during age-
ing (Di Gregorio & Duennwald, 2018). In yeast, damaged and misfolded proteins are de-
posited in aggregates such as the IPOD, Insoluble Protein Deposit and JUNQ, JUxta Nu-
clear Quality control compartment (Spokoini et al., 2012). These aggregates sequester po-
tentially toxic proteins and allow for their bulk retention in aging mother cells(Nyström & 
Introduction 
 
44 
 
 
Liu, 2014). Cells lacking Hsp104 fail to form these compartments, leading to a breakdown 
in inheritance of aggregated proteins, with smaller aggregates passing through the bud 
neck to the daughter cell (Spokoini et al., 2012). Sir2 has also been implicated in the asym-
metric partitioning of aggregated proteins highlighting a potential role in ageing for these 
aggregates (Sampaio-Marques et al., 2012). 
Whether aggregates are actively or passively retained in mother cells remains to be proven. 
Modelling of aggregate motility suggested that similarly to ERCs, the geometry of the bud-
ding yeast cell prevents the inheritance of aggregates due to their slow diffusion rate. Bud 
neck diameter and mitosis time were found to be key factors in the model of aggregate 
inheritance (Zhou et al., 2011) although this modelling was based on an average of the 
diffusion coefficients of observed aggregates. For larger aggregates such as JUNQ and 
IPOD that are attached to organelles, evidence of active transport supporting retention in 
mother cells has been reported. Large scale genetic screens identified the actin cable nu-
cleating polarisome machinery as an essential component for protein aggregate retention 
(Liu et al., 2010; Tessarz et al., 2009) and Sir2 may be affecting the function of actin when 
regulating retention. Protein aggregates have also been shown to localise with actin in live 
cell imaging experiments (Liu et al., 2011). Multiple studies have also shown that aggregates 
may associate with various organelles and could be co-trafficked to ensure their retention 
(Kaganovich et al., 2008; S. B. Miller et al., 2015; Specht et al., 2011; Zhou et al., 2014). 
Functional protein aggregates, that are related to inclusions in neurodegenerative diseases 
(such as stress granules and p-bodies) have not been thoroughly investigated during rep-
licative ageing. P-bodies, unlike damaged protein aggregates, have been shown to be 
inherited by daughter cells, rather than retained in the mother (Garmendia-Torres et al., 
2014). The mechanism of this inheritance has not been confirmed but appears to rely on 
the mRNA transport machinery, as deletion mutants for components of this machinery 
showed a reduction in p-body inheritance. Another possibility is that the conditions in 
which p-bodies are induced, dietary restriction or mild heat shock, have some impact on 
the diffusion barrier at the bud neck, enabling transport of these aggregates. 
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2.4.4 Dietary restriction and downstream signalling pathways 
Dietary restriction (DR), in which the caloric intake of an organism is restricted to below 
usual levels, acts through a number of signalling pathways. DR has been shown to increase 
replicative lifespan in yeast and lifespan in a number of multicellular organisms (B. K. 
Kennedy et al., 2007; Omodei & Fontana, 2011). The downstream effects of DR are thought 
to prolong lifespan in different ways, including a reduction in protein synthesis and asso-
ciated misfolding of proteins (Kaeberlein, 2013), a general increase in autophagy of dam-
aged cellular components (Johnson et al., 2013) and changes in mitochondrial respiration 
(Hempenstall et al., 2012). DR appears to work by influencing nutrient sensing signalling 
pathways within the cell, to decrease activities associated with cell growth and increase 
activities associated with the response to stress. 
An increase in mitochondrial aerobic respiration compared to anaerobic respiration ap-
pears to be conserved across species, although there is contradictory evidence in yeast, in 
that a lack of mitochondrial DNA does not remove the impact of DR on replicative life span 
(Hempenstall et al., 2012; Kaeberlein et al., 2005). An increase in aerobic respiration appears 
to contradict the long held theory that reactive oxygen species (ROS) from aerobic respi-
ration are one of the main drivers of cellular ageing, causing damage to many components 
of the cell (Harman, 2006). It may be that a breakdown of the asymmetrical inheritance of 
damage could extend mother lifespan while reducing overall fitness, although how this 
would work in multicellular organisms remains unclear. Another possibility is that the as-
sociated upregulation of autophagy compensates for the increase in ROS, as autophagy 
normally diminishes with age (Cuervo, 2008). Surprisingly, an increase in autophagy alone 
does not increase RLS in yeast (Wasko & Kaeberlein, 2014). 
Dietary restriction influences nutrient sensing signalling pathways that are responsible for 
the downstream effects that increase RLS. TOR signalling is responsible for a wide range 
of regulatory functions in eukaryotic cells and is conserved from yeast to humans. Genetic 
strategies to inhibit TOR signalling in yeast, worms, flies and mice have all been shown to 
increase lifespan (Kapahi et al., 2004; Lamming et al., 2012; Vellai et al., 2003) and the use 
of the immunosuppressant drug rapamycin has a similar effect (Bjedov et al., 2010; Harrison 
et al., 2009; Medvedik et al., 2007; Robida-Stubbs et al., 2012). In Yeast, the TOR 
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homolog,TORC1 regulates global mRNA translation rates as well as autophagy and the 
response to stress and an ortholog of the yeast substrate of TORC1, the serine threonine 
protein kinase, Sch9 has similar activity in multicellular organisms (Jorgensen et al., 2002; 
Stanfel et al., 2009; Urban et al., 2007). Inhibition of TOR signalling can also increase mito-
chondrial biogenesis leading to increased respiration (Wasko & Kaeberlein, 2014). 
Dietary restriction also inhibits signalling via Protein Kinase A, a cyclic AMP dependent 
kinase complex (Lin et al., 2000; Toda et al., 1987). PKA signalling is similar to TOR, in that 
it negatively regulates the stress response, including stress responsive transcription factors. 
Reducing PKA signalling genetically mimics the effect of dietary restriction in yeast (Lin et 
al., 2000), and has a corresponding effect on replicative lifespan which cannot be enhanced 
by dietary restriction in the same strain. Interestingly, both PKA and TOR signalling have 
been found to be important in the regulation and assembly of mRNP granules including 
p-bodies and stress granules during the response to stress in yeast (Ramachandran et al., 
2011; Sfakianos et al., 2018; Vindry et al., 2017). 
The underlying pathways of ageing appear to be conserved from single-celled eukaryotes 
such as budding yeast to multicellular eukaryotes. Factors such as genome instability, nu-
trient signalling, mitochondrial dysfunction and proteostasis all appear to play roles in con-
tributing to the ageing process. Interestingly the mechanisms by which ageing can be in-
terrupted, including TOR and PKA signalling also promote the activity of stress responsive 
elements such as p-bodies within the cell. Although the interventions that increase RLS in 
yeast (and general lifespan in higher eukaryotes) do not necessarily equate to improve-
ments in selective fitness, they may not be of great importance in the treatment and/or 
prevention of neurodegenerative diseases that appear later in life. Understanding the re-
lationship between the ageing process and the stress response, including the function of 
p bodies, will help us develop a systems level view of eukaryotic ageing, the beginnings of 
which are outlined in figure 10. 
2.5 Objectives 
It is clear from the existing literature that there exists some form of relationship between 
the progression of ageing in eukaryotic cells and the response to stress in the cellular 
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environment. Signalling pathways, in which interventions can lengthen lifespan in model 
organisms, control the transcriptional and post-transcriptional response to stress, including 
the formation and regulation of cytoplasmic mRNP granules. The full functionality of these 
mRNP granules remains elusive. They may play a role in mRNA decay and/or storage, and 
more recently they have been implicated in the transport of mRNA in dividing cells. Few 
data have been gathered on the changes that may occur to p-bodies during the ageing 
process. 
Saccharomyces cerevisiae represents an attractive model organism for the study of ageing 
and age-related effects on organelles/cellular compartments such as p-bodies. The easy 
of creating genetic modifications such as introducing fluorescent protein fusions makes 
live cell imaging possible and many other genetic tools have been developed to aid re-
search in this organism. Recently, age related research in yeast has been greatly facilitated 
by the introduction and use of microfluidic devices capable of selectively retaining yeast 
mother cells while removing the daughters. This allows cells to be monitored for the dura-
tion of their replicative lifespan. 
This study aimed to take advantage of the recent advances in fluorescence microscopy 
and microfluidics as powerful tools for use in the investigation of the impact of age on the 
Figure 10: Regulatory interactions affecting cellular ageing in budding yeast. Interventions 
are shown with the signalling pathways they are thought to effect. Signalling pathways 
target specific cellular processes that have been shown to affect the lifespan of budding 
yeast cells. 
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localisation and function of p-bodies in the budding yeast Saccharomyces cerevisiae. Mod-
ern fluorescent proteins, with improved brightness and reduced photobleaching were used 
to allow longer-term imaging of p-bodies alongside other organelles. Automated time-
lapse microscopy was used to capture images at defined intervals and track individual p-
bodies as they moved within and between cells. Additionally, a series of microfluidic dis-
section platforms were evaluated for their use in the study of p-bodies during replicative 
ageing of budding yeast. The-best suited platform was then utilised to study changes in 
localisation and dynamics of p-bodies in yeast cells of advanced replicative age. Finally, 
the inheritance of p-bodies was investigated further with focus on the role of the decap-
ping protein Dcp1. 
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3 Materials and Methods 
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3.1 Molecular Cloning 
Multiple plasmids were constructed for this work using a number of molecular cloning 
methods, making it unfeasible to describe the construction of each in detail. Instead a 
detailed summary of each technique is presented as well as the necessary oligonucleotide 
primers and plasmid descriptions (Appendix). 
3.1.1 DNA Manipulation 
 Restriction Cloning 
For plasmids constructed using traditional restriction cloning, DNA fragments were gener-
ated in one of 2 ways. Either the fragment was directly excised from an existing plasmid 
using restriction enzymes, or the fragment was amplified from a template using PCR with 
oligonucleotide primers containing restriction sites, which were then digested. 
For directly excised fragments, 1 μg of the source plasmid was incubated with the required 
restriction enzymes (New England Biolabs, ThermoFisher Scientific) and suitable buffer so-
lution at a temperature and time according to the manufacturer’s recommendations in a 
total volume of 40 μl. After incubation the reaction mixture was mixed with a 6X DNA 
Loading Dye (New England Biolabs) at a ratio of 5:1. Agarose gels were prepared using 1% 
w/v agarose (Sigma) dissolved in 1X TAE Buffer (see appendix for composition) containing 
0.5μg/ml ethidium bromide. DNA fragments were loading in their entirety into the wells of 
the agarose gels and electrophoretic separation was performed at 100V constant voltage 
for 45 minutes in a horizontal electrophoresis gel tank (Bio-Rad) alongside a marker of 
standard dsDNA lengths. After separation, DNA fragments of the correct size were excised 
from the gel using gel excision pipette tips under UV light illumination and the DNA was 
purified using a spin column-based DNA recovery kit (Zymo Research). Finally, the eluted 
DNA concentration was measured using an automated UV-Vis Spectrophotometer 
(Nanodrop 2000 - Thermo Scientific). 
For fragments generated via PCR, oligonucleotide primers were designed, by standard 
design principles, that complemented the ends of the desired region of amplification, and 
also included a suitable restriction site at each end. Where the plasmid was to yield an 
open reading frame, restriction sites were placed so that the final sequence would be in 
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frame with the existing ORF. PCR amplification was performed using a high fidelity proof 
reading polymerase (Q5 - New England Biolabs) with buffer and nucleotide concentrations 
as well as thermal profiles according to the manufacturers recommendations in an auto-
mated thermocycler (T100 - Bio-Rad) at a total volume of 50 μl. After amplification PCR 
products were purified using a spin column based DNA purification kit (Zymo Research) 
and DNA concentration was measured via a spectrophotometer as with restriction digest 
fragments. 
Destination plasmids were digested, isolated and purified in the same manner as restriction 
fragments, but were further treated with alkaline phosphatase before isolation to remove 
phosphate groups from the DNA ends to prevent re-annealing of the plasmid. 1 μl alkaline 
phosphatase (Calf intestinal – New England Biolabs) was added to the digestion reaction 
mixture and incubated at 37°C for 30 minutes after which the isolation and purification 
steps proceeded as previously.  
After generation, DNA fragments were annealed by incubating with T4 DNA ligase and a 
corresponding buffer system (New England Biolabs) for 20 minutes at room temperature, 
after which they were placed on ice. Fragments were ligated in a molar ratio of 3 parts 
insert to 1-part destination plasmid forming a total of 100ng of DNA. 5 μl of the ligation 
mixture was used directly as the DNA for bacterial transformation (see Bacteria Transfor-
mation). 
 Gibson assembly 
For plasmids constructed via Gibson assembly, there were again 2 methods of fragment 
generation. Gibson assembly requires overlapping ends between fragments; the required 
overlap can be introduced on both, or a single fragment depending on the convenience 
of adding overlaps via PCR. When joining multiple fragments from different sources, oli-
gonucleotide primers for the PCR fragments can be designed that include the necessary 
overlaps, making it possible to include restriction only fragments in the assembly as well. 
For an overview of the assembly process see Figure 11.  
Fragments generated for plasmids in this project fall into 3 categories; PCR fragments for 
ligating to other PCR fragments (Type 1), PCR fragments for ligating to restriction fragments 
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(Type 2) and restriction fragments (Type 3).  
Figure 11: An overview of the Gibson assembly cloning process used to create plasmids in 
this study. Gibson assembly allowed the ligation of multiple fragments in a single reaction 
to simplify and speed up the cloning process. 3 fragment types were generated as outline 
in the upper panel. These fragments underwent 5’ digestion, followed by overlapping com-
plimentary ends, and polymerase extension and ligation to create complete plasmids. 
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For Type 1 fragments, 40 nucleotide primers were designed according to standard design 
principles and included 20 bp tails, complementary to the primer sequence of the adjacent 
PCR fragment in the assembly so that the primers for adjacent fragments are reverse com-
plements of each other. Fragments were amplified from template DNA using a high-fidelity 
proofreading polymerase (Expand High-Fidelity PCR System – Roche) with buffer and nu-
cleotide concentrations as well as thermal profiles according to the manufacturers recom-
mendations in an automated thermocycler (T100 - Bio-Rad) at a total volume of 50 μl. After 
amplification PCR products were purified using a spin column-based DNA purification kit 
(Zymo Research) and DNA concentration was measured using an automated UV-Vis Spec-
trophotometer (Nanodrop 2000 - Thermo Scientific).  
For Type 2 fragments, 60 nucleotide primers were designed according to standard design 
principles and included 40 bp tails, complementary to the DNA sequence of the adjacent 
DNA fragment in the assembly. PCR was performed as with type 1 fragments. 
For Type 3 fragments, restriction digest and gel extraction were performed identically to 
the process for restriction cloning. 
After fragment generation, assembly was performed using 2X Gibson assembly master mix 
(New England Biolabs). Fragments were mixed with ddH2O in a ratio according to the 
manufacturer’s recommendations to a total volume of 10 μl. The fragment mixture was 
then mixed with 10 μl of 2X Gibson assembly master mix and incubated at 50°C for 60 
minutes before placing on ice prior to bacterial transformation. 
 Bacterial Transformation 
Bacterial transformation with plasmid DNA was performed using chemically competent 
Escherichia coli. Top10 Competent cells were created using the following protocol:  
Seed stocks were first prepared as follows: Top10 cells were streaked for single colonies on 
SOB Agar media (see appendix for composition) plates and incubated overnight at room 
temperature. Single colonies were picked using a sterile pipette tip and inoculated into 2 
ml SOB liquid media (see appendix for composition) and incubated overnight at room 
temperature. After incubation, 60% glycerol was added to 15% and 1ml aliquots were dis-
pensed into cryo-tubes and placed at -80˚C for storage. 
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To prepare competent cells, 250ml SOB was inoculated with a single 1 ml seed stock and 
incubated at room temperature until the culture reached OD600 0.3, approximately 14 
hours (usually overnight). Cells were centrifuged at 3000 rpm in pre-chilled centrifuge 
tubes at 4˚C for 10 minutes. Supernatant was discarded, and cells were resuspended in a 
total volume of 80 ml CCMB80 buffer (see appendix for composition) before incubating 
on ice for 20 minutes. Cells were again centrifuged as previously and resuspended in a 
total volume of 10 ml CCMB80 buffer. Chilled CCMB80 buffer was added until an OD of 1 
– 1.5 was achieved when 50 μl cells were mixed with 200 μl SOB media. Competent cells 
were aliquoted in 50 μl volumes in Eppendorf tubes and stored at -80˚C. Competence was 
tested using 1 μl of standard pUC19 plasmid (Invitrogen). 
To transform chemically competent cells with plasmid DNA, 1 50 μl aliquot of cells per 
transformation was thawed on ice. 1 - 5 μl of ligation/Gibson mixture, derived from a mix-
ture of the previously described fragment types, was added to the cells before incubation 
on ice for 30 minutes. Cells were then heat shocked for 45 – 60 seconds at 42˚C in a dry 
heat block (Eppendorf) before returning to ice for 2 minutes. 250 μl SOB liquid media was 
added per tube and then incubated at 37˚C for 2 hours in a shaking incubator at 200 rpm. 
Cells were plated on appropriate antibiotic containing media (see appendix for details) at 
1 μl, 10 μl and 289 μl volumes on 3 separate plates and incubated overnight at 37˚C. 
 Clone Screening 
Bacterial clones were screened in multiple ways to ensure the correct plasmid sequence 
was present. Where suitable primers were available, cloned were screened using colony 
PCR. To further confirm that plasmids were correct, or where colony PCR was not suitable, 
plasmids were purified using a commercial miniprep kit and digested with restriction en-
zymes and compared to expected digestion profiles. Finally, purified plasmids were sent 
for DNA sequencing with suitable primers to a commercial DNA sequencing service (GATC, 
Cologne, Germany). 
To perform colony PCR, a 20 μl PCR master mix was prepared with 2X DreamTaq Green 
PCR Master Mix (Thermo Fisher Scientific) according to the manufacturers recommenda-
tions but replacing template DNA with ddH2O. Primers were selected to amplify a region 
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of the plasmid so that it would be distinguishable from the original insert and vector plas-
mids. Single colonies were picked using a sterile pipette tip and dipped into the PCR master 
mix, after which the tip was deposited into 2ml LB media (see appendix for composition) 
+ appropriate antibiotic. PCR was performed using thermal profiles according to the man-
ufacturer’s recommendations in an automated thermocycler (T100 - Bio-Rad), while the 
inoculated media was incubated overnight at 37˚C. 10 μl of the PCR products were loaded 
directly onto a 1% agarose gel and observed under UV illumination as described previously. 
Gels were imaged using a gel documentation system (Gel Doc XR+, Bio-Rad) and docu-
mented via image acquisition. Colonies showing the expected PCR profile were selected 
for further confirmation, by purification of the plasmid from the overnight culture. 
Before further confirmation, either restriction digest or sequencing, plasmid DNA was pu-
rified using a commercial plasmid purification (miniprep) kit (Thermo Fisher Scientific). 
Briefly, the 2 ml culture was harvested by centrifugation in a 2ml Eppendorf tube at 13,000 
g for 1 minute. Supernatant was discarded, and cells were resuspended in 250 μl resus-
pension buffer. 250 μl lysis buffer was added and mixed by inversion 4 – 6 times. 350 μl 
neutralization buffer was added to the tube and mixed by inversion 4 – 6 times. The tube 
was then centrifuged at 13,000 g for 5 minutes before adding the supernatant to the spin 
column. The spin column was centrifuged for 1 minute discarding the flow through before 
addition of 500 ml wash buffer, followed by a further centrifugation of 1 minute, discarding 
the flow through and centrifuging for a further 2 minutes to clear residual wash buffer. 50 
μl ddH2O was added to the spin column and it was placed in a fresh 1.5 ml Eppendorf 
before centrifugation for 1 minute at 13,000 g. DNA concentration was measured using an 
automated UV-Vis Spectrophotometer (Nanodrop 2000 - Thermo Scientific).  
Purified plasmids were confirmed as correct by restriction digest. Digests were performed 
as with restriction cloning, and fragments were analysed via agarose gel electrophoresis 
and images captured as previously. Restriction profiles were compared to those expected 
from the desired and source plasmids to confirm the correct insertion or modification had 
been made. 
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Speculatively correct plasmids were finally confirmed via DNA sequencing. DNA sequenc-
ing primers were designed that would ensure coverage of the entire modified region and 
prepared for sequencing along with the plasmid according to the requirements from the 
DNA sequencing service (GATC Lightrun). Sequence files were analysed with a DNA se-
quence manipulation software (Snapgene) to compare to the desired sequence. Plasmid 
with the correct sequence were retransformed into bacterial hosts and stocked as both 
DNA and bacterial stocks. 
 Plasmid Stocking 
Confirmed plasmids were stocked in both DNA and bacterial format. For DNA stocks, 10 μl 
of the purified plasmid was directly stored at -80˚C. For bacterial stocks; the retransformed 
bacterial culture was mixed with 60% glycerol to a final percentage of 15% in 2ml cryo 
tubes before storage at -80˚C. 
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3.1.2 Yeast Strain construction 
 Yeast integration 
Modifications to the genome of various Saccharomyces cerevisiae background strains were 
made using standard yeast integration methods. DNA fragments for insertion were syn-
thesized by PCR from source DNA in the form of plasmids. Oligonucleotide primers were 
designed using standard design principles for binding to the source DNA and including a 
40 bp region complementary to the desired insertion site within the yeast genome. PCR 
was performed using a high-fidelity proofreading polymerase (Expand High-Fidelity PCR 
System – Roche) with buffer and nucleotide concentrations as well as thermal profiles ac-
cording to the manufacturers recommendations in an automated thermocycler (T100 - 
Figure 12: The main plasmids used in this study,  
Top Row – A & B, plasmids for integrating fluorescent proteins to create fusion with en-
dogenous yeast proteins. C - Lifeact plasmid created from mRuby2 fluorescent protein and 
yeast actin binding protein sequence used to visualise actin in live yeast cells. D – DCP2-
mRuby 2 expressing plasmid used for the visualisation of p-bodies when combined with 
yeastGFP collection strains. 
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Bio-Rad) at a total volume of 50 μl. 5 μl of the PCR product was run on an agarose gel as 
previously to confirm amplification of the target sequence. Multiple PCR reactions were 
performed to produce the quantity of DNA required for yeast integration. DNA was puri-
fied by ethanol precipitation; 2.5 volumes of 100% ethanol were added to the completed 
PCR reaction along with 0.1 volumes of Sodium Acetate. This mixture was incubated at -
20˚C for 20 minutes and then centrifuged at 13,000 g for 10 minutes. The supernatant was 
discarded, and the DNA pellet was washed once with 1ml 70% ethanol before drying in a 
laminar flow hood and resuspension in 10 μl ddH2O.  
Integration into the yeast genome was performed using a protocol adapted from Gietz & 
Woods, 2002. Briefly, a 5 ml culture of yeast growth media, either YPAD or SC lacking 
specific nutrients (see appendix for compositions), was inoculated with the yeast strain to 
be transformed from either glycerol stock or agar plate. The culture was incubated over-
night at 30˚C in a shaking incubator at 200 rpm. The following day, 50 ml pre-warmed 2X 
YPAD or SC media was inoculated with the culture to give an OD600 of 0.2 as measured 
by a spectrophotometer. The culture was incubated at 30˚C for 3-4 hours until the OD600 
reached 0.6. Cells were then harvested by centrifugation at 4000 rpm in a bench top cen-
trifuge (5810R, Eppendorf) using 50 ml centrifuge tubes. Cells were washed once in 25 ml 
ddH2O and then resuspended in 1 ml ddH2O and transferred to 2 ml Eppendorf tubes. 
Cells were centrifuged again at 13,000 g for 30 seconds and washed in 1.5 ml freshly pre-
pared 1X TE/Lithium Acetate buffer (see appendix for details) before resuspension in a final 
volume of 200 μl 1X TE/Lithium Acetate buffer. For a single transformation, 2 μg of DNA 
for integration was mixed with 10 μl salmon sperm DNA (Invitrogen). Salmon sperm DNA 
was pre-boiled at 95˚C for 10 minutes and placed on ice for at least 10 minutes before 
transformation. 50 μl cells in buffer were added to the mixture, followed by 240 μl of 
PEG/TE/Lithium Acetate buffer (see appendix for details) and the mixture was topped up 
to 360 μl with ddH2O. The transformation mix was first incubated for 30 minutes at 30˚C 
followed by 45 minutes at 42˚C after which 1 ml YPD was added to the mixture and it was 
transferred to a loose top 12 ml growth tube. The transformation mix was incubated over-
night at 30˚C then transferred back to a 2ml Eppendorf tube before centrifugation at 13,000 
g for 1 minute. The cell pellet was then washed once in 1 ml ddH2O, resuspended in 1 ml 
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ddH2O and then plated onto the appropriate selection media + agar (see appendix for 
compositions) at volumes of 10 μl, 100 μl and 890 μl and incubated for 3 days at 30˚C. 
Colonies appearing on plates after this time were screened for positive integrations as 
described below. 
 Yeast plasmid transformation 
Plasmid transformation of Saccharomyces cerevisiae strains was performed following the 
same protocol as DNA integration, with slight modification. Plasmid DNA was used instead 
of PCR products, in a total quantity of 100 – 500 ng. The step in yeast integration of re-
freshing the yeast culture to OD600 0.2 was omitted, and cultures were processed directly 
from overnight growth. Plasmid transformations of yeast strains were assumed to be suc-
cessful if the colonies grew on selective media after streaking for single colonies from the 
original selection plate. 
 CRISPR Yeast integration 
For certain experiments it was desirable to integrate a DNA sequence into the yeast ge-
nome without a selection marker in order to maintain the 3’ UTR of the modified ORF. To 
achieve this marker-less integration, CRISPR based genome editing was employed as de-
scribed in Dicarlo et al., 2013. Cas9 and gRNA plasmids were constructed as described in 
Figure 13: Plasmids used in the CRISPR-Cas9 Genome modification process.  
Left – the Cas9 protein was carried on a yeast centromeric plasmid for constant expres-
sion in yeast cells. Right – A yeast 2-micron plasmid was used to express 2 different gRNA 
constructs, cutting at 2 separate locations within the yeast genome.  Target strains were 
transformed with both plasmids to allow Cas9 targeting of the gRNA sequence. Strains 
were co-transformed with homologous DNA to replace the excised fragment. 
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the Molecular Cloning section of this document. The gRNA plasmid was modified to in-
clude 2 gRNA target sequences, one at the start of the desired insertion site and one at 
the end, in order to induce 2 double stranded DNA breaks. Donor DNA was synthesized 
via PCR as described previously for yeast integration, but any marker region was omitted 
from the target sequence. The Cas9 expression plasmid was first transformed into the tar-
get strain and confirmed, followed by a dual transformation with the gRNA plasmid and 
donor DNA. Selective media was used to select for both the Cas9 and gRNA plasmid after 
which colonies were screened for the integration product as described below. Confirmed 
colonies were then grown for several generations in liquid rich media (YPD – see appendix 
for composition) in order to remove the Cas9 and gRNA plasmids. The plasmids involved 
in this process are shown in Figure 13. 
3.1.3 GFP Library replication 
Multiple strains that were to be used in this study were derived from the Yeast GFP library 
described in Huh, W.K. et al. (2003), purchased from Invitrogen. To safely retrieve these 
strains from the library without risk of contamination, the library collection was replicated 
using a liquid handling robot (Freedom EVO 200, Tecan). This robot was equipped with a 
96 well plate carousel; plate handling arm and 96 well pipetting head. A script was created 
(see appendix) in the robot’s accompanying software to replicate plate with the following 
protocol: 96 well plates containing the yeast strains were retrieved from the carousel and 
shaken for 1 minute, followed by 3 empty 96 well plates using, the plate handling arm. The 
empty plates were filled with 150 μl sterile SC – His media per well (see appendix or com-
position) using the 96 well pipetting head, after which 5 μl of culture from the yeast plate 
was added to the corresponding well in the 3 new plates, using fresh pipette tips for each 
new source plate. Plates were returned to the carousel, after which the source plate was 
returned to -80˚C for storage. The 3 replicate plates were incubated, without shaking at 
30˚C for 2 days, after which 60% glycerol was added to each well to a final percentage of 
15% using an electronic pipette in a bio-containment hood. These replica plates were then 
stored at -80˚C and used as the source for the desired clones. Before use in experiments, 
clones were confirmed via PCR as described below. 
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 High throughput plasmid transformation 
Where strains from the GFP collection were augmented with plasmids, a modified yeast 
plasmid transformation protocol was used to increase throughput. For each well in a 96 
well plate, the plasmid transformation protocol was reduced in scale, with a starting culture 
of 150 μl. After centrifugation in a plate centrifuge (5810R, Eppendorf) and 2 washes in 150 
μl ddH2O, cells were resuspended in a transformation mixture of 25 μl TE/Lithium Acetate 
Buffer, 100 ng plasmid DNA, 5 μl pre-boiled salmon sperm DNA (prepared as described 
previously), and 120 μl PEG/TE/Lithium Acetate buffer, topped up to a total of 180 μl with 
ddH2O. The 96 well plate was incubated at 42˚C for 45 minutes after which the plate was 
centrifuged, and the cell pellets were resuspended ddH2O. Cells from individual wells were 
spotted onto selective media using a multichannel pipette and incubated for 3 days at 
30˚C after which the spots were restreaked onto segments of selective agar media plates 
and assumed to be correctly transformed if growth was observed after 2 days incubation 
at 30˚C. 
3.1.4 PCR Clone screening 
To verify correct integration of genomic construct, or transformation of plasmid into the S. 
cerevisiae strains, PCR was used to amplify regions present only in the desired modified 
strains. Before PCR amplification, genomic and plasmid DNA was purified from the poten-
tial clones using the following protocol; from a selective plate following transformation, a 
single colony was picked using a sterile pipette tip and resuspended in 100ul of yeast Lysis 
Buffer (see appendix for composition) in an Eppendorf tube. The tube was placed in a dry 
heat block at 70˚C for 15 minutes before the addition of 300 μl 100% ethanol and centrif-
ugation at 15 000 g for 12 minutes. The supernatant was discarded, and the pellet resus-
pended in 50 μl of ddH2O before centrifuging at 13,000 g for 1 minute after which the 
supernatant was used as the template for PCR. PCR was performed as with colony PCR for 
bacterial strain confirmation, briefly; primers were selected to amplify a region present in 
the genomic construct or plasmid so that it would be distinguishable from the original 
strain. An 18 μl PCR master mix was prepared with 2X DreamTaq Green PCR Master Mix 
(Thermo Fisher Scientific) according to the manufacturer’s recommendations, including 
relevant primers. 2 μl of purified yeast DNA was added so the final PCR volume was 20 μl. 
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PCR was performed using thermal profiles according to the manufacturer’s recommenda-
tions in an automated thermocycler (T100 - Bio-Rad) after which 10 μl of the reaction mix-
ture (that included a DNA loading dye in the master mix) was loaded directly onto an 
agarose gel and analysed as described previously. Strains showing the expected DNA 
product were restreaked onto fresh selective media plates and carried forward for further 
confirmation. Example gel images are shown in Figure 14. 
3.1.5 DNA Sequencing 
For some genome modifications it was necessary to confirm the exact sequence of the 
integrated product. Genomic DNA extraction was performed as described previously, after 
which PCR was used to amplify the region for sequencing. PCR was performed using a 
proofreading DNA polymerase and appropriate buffer system (Q5 – New England Biolabs) 
with buffer and nucleotide concentrations as well as thermal profiles according to the man-
ufacturers recommendations in an automated thermocycler (T100 - Bio-Rad) at a total 
volume of 50 μl. After amplification PCR products were purified using a spin column based 
DNA purification kit (Zymo Research) and DNA concentration was measured via a 
Figure 14: Example of DNA 
agarose gel. Gel results were 
first simulated in a software 
(Snapgene, GSL Biotech, USA) 
to calculate the expected band 
pattern. After running samples 
on agarose gels, they were 
compared with the simulation 
to find correct integrations or 
plasmid constructs. Correct re-
sults were carried forward for 
further experimentation. 
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spectrophotometer as with restriction digest fragments. The purified PCR product was sent 
for DNA sequencing to a commercial DNA sequencing service (GATC Lightrun) in a mixture 
according to the service’s specification. Primers were designed to be 10-20 bp downstream 
of the PCR amplification primers. Multiple PCR and sequencing runs were performed where 
the region to be sequenced exceeded the maximum run length for the DNA sequencing 
service (roughly 1.2 kb). After confirmation by sequencing, strains were either stocked as 
described below or further analysed by fluorescence microscopy. 
3.1.6 Fluorescence screening 
As a final confirmation measure for strains that were designed to express a fluorescent 
protein, either as a fusion or individual protein, a fluorescence microscope was used to 
ensure that cells were indeed expressing the desired protein, and that the localisation of 
proteins was not altered by the fusion of the fluorescent tag. To prepare cells for micros-
copy, a single colony of cells was picked with a sterile pipette tip and inoculated into 10ml 
low fluorescence media (see appendix for composition) then grown overnight at 30˚C in a 
shaking incubator at 200 rpm. In the morning cells were diluted to an OD600 of 0.2 and 
grown in the same manner as previously until the OD600 reached 0.6. 1 ml of cells were 
then centrifuged at 13,000 g for 1 minute and resuspended in 100 μl low fluorescence me-
dia. 3 μl of the concentrated yeast suspension was placed on a standard glass microscope 
slide and covered with a 22 x 22 mm #1.5 glass coverslip, which sealed to the slide through 
capillary action. The prepared slide was analysed using an inverted fluorescence micro-
scope (Axio Vert.A1 – Zeiss) equipped with a 60X NA 1.4 oil objective lens. Fluorescence 
illumination was achieved with a metal halide light source (HXP 120 – Zeiss) and filtered 
through appropriate excitation and emission filter sets for the fluorophore in question. 
Images were captured using a monochrome CCD camera (Axiocam ICm – Zeiss) using the 
Zeiss Zen software. Clones were selected for further experimentation if the fluorescent 
protein was visible as expected, and the localisation of the fusion protein corresponded to 
the established literature. Example images are shown in Figure 15. 
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For fluorescent tags of proteins involved in p-body or stress granule formation, where 
stress conditions such as glucose deprivation were expected to cause a change in locali-
sation, further confirmation was performed to ensure the fluorescent tag had no effect on 
the ability to enter these mRNP granules. Cells were grown overnight as with standard 
fluorescence screening and refreshed to OD600 0.2 in the morning. After achieving an 
OD600 of 0.6, cells were centrifuged at 13,000 g for 1 minute before 3 washes in low fluo-
rescence media lacking glucose. Cells were resuspended to the original volume in low 
fluorescence media lacking glucose and incubated at 30˚C, shaking at 200 rpm, for 60 
minutes before proceeding with microscopy as previously. 
3.1.7 Yeast strain stocking 
After confirmation yeast strains were stocked for use in further experimentation. 2 ml over-
night cultures were grown at 30˚C, shaking at 200 rpm, in appropriate media. After growth, 
750 ml of each culture was mixed with 250 ml 60% glycerol in a cryo tube and stored at -
80˚C until use. 
3.2 Microfluidic system fabrication 
3.2.1 Microfluidic mask design 
To create digital designs for use in the production of microfluidic moulds, a 3D design 
software (AutoCAD) was used to create accurate scaled drawings. The polyline tool was 
used for drawing the outlines of the desired shapes, and all drawings were confined in a 
design template corresponding to the size of the microfluidic mask. A summary of each of 
the designs used in this study is shown in Figure 16. Completed designs were sent to a 
commercial printing service (Micro Lithography Services Ltd) for production of acetate or 
chromium masks depending on the required feature size. Further details of the designs 
Figure 15: Example micrographs of transformed yeast strains. These images show examples 
of positive integrations of mNeonGreen into organelle markers. 
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used in this study are outlined in the subsequent sections. 
3.2.2 Su-8 Mould fabrication 
Su-8 moulds for this study were obtained from 2 separate sources. Originally, moulds were 
purchased from a commercial mould making service (MicroLiquid – Spain). For some of 
these moulds it was found that the resolution was insufficient for the size of trap structure 
used in the desired microfluidic chips, leading to failure to trap cells of Saccharomyces 
cerevisiae. Therefore, collaboration was sought with a group at the university with the ca-
pability to more accurately produce the moulds. For the chips used in this study Su-8 
moulds were produced by the research group of Marco Polin, University of Warwick, De-
partment of Physics. Production was carried out as performed in Jo et al. (2015). Briefly, 
Su-8 2005 (MicroChem) was spun onto a 4” silicon wafer (Si-Mat Silicon Materials) at the 
recommended rpm, time and acceleration to achieve a 5 μm thick layer, according to the 
manufacturer. Wafers were then soft baked at 65˚C for 1 minute followed by 3 minutes at 
95˚C. UV light exposure was used to pattern the wafer with the desired mask design; the 
wafer was exposed to 150 mJ/cm2 UV light using a mask aligner (SÜSS Microtec AG, Model 
MJB4). Post exposure baking was performed at 65˚C for 1 minute and 95˚C for 2 minutes, 
followed by developing in Su-8 developer for 3 minutes and a final hard bake at 150˚C for 
30 minutes. These wafers were then used as the moulds to produce PDMS microfluidic 
chips.  
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3.2.3 PDMS Chip fabrication 
PDMS chips were fabricated using established procedures. All steps were carried out in a 
laminar flow hood. Sylgard 184 base and catalyst (Dow Corning) were mixed thoroughly in 
a ratio of 10:1 before degassing in a vacuum chamber. The wafer mould was placed in an 
aluminium foil lined 120mm borosilicate glass petri dish and the mixture was poured onto 
the wafer to a depth of 0.5 – 1 mm before degassing again. The petri dish was then covered 
with its corresponding glass lid and placed in a 65˚C oven for 2 hours. Once cured, the 
PDMS slab was diced into individual chips (see figure 16). Inlet/outlet holes were punched 
using blunted and polished 21 Gauge needles to give smooth sided channels for making 
connections. Where inlet/outlet channels were ripped during punching, the channel was 
abandoned due to the possibility of leakage. After punching, excess PDMS debris was 
Figure 16: Designs of microfluidic masks fabricated for this study.  
A, CliC 2 device, B – HYAA device, C, ALCATRAS device, D – Lee et al microfluidic 
dissection device.  See figures 19 -22 for further detail. 
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cleaned off using scotch tape (3M) after which individual PDMS chips were rinsed in 100% 
ethanol before 3 washes in 0.2 μm filtered ddH2O and drying pattern side up on whatman 
paper. Punched and cleaned PDMS chips were then bonded to coverslips. 24 x 60 mm 
#1.5 glass coverslips (Scientific Laboratory Supplies) were washed in isopropanol before 
drying with filtered compressed air. Both the coverslip and PDMS chip were cleaned on 
the bonding side with scotch tape before placing in a plasma cleaner (Expanded table top 
Plasma Cleaner - Harrick Plasma). The plasma cleaner chamber was purged with 100% 
oxygen before evacuation with a vacuum pump to a pressure of 300 mTorr. The plasma 
cleaner was run for 60 seconds on its highest setting, before re-pressurising the chamber. 
The bondable sides of the coverslip and PDMS chip were immediately placed in contact 
and incubated on a hotplate for 20 minutes at 65˚C, completing the fabrication process. 
Bonding was tested after 1 hour by attempting to peel the coverslip from the chip to ensure 
the bond would hold under pressure. 
3.2.4 Epoxy/Polyurethane replica moulding 
To preserve the original Su-8 master moulds in optimal condition, an un-bonded chip was 
used to create a replica mould that was used for all subsequent mouldings. A diced PDMS 
chip was placed pattern side up in a 50 x 70 mm silicon cake mould and held in place by 
the native silicon-silicon bond. A 2-part polyurethane casting resin (Fast Cast – easycompo-
sites) was mixed in the manufacturers recommended ratio and poured into the mould, 
degassing was unnecessary due to the low viscosity of the resin. The resin was cured at 
room temperature until solid, after which the resin block was removed from the mould, 
and the now embedded chip removed from the block. The resin block was then used as a 
mould for the fabrication of further PDMS chips, as described previously, although curing 
of the PDMS was carried out overnight at room temperature and no degassing of the 
PDMS took place after pouring. 
3.2.5 Fluid reservoir fabrication 
Due to the expense of commercial microfluidic reservoirs, custom reservoirs were con-
structed to allow the operation of multiple microfluidic channels simultaneously. Reservoirs 
were created in volumes of 2 ml, 50 ml and 100 ml for use in various experiments. 
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To create 2 ml reservoirs a 5 mm layer of 2-part polyurethane resin (mixed as previously) 
was poured into a 50 x 70 mm silicon cake mould. 8 x 2 ml screw cap tubes (Sarstedt) were 
then placed open end down onto the cured resin block. A further layer of polyurethane 
resin, sufficient only to cover the thread of the 2 ml tubes was poured into the mould and 
allowed to cure. Once cured, the 2 ml tubes were removed by unscrewing from the resin 
block and an appropriately sized O-ring was placed into each formed cavity. Inlet and 
outlet holes were created by heating a 21-gauge needle and inserting it into the top of the 
cavities to form 2 holes spanning the 5 mm polyurethane layer. A 21-gauge leur lock nee-
dle was then place into one of the holes of each cavity and sealed using a small amount 
of polyurethane resin. A 3-inch length of 21-gauge tubing was inserted into the second of 
the holes to a depth corresponding to the bottom of the 2 ml tube and again sealed with 
polyurethane resin. These completed resin blocks were then used as microfluidic reservoir 
manifolds, able to hold 8 fresh, sterile 2 ml tubes and be connected to a pressure source 
via the luer lock needle and pump fluid using the 3” tubing outlet. The manifold was ster-
ilized with 70% ethanol before each new experiment. 
50 ml reservoirs were created in a similar fashion to 2 ml reservoirs. An initial 5 mm layer 
of polyurethane resin was poured and cured in the cake mould. 2 x 50 ml polypropylene 
centrifuge tubes (Centristar - Corning) were placed, open end down onto the resin layer. 
A further layer of polyurethane resin, sufficient only to cover the thread of the 50 ml tubes 
was poured into the mould and allowed to cure. The tubes were then removed from the 
resin block and the block was removed from the cake mould and inverted before replacing 
it into the mould. 2 x 1/4”- 28 male threaded Teflon connectors (Elveflow) were placed 
thread down over the locations of each cavity at even spacing. A third layer of polyure-
thane resin was then poured to cover the threads of these connectors. The time between 
pouring/curing of these 3 layers was minimised to maximise the bonding between layers. 
Once cured the connecters were removed by unscrewing them from the resin block. In the 
cavities formed by these connectors, a 1.6 mm hole was drilled in the original layer. To 
allow the passage of microfluidic tubing into the 50 ml tubes. The completed reservoirs 
were removed from the cake mould and into one of the threaded cavities, a 1/4”- 28 male 
threaded 3/32” OD hose barb was inserted, sealed with PTFE tape. For experiments, 
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pressure was provided via flexible silicon tubing connected to the hose barb, while micro-
fluidic tubing was connected via the second cavity using a 1/4”- 28 male threaded Teflon 
connector and associated ferule (Elveflow). Fresh 50 ml sterile tubes were used for each 
experiment, while the reservoirs were sterilized with 70% ethanol. 
100 ml reservoirs were created using GL45 threaded bottle caps. Bottle caps with 20 mm 
apertures designed for septa (Duran Group) were placed top down in a silicon cake mould 
(described previously). 2-part polyurethane resin was poured into the cap at a depth of 5 
mm and allowed to set until rigid enough to move. The cap was then inverted and a 25 
mm diameter x 20mm plastic tube was placed over the setting polyurethane. 2 x 1/4”- 28 
male threaded Teflon connectors (Elveflow) were placed thread down evenly spaced inside 
the tube and 2-part polyurethane resin was poured to cover the threads. Once both resin 
parts were fully set, a 1.6 mm hole was drilled through the initial layer to allow for tubing 
to be inserted. For experiments, pressure was provided via flexible silicon tubing connected 
to the hose barb, while microfluidic tubing was connected via the second cavity using a 
1/4”- 28 male threaded Teflon connector and associated ferule (Elveflow). Fresh 100 ml 
media bottle (Duran Group) were sterilized by autoclaving with media already inside, and 
then attached to the fabricated lids for experiments, while the lids were sterilized with 70% 
ethanol. These reservoirs were also used for larger media bottles with GL45 threads for 
longer experiments. 
3.2.6 Fluidic connection fabrication 
Connectors to bridge the gap between microfluidic tubing and PDMS microfluidic chips 
were fabricated using 21-gauge 316L stainless steel tubing (Coopers Needle Works). Tub-
ing was cut to 2-inch lengths using a diamond edge blade on a rotary tool. Openings at 
each end were polished and cleaned using a sanding disk and burr attached to a rotary 
tool. A 90˚ bend was then introduced 2/3 of the way along the length. These metal con-
nectors were inserted one end into the punched inlet of the PDMS chip, lubricated using 
isopropanol, and one end into 1/32” ID PTFE Tubing (Sigma), inserted into the media res-
ervoirs. Both tubing and connectors were sterilized by autoclaving before experiments. 
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3.3 Microscopy 
3.3.1 CellASIC microfluidic platform set-up 
For experiments using the CellASIC microfluidic platform, CellASIC Y04C plates were used 
to trap cells in a single focal plane. To prepare the cells and plates for imaging, cells were 
grown overnight in 10 ml YEP with 2 % glucose followed by re-inoculation to and OD600 
of 0.2. Cells were then allowed to grow for several hours until reaching an OD600 of 0.6 
or above. CellASIC plates were removed from their packaging on the morning of the ex-
periment and allowed to equilibrate with in a 30˚C incubator until use. The storage buffer 
(present in the packaging) was removed from all wells and they were washed 3 times with 
filter-sterilized ddH2O. Wells were then filled with the relevant media to the maximum al-
lowed volume, 300 μl for wells 1 – 6. Well 7 was left empty for waste collection and well 8, 
the cell loading well, was loaded with 50ul 2 % glucose version of the media to be used in 
the experiment. The CellASIC plate was connected to the controller and wells 1 – 6 were 
infused for 5 minutes at 5 μl/hour to remove residual storage buffer from the microfluidic 
channels. Well 8 was then infused for 5 seconds at 8 μl/hour to remove residual buffer 
from that channel. The plate was disconnected from the controller and the media was 
removed from well 8 and replaced with 50 μl of log phase cell culture. The plate was 
reloaded onto the controller and cells were infused into the imaging area at 8 μl/hour in 5 
second bursts until sufficient cells were visible to begin the experiment. Once cells were 
loaded, the relevant infusion program was started, and imaging was initiated. 
3.3.2 Microfluidic chip platform set-up   
For experiments using the aforementioned microfluidic chips, a customized microfluidic 
platform was used to provide constant media to the cells. The set-up was split into 3 steps, 
priming, cell loading and running. In the priming step, media was flown into the chips to 
remove any debris present and fill the channels with liquid. Cells were then loaded into the 
chip, using different methods depending on the chip in use. Finally, conditions for the 
experiment were set and media was infused at a constant rate for the duration or the 
experiment.  
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Before priming the chips, all necessary connections were made between the chip, the me-
dia source and the waste outlet. To simplify the running process of multichannel chips, a 
single pneumatic pressure source (MFCS-EZ – Fluigent) was split into multiple outputs us-
ing t-shaped push in connectors and used to provide the pressure to drive media flow. 
Each positive pressure output was connected to a media reservoir (as previously described) 
using a 1/4”- 28 threaded 3/32” OD hose barb (Elveflow) via silicon tubing (Sigma). Con-
nection to the chips was made using 1/16” ID / 1/32” OD PTFE Tubing (Sigma) inserted into 
the fabricated holes in the reservoirs and sealed using 1/4”- 28 male threaded Teflon con-
nectors and associated ferules (Elveflow). Air pressure was increased to a level where visible 
movement of the media could be seen in the PTFE tubing, and halted when the media 
reached the open end of the tubing. At this point, the tubing was connected to the stain-
less-steel connector at the main inlet in the microfluidic chip by plugging the connector 
into the internal part of the tubing. Air pressure was then dramatically reduced so as not 
to damage the internal structure of the chip. At the outlets of the chip, further lengths of 
PTFE tubing were connected to the stainless-steel connectors and fed into a 500 ml glass 
Duran bottle acting as a waste reservoir. Between one of these tubing lengths and the 
waste reservoir, a microfluidic flow rate monitor (Fluigent) was connected using the sup-
plied connectors in order to monitor the flow rate through one channel as a proxy for 
Figure 17: Diagram of the microfluidic plat-
form as used in this study. Media flow to the 
microfluidic chips was controllerd with an air 
pressure controller. The chips were placed 
above the objective lens of an inverted 
microscope to alow observation of cells 
during growth. 
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every channel. A pressure limit of 1 bar was then set in the control software to prevent over 
pressurization of the microfluidic chip and flow rate identification, the software process in 
which the flow rate/unit pressure is calculated, was performed. 
The chips were then sealed to a 3D printed support, designed to add rigidity to the co-
verslip, using rubber cement (Fixogum), which was attached to a microscope stage insert 
(ASI) with a single circular opening for access by an inverted microscope objective lens. 
Once the fluidic connections were made and the chips were primed with media, cells were 
loading into the imaging areas of each chip. This process varied between chip designs. For 
the HYAA chips, a second inlet is available for cell loading; this inlet was blocked using a 
stainless-steel pin (Linton Instrumentation) connected to PTFE tubing during priming. Once 
the pin and tubing were removed, media flow followed the path of least resistance through 
this inlet connector in order to remove any bubbles. Cells were vortexed to create a ho-
mogenous cell suspension before loading into a syringe for infusion into the microfluidic 
chips. Cells were loaded using 1 ml syringes (Plastic Sterile - BD) tipped with 20-gauge luer 
stubs (Linton Instrumentation) and connected to a short length of PTFE tubing. Gentle 
pressure was applied until the cell culture reached the end of the tubing, after which the 
tubing was threaded around the inlet connector. Further pressure was applied while ob-
serving the chip under phase contrast microscopy until cells occupied > 80% of traps in 
the targeted channel. Media flow was kept constant at 5 μl/min during this process so as 
not to over pressurize the chip. Once loading was complete the syringe was disconnected 
from the chip and media was allowed to flow through the loading inlet for around 2 
minutes to purge any settled cells that may have casued clogging at a later stage. The 
pin/tubing block was then reinserted to force media flow through the main channel. This 
process was repeated for each channel until the required channels were occupied with 
cells, after which the flow rate was increased to the published optimum of 8 μl/min. 
As the second device used for experiments, the CliC 2, has only an inlet and outlet, the 
loading procedure was somewhat different. After the chip was primed, the main inlet tub-
ing was disconnected from the chip, leaving only the stainless-steel connector pin. A 1 ml 
syringe was loaded in the same manner as for the HYAA chips but connected directly to 
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the main inlet of the CliC 2 chip. Pressure was then applied until several cells were visible 
in each trapping area (no the cavities) after which the syringe was disconnected, and the 
main inlet reconnected. This method was chosen over the recommendation of the devel-
opers of this chip to use the outlet for loading, as it was observed that large quantities of 
cells would accumulate in the inlet tubing when loading form the outlet which often caused 
clogging of the tubing leading to a build-up of pressure but no increase in flow rate. As 
the inlet was used for loading, flow rate was not measured, and the pressure source was 
not active during the loading process. Once cells were loaded, the priming process of 
moving the media to the end of the tubing before connecting was repeated to minimize 
bubble formation, and the flow rate was set to the recommended rate of 8 μl/min. 
Once priming and cell loading were complete, the pressure was maintained at a level to 
provide the appropriate flow rate, which was determined by the control software of the 
pressure controller (Fluigent). The desired imaging protocol was then started on the mi-
croscope platform. 
3.3.3 Microscope Set-up 
3 types of microscopy were used for this study, either widefield fluorescence microscopy 
or spinning disk confocal fluorescence microscopy. The microfluidic chip set-up for each 
microscope did not vary as they were based on the same platform, a Nikon Ti-E. The chip 
was placed within a temperature-controlled incubator (Okolab) set to 30˚C at least 2 hours 
before the experiment in order to acclimatize, after which the priming process was carried 
out and the chip left for a further hour. Once cells were loaded and the proper flow rates 
were established, imaging was started. Control of the microscope hardware and imaging 
protocols was performed using Nikon Elements AR (Nikon) software.  
Spinning disk imaging was carried out using Nikon/Andor imaging system-combining 
equipment from multiple manufacturers. Excitation was achieved using a Laser stack 
providing 50 mW lasers at 488 and 561 nm (Andor) directed through 60 or 100 x NA 1.4 
phase contrast objective lenses (Nikon). Emission filtering was performed using an Auto-
mated filter wheel (Andor) and appropriate optical filters (Semrock). For mRuby2 an RFP 
filter set was used, while for mNeonGreen, a filter set for GRP was used. Light was further 
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directed through a Yokogawa CSU-X1 Spinning Disk Unit to produce confocality. Images 
were then captured using a 1024 x 1024 pixel EMCCD camera (Andor iXon 888). Sample 
position was controlled with an automated XY stage with Piezo Z control (ASI).  A white 
led excitation module (CoolLED) was used to illuminate the sample through a condenser 
to capture phase contrast images of cells, all lenses used were phase contrast compatible. 
Focus was maintained using an infrared LED based automatic focusing (Nikon PFS) system 
that kept the coverglass at the specified from the objective lens. 
For widefield fluorescence microscopy, images were captured as in spinning disk micros-
copy, with the following changes in equipment; Excitation was achieved using a multi-
wavelength LED illumination device (Xcite XLED1), with both 488 and 560 nm LEDs, filtered 
through filter cubes containing both excitation filter, dichroic mirror and emission filter for 
the selected fluorophore. Images were captured on a 2048 x 2048 sCMOS camera (Andor 
Zyla 4.2). 
3.4 Image analysis 
3.4.1 Segmentation of Cells 
In order to analyse the microscopy images produced in this study on a single cell level, it 
was necessary to segment each image into mask that could be used to direct analysis at 
specific regions of the image, i.e. individual cells. To segment individual cells, an image 
processing protocol was developed using the image analysis software ImageJ (NIH), mak-
ing use of the inbuilt macro language to automate the process. A summary of the outputs 
of each section are shown in Figure 18. Entire folders of images were processed by looping 
through each image in the folder and performing the analysis/image processing tasks be-
fore saving to a new location. Images were first opened using the “Bio-formats importer” 
plugin, that allowed importing of many different file types, in this case ND2 files as they 
were produced using the Nikon Elements AR software. Where images were a time-lapse 
series, each time point was opened separately for individual processing.  
Images were split into their individual channels, e.g. green, red, Phase and the fluorescence 
channels were closed as segmentation was based on the phase contrast images. The 
smooth function was used to reduce noise in this image. A binary image of the phase 
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contrast channel was then produced using the inbuilt automatic thresholding tool with the 
method set to “Otsu”. This produced a rough outline of the cells requiring further pro-
cessing, the watershed function was used to split and adjoining cells to create a binary 
image of cell outlines and surrounding areas. The fill tool was then used, with the colour 
set to white, to manually remove the area outside the cells that was included in the thresh-
olding limit. This produced a binary image in which the cell areas were represented as 
black shapes (pixel value 255) and the background/empty regions were white (pixel value 
0). 
To create a list of cell areas, the “Analyze Particles” tool was used, this selects the outline 
of each black shape in the image and adds it to a list of “Regions of Interest”. This list was 
saved for each image and served as the list of cell outlines when performing analysis on 
the fluorescence channels. 
3.4.2 Counting p-bodies 
To count the number of p-bodies within the cell, a second macro was written in imageJ to 
automate the process, again entire directories of images were analysed automatically. This 
time only the channel with the p-body protein was used for analysis. For each segmented 
ROI (cell) in the specified images, the “Find Maxima” tool was used to find points of local 
maximum intensity, which correlated to P-bodies. Several values for noise reduction were 
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trialled until a final value of 200 was selected as it gave a consistently similar output to 
Figure 18: Demonstration of the cell segmentation and p-body analysis routine.  
Cells are first segmented from a bulk image into individual cells. Next an individual ROI, cor-
relating to a cell is further segmented in the fluorescence channel using the find maxima 
algorithm to identify p-bodies (local fluorescence maxima) within the cell. The identified max-
ima are analysed for size and intensity to register differences in morphology under various 
conditions. 
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manual selection. The total number of these maxima was recorded in a list for each cell. 
3.4.3 Measuring p-body size and intensity 
To measure the size and intensity of p-bodies within each cell the p-body counting script 
was adapted to include further processing steps. After using the “Find Maxima” tool, the 
sections were output as a binary image with single pixel dots representing the locations of 
p-bodies. These dots were expanded by 8 pixels and added to the list of ROIs using the 
“Analyze Particles” tool. This list was then used to cycle through the p-bodies and perform 
further analysis. For each p-body the ROI was duplicated from the main image, giving just 
an image of the body. This p-body image was then segmented using the “Otsu” thresh-
olding method to give a binary image of the p-body. This binary image was converted to 
an ROI, once again using the “Analyze Particles” tool and this ROI was overlaid onto the 
image of the p-body. Finally, the ROI measure function was used to measure the area of 
the ROI, and hence the p-body, as well as the fluorescence intensity of the p-body based 
on the total grey value present with in the ROI. 
3.4.4 Manual Curation 
Each step in this automated imaging analysis protocol was manually curated by pausing 
the macro at certain points and checking the images for accurate segmentation. P-body 
selections were also checked for each image to ensure validity of the automated process. 
3.4.5 Replicative age quantification 
Automated counting of replicative ageing proved difficult using ImageJ due to the limited 
programming functions available in the standard macro language. Instead of automated 
counting, a semi-automated process was employed, where images were presented auto-
matically and manually input was required for fully processing. For each time lapse series, 
the series was split into individual time points and saved as separate files. Files were opened 
in sequence and a user prompt was given instructing the user to select the relevant cell by 
clicking on it. After clicking on the cell, an image crop containing the cell and a small border 
was saved in a specified directory. Each cropped image was processed using the above 
outlined processing methods to produce a series of segmented images with p-body 
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location and quantification for each image. The segmented images were used to manually 
quantify the replicative age of the cells by counting the number of buds per cell. 
3.4.6 P-body inheritance 
To quantify p-body inheritance, the same processing steps as with replicative ageing were 
performed, except that the target for the crop was the p-body rather than the mother cell.  
Once segmentation and processing were complete, the segmentation masks and p-body 
spot locations were then overlaid to produce a diagrammatic representation of the p-body 
movement between cells. These overlays were observed when combined as a time-lapse 
movie and the movement between cells was quantified manually. Inheritance was recorded 
as positive when the p-body moved between cells without returning to the mother cell 
before cytokinesis. For each p-body, the number of inheritance events was recorded by 
following the p-body for the duration of the time lapse acquisition. 
3.4.7 Cell cycle phase determination 
To determine the position of p-bodies within the cell at various points within the cell cycle, 
segmentation of cells was performed as previously described. Each segmented image was 
then manually categorized based on the cellular morphology following the guide (Figure 
19). For truly automated analysis of cell cycle stage based on morphology, a nuclear signal 
is needed to determine the transition from S to G2 to M phase, however not all of the 
images in this study contained a nuclear tag, and so more simple features were used to 
Figure 19: Cell cycle phase was determined based on shape characteristics of phase con-
trast cell images. AR represents the aspect ratio of the segmented cell; a higher aspect 
ratio means a later stage cell. Circ represents the circularity of the cell, a greater value 
represents a more circular shape, and hence an earlier cell cycle stage. Cells with fluores-
cent tags of the Myosin ring and nucleus were used to determine the values of AR and 
Circ for each transition point in the cell cycle. 
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estimate cell cycle stage. The 2 features chosen to indicate cell cycle stage were aspect 
ratio, where higher values indicated progression further towards cytokinesis, and circularity, 
where the lower values indicated a progression further into the cell cycle. For each cell/cell-
bud these feature values were calculated to give an estimate of cell cycle stage, this was 
then correlated to p-body position within the cell. Cells with buds were identified manually, 
after which the aspect ratio and circularity were used to distinguish S and G2/M phase cells 
with a cut-off of AR = 1.8 and Circ = 0.62 
3.4.8 Co-localization of p-bodies and organelles 
To determine the p-body’s most common position at various stages of the cell cycle, 2-
colour images were subjected to co-localization analysis. Cells were segmented as de-
scribed previously, then combined into one large image. The ImageJ Coloc2 plugin was 
used to analyses these large images, using the segmented image masks as an ROI for this 
analysis, i.e. the analysis was only performed within the cell boundaries. Coloc2 reports 
several different measures of co-localization. The co-localization analysis was performed 
on only subsets of the images corresponding to the different cell-cycle stages as outlined 
above. 
The metric used to analyse p-body colocalisation with the specified organelles was the 
Mander’s correlation coefficient as outlined below: 
 𝑀1 =  
∑ 𝑅𝑖,𝑐𝑜𝑙𝑜𝑐𝑎𝑙𝑖
∑ 𝑅𝑖𝑖
 
where Ri,colocal = Ri if Gi > 0 and Ri,colocal = 0 if Gi = 0. This represents the fractional overlap 
of red and green signals. In simple terms, it measures the intensity of red pixels, where the 
corresponding green pixel value is not equal to 0. The corresponding measure for green 
signal is: 
𝑀2 =  
∑ 𝐺𝑖,𝑐𝑜𝑙𝑜𝑐𝑎𝑙𝑖
∑ 𝐺𝑖𝑖
 
where Gi,colocal = Gi if Ri > 0 and Gi,colocal = 0 if Ri = 0. 
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As this metric measures only values with a non-zero pixel value for the colocalisation 
marker, the subtraction of background signal is important in order to accurately identify 
pixels with signal as opposed to background. 
Due to the small size and diffuse nature of some of the markers used in this study, the 
ideal method of thresholding (background subtraction to give 0 values), known as the 
Costes method proved ineffective as M values were consistently 0 using this method and 
thresholds gave por segmentation compared to manual observation where clear overlap 
was visible in micrographs. Instead, an automated threshold level was set by implementing 
the Otsu threshold in ImageJ (NIH). This algorithm sets the threshold by maximising the 
inter-class (black vs white) variance and was found to accurately represent the imaged 
compartments when compared to manual observation. Using this method eliminates bias 
in threshold setting that could otherwise influence the Mander’s coefficients. 
As a control, each analysed image was re-analysed, rotating one channel by 90 degrees, 
and re-running the analysis using the same threshold value as in the original analysis. This 
creates a control dataset in which there is only expected to be overlap due to chance. 
These two data sets were then compared by students t test to assess the significance of 
the overlap in the experimental set. 
3.4.9 P-body tracking and velocity measurement 
To follow the movement of p-bodies through the cell-cycle and calculate the changes in 
their velocity over these periods, the ImageJ plugin MTrackJ as utilized. MTrackJ allows the 
user to add tracks to a time-lapse image based on mouse clicks and calculate associated 
values. Fast time-lapse Images were cropped into small sections containing just a few cells, 
with a central cell in G1 phase of the cell cycle, and MTrackJ was used, clicking on a single 
p body and overlaying a track only the image after which the results for velocity were 
calculated using the distance between clicks and frame time interval. Velocities were then 
correlated to the time that they happened during the cell-cycle based on the recorded 
time point in the image and manual classification of the cell-cycle stage at that point. 
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4 Development of a robust protocol for analysis of p-bodies 
in Saccharomyces cerevisiae during replicative ageing 
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4.1 Existing imaging methodologies 
The traditional method of p-body analysis in Saccharomyces cerevisiae involves growth of 
the cells in liquid rich media, containing sufficient glucose or other carbon source (normally 
YEP 2% glucose w/v) to allow optimal growth for at least 2 cell divisions following re-
inoculation from an overnight culture. This would be followed by centrifugation of the 
culture to pellet cells and replacement of the media with a synthetic minimal media for a 
specified time period. The cells would them be placed on glass microscope slides, covered 
with a glass coverslip and imaged using a fluorescence microscope to visualise fluores-
cently tagged proteins (Nissan & Parker, 2008). This method has been used extensively for 
the in vivo visualisation of p-bodies and while it has provided much data on the numbers, 
localisation and protein composition of p-bodies (J. R. Buchan et al., 2008, 2011; Teixeira et 
al., 2005) it limits investigations to a few minutes after mounting cells. Due to these limita-
tions researchers have developed multiple new methods for mounting cells for fluorescent 
microscopy. 
As p-bodies, as well as some other mRNP granules, are often seen as a product of cellular 
stress, there are particular considerations that must be made when designing any new 
experimental technique relating to their analysis. In terms of microscopic analysis, any 
mounting/immobilisation devices for prolonged visualisation must be capable of delivering 
sufficient nutrients to the cells at an even rate over the experiment. This means that any 
new technique needs to be robustly evaluated before use in the study of p-bodies, as any 
change in conditions bought about by the technique could potentially bias results towards 
a certain conclusion. Single plane microfluidic devices such as the P-body 3.0 device 
(Garmendia-Torres et al., 2014) and commercially available CellASIC system have been 
used successfully in the study of p-bodies, as it is possible to finely tune the nutrient levels 
within the device to achieve reproducible results. 
For this study, an experimental technique known as microfluidic dissection was used to 
study the changes in p-body morphology and movement during the replicative ageing 
process of Saccharomyces cerevisiae. Microfluidic dissection involves the immobilisation of 
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single cells of Saccharomyces cerevisiae in microfluidic traps, constructed as described pre-
Figure 20: Microfluidic Dissection Device of Lee et al. Shown top left is the overall design 
of the chip. Inlets are punched at the 2 forks of the Y shape as well as the secondary side 
channel. Outlet is punched at the base of the Y shape.  An array of pads (shown top right) 
is used to trap multiple cells. The size of the pads, shown centre are engineered to account 
for slight movements in cells, units are in micrometres. Cells are trapped beneath these 
pads due to the close proximity (4 µm depending on fabrication) to the coverslip glass.  
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viously, followed by the application of media flow to remove the daughter cells and ob-
serve only the replicatively ageing mother. These trapping devices are then placed above 
the objective of an inverted fluorescence microscope, which is used to visualise the cells 
and any fluorescently labelled proteins within them. Microfluidic dissection devices are nec-
essary due to the exponential nature of yeast cell growth, meaning that without removing 
daughter cells, an imaging field would be completely filled with cells in a matter of hours, 
making replicative age analysis impossible. While multiple designs for these trapping de-
vices have been published (Jo & Qin, 2016), none had previously been applied to the study 
of p-bodies, or any other stress induced mRNP aggregates, so no data was available on 
the suitability of these devices for such a study. It was therefore necessary to evaluate 
multiple design options to find the most suitable device for the analysis of p-bodies over 
the Saccharomyces cerevisiae replicative lifespan. 
4.2 Microfluidic dissection devices available for evaluation 
Four different device designs were obtained from the original publishers in order to eval-
uate their suitability for the study of p-bodies. The design principles of each of these de-
vices can be seen in Figure 20 to Figure 23.  
The microfluidic dissection device of S. Lee et al., 2012, is a multilayer single channel device 
that retains cells below multiple columns attached to the roof of the channel (imagine a 
stalactite). This column ends approximately 4 μm from the glass coverslip, while the chan-
nel roof is significantly higher. Mother cells are loaded below the columns by flowing cells 
into the device above the normal operating pressure, pushing the columns upwards and 
trapping cells when the pressure is released. Media is then flowed through at a reduced 
pressure, cells begin to grow, and daughter cells are removed in the media flow as they 
grow beyond the area of the base of the column. 
The ALCATRAS (Crane et al., 2014) and HYAA (Jo et al., 2015) devices use similar concepts 
in order to trap the mother yeast cells. Either V shape or cup shaped traps are placed in 
an array within a microfluidic channel, and cells are flowed through the channel in a uni-
directional manner. Mother cells become trapped against/within the trapping structures 
due to the pressure of the media flow and daughter cells, budding either above or through 
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the gaps in the trap structure, are washed away. One of the main advantages of these 
devices is that they are single layer of 5 - 6 μm, making the fabrication process significantly 
Figure 21: The High throughput Yeast Ageing Array device can accommodate up to 16 
strains simultaneously via separate loading and media flow channels.  Cells are held in 
place by the force of media flow and buds are removed in this flow by budding either 
through or above the traps. The distance between the 2 trap elements is optimised to 
allow budding of cells while retaining mother cells. 
Development of a robust protocol for analysis of p-bodies in Saccharomyces cerevisiae during replicative ageing 
 
86 
 
 
simpler and less time consuming. The HYAA device also allows multiple strains to be pro-
cessed on the same device, greatly increasing throughput.  
The final device considered was the CliC (Cell loaded into cavity) device (Fehrmann et al., 
2013).  While this device was originally published as a single channel, low throughput de-
vice, the designers of the chip have recently developed a high throughput 10-channel ver-
sion that was used in this study. This device works in a similar way to the single plane 
microfluidic devices mentioned previously, with a few key differences. In the CliC device 
the imaging plane is a 3.3 μm tall, in order to trap the yeast cells when sufficient pressure 
is applied to raise the channel roof during loading. Around this single plane imaging area 
there is a much deeper channel for media flow, which also allows for cells growing beyond 
the imaging area to be washed away and prevent clogging of the device. Finally, inside 
the imaging plane, there are a series of long cavity structures, formed by a layer of PDMS 
(the construction material) that contacts the glass coverslip. As cells grow across the imag-
ing plane, they fill these cavities. When a cell begins to bud in the direction of the cavity 
opening, it pushes all subsequent daughter cells out of the cavity, and they are eventually 
washed away into the deeper media channel. As most wild type yeast strains bud in a 
Figure 22: The ALCATRAS microfluidic device uses the same trapping concept as the 
HYAA chip, although a single channel is used rather than multiple channels, and a 
higher number of inlet channels allows for variation of media conditions during the 
experiment with aster switching times than external control methods. 
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unipolar manner for their replicative lifespan, this allows the mother cell to be trapped 
within the cavity while all daughter cells are removed. The advantage of this chip design is 
Figure 23: The CliC High throughput ageing device uses cavities within a PDMS trapping 
area to trap cells on a single focal plane. Mother cells are then immobilised within the 
cavities as daughter cells bud towards the entrance putting pressure on the mother cells. 
This design has the advantage of multiple independent channels allowing several strains 
to be analysed in one imaging cycle, as well as a reduced possibility of clogging due to the 
variation in chamber height between the trapping and flow areas. 
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that it is not dependent on the media flow to trap the cell, and once within the cavity, the 
mother cell is trapped by the presence of other dividing yeast cells. This allows the media 
flow rate to be adjusted across a much larger range of values for various studies and make 
the CliC device the most similar to those used in the past for p-body analysis. 
For the Lee et al device, the ALCATRAS and the HYAA, CAD design files were obtained 
from the original authors. The CAD files were used to create Su-8 moulds for PDMS casting 
as described previously. For the CliC device, an unbonded PDMS chip was obtained from 
the authors and reverse moulded as described previously. 
4.3 Testing and evaluation of microfluidic dissection devices 
Due to the triple layer structure of the Lee et al design, as well as the difficulty in adhering 
it to the coverslip while ensuring the columns remained unattached after plasma bonding, 
this design was not used in the design comparison. Furthermore, as the ALCATRAS and 
HYAA designs use essentially the same trapping concept, while the HYAA allows signifi-
cantly more strains to be tested at one time, only the HYAA chip was compared. This meant 
the comparison was between the HYAA and CliC chips. Figure 20 to 23 show the various 
attributes of these chips, including the number of strains and method of retention that 
informed the choice to compare these chips. 
The most suitable device for this study was assessed through testing the devices after op-
timisation of a protocol for each device, and comparing data on retention rates, p-body 
number in low and high glucose conditions as well as average body intensity and size. In 
the latter comparisons, involving p body numbers and characteristics, each chip was also 
compared to a the cellASIC, in which cells were grown under optimised protocols for low 
and high glucose conditions. 
Both the HYAA and CliC microfluidic devices were loaded with Saccharomyces cerevisiae 
cells as described in the Methods. The cells used had been previously transformed with a 
genomic integration construct that created a fusion protein of Edc3p, one of the major 
components of p-bodies used as a marker protein, with a yeast-optimised mRuby2 fluo-
rescent protein. Following loading cells were grown under constant media conditions for 
60 hours. The devices and the cells within them were observed by spinning-disk confocal 
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microscopy as described in the Methods, with images captured every 10 minutes in the 
phase contrast channel, and every 2 hours in the fluorescence channels to minimize photo 
bleaching and photo toxicity. Cells grown in the CellASIC device were imaged in the same 
manner. 
4.3.1 CliC retains cells longer than HYAA 
Retention rates in hours were calculated for each device and are shown in Figure 24. For 
the HYAA device, retention rates were based on 100 cells that were trapped within the cup-
shaped traps at the start of the imaging run. For the CliC device, cells were grown overnight 
with phase contrast imaging only, allowing cells to populate the cavities, followed by 60 
hours as previously described. Retention rates for the CliC device were then based on 100 
cells that were budding in the correct orientation after entering a cavity. Retention rates 
for both devices were based on 100 cells over 3 separate experiments. Media flow rates 
for the devices were based on those used in the published materials.  
Figure 24: Cell retention in the Clic2 and HYAA microfluidic dissection devices. 100 cells across 
3 individual experiments were followed for retention in the trapping structures of the two chip 
designs. Exact retention numbers over time are plotted. Clic2 retained a greater number of cells 
after 60 hours of growth. 
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The CliC device showed a better average retention rate over the 60 hour tests than the 
HYAA device, although both devices retention rates were well below the reported values 
of 65% cells retained over their replicative lifespan for CliC (Fehrmann et al., 2013) and 
approx. 90% over 96 hours for HYAA. For the CliC device the retention rate at 60 hours 
was 14% and the average retention rate was 40 hours, for HYAA the retention rate at 60 
hours was only 9% (as shown in figure 24), 1/10th of the reported rate, and the average 
retention rate was only 24 hours. These differences in retention rates could be due to 
optimisation of protocols in the originating laboratories, although multiple cells were ob-
served to leave the trap structures in the same manner in these tests.  
Figure 25 shows how cells were commonly lost in the HYAA device. As the cell buds, the 
bud pushes against the internal sides of the trap, due to the budding orientation, rather 
than budding above or below the trap as intended. This causes the mother cell to be 
pushed upwards out of the trap, with any further buds exacerbating the issue and eventu-
ally leading to loss of the mother cell in the media flow. While tolerances in the fabrication 
process, for example, in the gap between the 2 trap elements, could cause this effect, it 
was observed over multiple chips from 3 wafers in which this gap was varied by 0.5 μm 
from 2 to 3 μm. This points to the overall design being at fault. 
For the CliC device, there were 2 issues preventing maximum retention. Firstly, cells were 
often rotated to bud into the cavity due to the budding action of cells around them, this 
Figure 25: Loss of retention in the HYAA (top row, 20-minute intervals) and CliC 2 (bot-
tom row, 10-minute intervals). In the HYAA device, buds often emerged oriented to-
wards the inside corner of the trap design, causing the mother cell to be pushed out of 
the trap upon bud growth, resulting in loss of tracking. In the CliC device, a change in 
budding polarity could cause the same effect, where a mother cell is pushed from the 
trap. Scale bar 5 µm. 
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then forced the mother cell out of the cavity as it, and its progeny, continued to bud. This 
is not likely to be due to experimental set-up, as the budding direction of cells was not 
determined by media flow due to their location with the cavity. Secondly, on occasion, cells 
did switch bud site across the axis of the cell, causing a trapped cell to begin budding into 
the cavity and be forced out. This loss of retention is visualised in Figure 25. Even with 
these issues the CliC device was still superior to the HYAA in terms of cell retention.  
4.3.2 P-body numbers and morphology 
As well as their ability to retain cells, the 2 device designs were tested for their ability to 
reproduce the conditions that induce p-bodies while allowing continued cell growth. Cells 
were first grown in 2 % glucose to check that the microfluidic devices did not intensify p-
body expression under optimal growth conditions. After confirmation that cells reproduce 
the p-body numbers of established methods in rich media, the media was then switched 
to a low glucose equivalent and the experiments repeated. In the CellASIC device, media 
flow of 8-10 μl per hour using synthetic media and 0.1 % glucose produces bright p-bodies, 
mostly 1 per cell with some smaller bodies sometimes visible. Under these conditions cells 
still divide at a similar rate to rich media conditions and the inheritance events can be 
observed. This would not directly translate to growth in other microfluidic devices, although 
the glucose concentration used in the CellASIC produces p-bodies at practically any flow 
rate. Given that the HYAA chip must be fed at a certain flow rate in order to effectively trap 
cells, the standard published flow rate of 8 μl/min was used for this device. The standard 
flow rate of 8 μl/min was used for the CliC device.  
For each device, cells were grown overnight, allowing them to adapt to the conditions 
within the microfluidic device, and in the case of the CliC 2 device, grow into the cavities, 
where actual replicative ageing would take place. For each device, single time point images 
were then captured in both phase contrast and fluorescence channels. Once again the 
cells used contained the Edc3p-mRuby2 fusion construct. For each chip design, and the 
CellASIC, images were processed as described in the methods section to identify both the 
number of p-bodies per cell, as well as the size and fluorescence intensity (Edc3p protein 
content) of each body (figure 26, middle and last panels). 
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Plots of the p-body number per cell for each device are shown in Figure 266. In rich media 
Figure 26: Analysis of p-body numbers and fluorescence density in the HYAA, CliC 2 and 
CellASIC Devices. Top row – frequency distributions of p-body numbers per cell in rich 
media (left) and low glucose (right conditions). Middle row – Average p-body numbers 
per cell for each device in rich media (left) and low glucose (right), error bars represent 
standard deviation. Bottom row – Average fluorescence density of each p-body analysed 
in all cells present in each device under rich media conditions (left) and low glucose 
conditions (right). Error bars represent standard deviation. (***, p = 0.001, * p = 0.05, 
two tailed t-test), n = number of cells, indicated in second row for the shared dataset 
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conditions, the majority of the cells contain either 1 or 2 p-bodies, upwards of 60 % for the 
CellASIC and CliC2 devices. However, for the HYAA device a stark lack of p-bodies was 
detected with over 80 % of cell containing no p-bodies, and the rest only ever containing 
a maximum of 1 body per cell. This observation is inconsistent with the idea that p-bodies 
are present during log phase growth in smaller and less concentrated foci (Ujwal Sheth & 
Parker, 2003) and points towards a bias in previous preparation protocols for microscopy 
that may induce p-bodies in such rapid fashion that they are perceived to be ubiquitous 
through all growth conditions. In either case the lack of p-bodies in the HYAA chip during 
growth in rich media differentiated it from established methods and introduced the further 
issue of how to induce p-body formation effectively for observation. In contrast, cells within 
the CliC 2 cavities displayed similar, although not identical p body induction to the estab-
lished method of the CellASIC device. 
In glucose restrictive conditions, i.e. 0.1 % glucose media, the results were similar to those 
of rich media conditions. Cells growing in both the CellASIC and CliC 2 device generally 
contained a single, or double p-body with less than 10% displaying no p-body formation. 
There was also an increase in the percentage of cells with a single p-body, consistent with 
the idea that glucose restriction, as a form of cellular stress, induces the aggregation of p-
bodies into larger structures with greater protein and mRNA content. In the HYAA device, 
there was again a very limited number of cells displaying p-bodies, with an even higher 
percentage, 89 %, displaying no p-body induction. When p-bodies were present in cells in 
the HYAA device, they were only ever single foci.  
To further test the suitability of the CliC and HYAA chips for the study of p-bodies, p-body 
morphology was assessed in terms of size and fluorescence intensity. Under similar condi-
tions, cells were expected to produce p-bodies of similar size and fluorescence intensity, 
as the available scaffolding proteins should be at similar levels, although some degree of 
stochastic noise should be expected. P-bodies identified previously were segmented and 
measured as outlined in the methods section and each chip was compared for similarity 
to the CellASIC as the established method of observation. Rather than using size or fluo-
rescence intensity as a single measure, the fluorescence density of each p-body was cal-
culated as the intensity/area and used to compare the p-body morphology induced in 
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each device. Using fluorescence density rather than size or intensity alone gives a more 
accurate picture of p-body induction, as variations in cell size and cell-cycle stage can 
affect the total protein available for incorporation into p-bodies (Nissan & Parker, 2008). 
Shown in Figure 26 (lower panel) are the average p body densities for each p-body in all 
of the cells analysed over the 3 repeat experiments. In rich media conditions, in the few p-
bodies that were formed, the HYAA device showed significantly lower p-body fluorescence 
density than either the CliC 2 device or the CellASIC when measured by two-tailed t-test. 
Although the density of p-bodies in CliC 2 was significantly higher than in the CellASIC, the 
mean density was considerably closer to the CellASIC than the HYAA chip. Increased den-
sity in the CliC 2 device could be due to limited nutrient exchange within the cavity regions 
as they fall outside the main area of flow, causing the possibility of increase nutrient re-
striction induce aggregation of p-bodies.  
In restricted glucose conditions, p-body density in both the CellASIC and CliC 2 devices 
was markedly increased, however p-bodies in the HYAA device showed reduced fluores-
cence density (figure 26, lower panel). P-body fluorescence density in the HYAA device in 
conditions of rich media and restrictive glucose media showed no significant difference 
(Students t-test, two-tailed, p = 0.36), when combined with the results of p-body counts 
per cell, this indicates that there was no significant induction of p-bodies in the experi-
mental conditions used. Even in conditions of further reduced glucose level (0.05 %), cells 
growing within the HYAA device showed a similar lack of p-body induction. CliC 2 on the 
other hand showed a significant increase in p-body density while numbers decreased when 
grown in glucose restrictive media. These results indicate an induction of p-bodies in the 
CliC 2 device when exposed to conditions of restrictive glucose and the aggregation of 
components proteins into denser but less abundant structures as previously reported 
(Decker & Parker, 2012). 
The flow rates used for each device were the same, but the structure of the channels in the 
devices was significantly different, with the channels for the HYAA device having a much 
smaller cross section, and hence a much faster refreshing rate in which the media is re-
placed. This fast refresh rate combined with the sparse spacing of cells in the HYAA device 
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may have meant that the glucose levels available to the cells was never limiting to the point 
of inducing p-bodies. Given that this flow rate is required to retain the cells in their traps 
in this device, a considerably lower glucose level may be required to induce p-bodies re-
producibly. The larger channels in the CliC 2 device give a slower refresh rate, as they have 
a higher total volume, this would allow cells closer to the main channels to consume more 
of the available glucose, limiting that available to cells further inside the device, in particular 
inside the cavities. The higher cell density within the trapping area would compound this 
effect, as a larger population of cells would consume the available glucose quicker and 
may also release waste products that would contribute to cellular stress and induction of 
p-bodies. Overall the clear induction of p-bodies in the CliC 2 device, along with the ability 
of cells to continue to grow while under induction conditions, and the greater retention of 
ageing cells, made the CliC 2 device the preferred choice for further experimentation. 
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4.4 Improved designs for microfluidic dissection devices to observe p-bod-
ies 
The CliC 2 device was capable of inducing p-bodies in low glucose conditions and retaining 
cells during replicative ageing. However, the level of retention and disparity of the envi-
ronment between the cavities and the rest of the trapping area (in which cells received 
faster media flow and hence increased glucose levels) means the device was still not ideal.  
As an addition to the available repertoire of microfluidic dissection devices, a new device 
was designed, guided by the above results, in order to better study the impact of ageing 
on p-body kinetics and morphology. The principal design features for this device were the 
simplicity of construction and ability to retain cells while still inducing p-body formation 
effectively in established media conditions of 0.1 % glucose. Designs drew on aspects of 
Figure 27: New Microfluidic dissection device designs. Left – full mask outline showing the 7 
chips, containing variations of the designs. Top right – illustration of the channels, contain-
ing multiple trapping structures. Bottom right – The first trap structure design, containing 
2 V shaped trap structures to capture the first virgin cell and allow growth inside a smaller 
region without limiting size.  Bottom left – The second trap structure design used a size 
exclusion trap followed by a cavity/exclusion hybrid to trap the first virgin daughter cell. 
And allow growth without excessive media flow. 
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both the HYAA device, in that they contained only a single layer for fabrication and allowed 
cell budding through size exclusive gaps in the trap structures, and the CliC 2 device, by 
elongating the trapping areas into cavity like structures no allow cells to be retained under 
lower media flow rates. The proposed designs for these microfluidic chips are shown in 
Figure 27.  
An Su-8 microfluidic mould, containing variations of these designs, based on alteration of 
the gaps between trapping elements, was produced as outlined in the methods section. 
Each individual chip contained 9 variations of one of 2 trapping structures. Variations were 
made in the distance between the 2 trap elements, the distance between the upper and 
lower traps, and the density of traps in the channel. These chips were designed to optimise 
these parameters and settle on the most suitable in terms of retention and p-body induc-
tion Unfortunately due to the time limitations of this study it was not possible to test these 
microfluidic chips, and it remains to be seen how effective the new designs are in retaining 
cells and replicating the correct conditions for the study of p-bodies. Further work there-
fore needs to be undertaken in order establish the suitability of these designs, based on 
the testing principles outlined above. 
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5 Processing body localisation during growth and ageing 
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5.1 Analysis of processing body localisation and morphology over the cell 
cycle. 
While multiple studies have explored the composition and function of p-bodies (J. R. 
Buchan et al., 2011), there is still limited information on their role(s) within the cell. Compo-
sitional information such as the presence of translation initiation factors, decapping factors 
and Xnr1 exonuclease indicate a role in the degradation and storage of mRNA (Kedersha 
et al., 2005). The presence of mRNA within these granules, and the demonstration that this 
mRNA can re-enter translation upon relief of cellular stress also points towards their func-
tion as points of mRNP remodelling during these stress events (Brengues et al., 2005).  
In yeast, the majority of these studies have been conducted under conditions of transla-
tional arrest. Conditions such as severe heat shock and total removal of carbon source 
cause the arrest of translation and subsequent induction of p-bodies. Other studies intro-
duced the relief of stress via refreshing of media or re-introduction of nutrients after star-
vation to study the disassembly of p-bodies and the fates of the mRNA and proteins within 
them (Aizer et al., 2008). Although these stress induction studies have revealed many as-
pects of p-body formation and disassembly, they have a potential flaw in that they do not 
accurately represent the conditions that cells would experience in their natural environ-
ment. In the example of Saccharomyces cerevisiae, the conditions in which cells live are 
unlikely to change in such a drastic fashion as simulated in these stress induction experi-
ments. Instead, cells are likely to undergo a transition from high to low nutrient levels as 
they consume the available nutrients, and very rarely would they experience the plentiful 
conditions of a laboratory made rich medium.  
This leaves a gap in the existing knowledge of yeast p-body function, as the majority of 
studies take place either in rich media, or conditions of complete arrest of growth via de-
pletion of nutrients or introduction of other stress factors. The behaviour of p-bodies in 
terms of their formation and function within the cell under conditions that induce their 
formation, but permit cell growth, is yet to be fully understood. One recent study 
(Garmendia-Torres et al., 2014) in S. cerevisiae showed that with a level of 0.1 % glucose in 
synthetic media, p-bodies are robustly induced as single granules, while cells continue to 
grow. Not only were p-bodies induced, but they were also shown to be transferred from 
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mother to daughter cells during the budding process. This inheritance of p-bodies was 
reliant on the established mRNA transport machinery in yeast, outlined in the introduction. 
The fact that p-bodies can be actively transported between mother and daughter cells 
indicates that they are not static entities reliant solely upon exchange of protein and mRNA 
for their function, and that they may have previously unidentified functions that require 
movement around the cell to interact with different cellular compartments. Given that lo-
calisation of mRNA, and the translation of mRNA in certain locations can have a key role 
in certain cellular process (Bertrand et al., 1998), including budding in S. cerevisiae, p-bodies 
may play an important role in regulating this process during conditions of restricted nutri-
tion. 
While studies have been performed in other organisms to show the interaction of p-bodies 
with various organelles (Cougot et al., 2012; Huang et al., 2011), information in yeast is still 
lacking. This means that the advanced techniques for studying age related changes in 
function that are applicable to budding yeast, such as microfluidic dissection, cannot be 
applied until these interactions are verified in S. cerevisiae. It was therefore necessary to 
establish that these interactions exist before moving on to study them at points of ad-
vanced replicative age. 
5.2 Colocalisation of processing bodies and cellular compartments 
To assess the possible interactions of processing bodies and other cellular compartments 
over the cell cycle, fluorescence microscopy was used to analyse the colocalisation of a 
range of these compartments, with a marker protein that is a core components of p-bod-
ies, Edc3p. S. cerevisiae strains were genetically modified to express fluorescent proteins 
fused to markers for the cellular compartments in question, while co-expressing a non-
overlapping fluorescent protein fused to Edc3p.  
Initially, the commonly used fluorescent proteins eGFP and mCherry were used to create 
these protein fusions, but it was found that, in the case of mCherry, fluorescence depletion 
through bleaching was too high to image cells at sufficient time resolution and duration. 
eGFP was stable over a longer period of time, but the level of illumination using blue light 
(eGFP excitation peak is at 488nm) required to view some of the lesser-expressed proteins 
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caused damage to the cells through photo-toxicity. After testing a range of fluorescent 
proteins, it was found that, in the red range, mRuby2 had sufficient longevity of fluores-
cence and brightness to be imaged for the required period. In the green range, mNeon-
Green was selected due to its high level of brightness, requiring lower illumination levels, 
which worked well for the required time-lapse experiments and did not induce noticeable 
photo-toxicity in the cells (Sidae Lee et al., 2013; Shaner et al., 2013). The target compart-
ments and tagged proteins are outlined in Figure 28. 
Each fluorescently tagged strain was grown overnight, using the CellASIC microfluidic plat-
form to restrict growth to a single horizontal imaging plane, and imaged using an inverted 
spinning disk fluorescence microscope as described in the methods section. Cells were 
grown in synthetic complete media containing 0.1% glucose as the carbon source. This 
resulted in induction of p-bodies while cell growth occurred at a reduced rate. Cells were 
imaged in phase contrast as well as green and red fluorescent channels in a single z-plane. 
Images were segmented and analysed as described previously, and colocalisation analysis 
was performed in ImageJ after thresholding to include only areas of fluorescence. For each 
strain, cell images were split, depending on their morphology, into groups representing 
their cell cycle position; G1, S or G2/M. Analysis was performed on each set of images for 
Figure 28: Overview of structures tagged in this study. Each structure was tagged with a 
marker protein fused to mNeonGreen and co-expressed with Edc3-mRuby2 via a genomic 
integration. 
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each cell cycle position as a group. Mander’s M1 and M2 coefficients were calculated to 
evaluate the level of colocalisation of the 2 marker proteins as outlined in the methods.  
Mander’s coefficients measure the fraction of one signal overlapping with the second 
(Dunn et al., 2011). Images were also manually analysed to check for points of colocalisation 
and are represented as merged colour images. Given that p-bodies appear as distinct foci 
within cells at high signal intensity, the relationship between fluorophore intensities is un-
likely to be linear, Mander’s coefficients were therefore used in interpretation of the results. 
All micrographs shown are presented as raw unscaled images, without background sub-
traction to show the full range of fluorescence signal. For automated analysis images were 
thresholded as described in the Methods section. 
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5.2.1 Sac6 / Actin patches 
P-bodies were originally shown to be motile in HeLa cells using fluorescence time-lapse 
microscopy to show their interaction with stress granules (P. Anderson & Kedersha, 2006). 
Further studies revealed that in mammalian cells, p-bodies are directly linked to the micro-
tubule cytoskeleton via static linker proteins including Myosin-Va and nesprin-1 (Lindsay & 
McCaffrey, 2011; Rajgor et al., 2014). P-body motion was identified to follow microtubule 
motion, rather than actively moving along the fibres via motor proteins or attaching to the 
microtubule tip. The motor protein Dynein has also been shown to colocalise with p-bodies 
under certain stress conditions (Loschi et al., 2009). This overall picture in mammalian cells 
therefore points to a model in which p-bodies rely upon microtubule attachment in order 
Figure 29: Time Lapse Micrographs of 
Sac6-mNeonGreen (left), marking actin 
patches, and Edc3-mRuby2, marking pro-
cessing bodies. Processing bodies appear 
to colocalise with actin patches during 
budding particularly at the bud tip. Locali-
sation in G1 and S phase cells appears 
more limited. This time-lapse shows a rep-
resentative set of images from a group of 
analysed experiments used for manual ob-
servations, not automated quantification. 
Scale bar 5 μm. Mander’s coefficients 
shown above show overlap of signals sig-
nificantly above control levels. 
Processing body localisation during growth and ageing 
 
104 
 
 
to move throughout the cytoplasm and interact with their target mRNA. However, p-bod-
ies have also be shown to associate with actin when stationary in mammalian cells, and in 
plants, actin cables appear to be the main mode of intracellular trafficking of p-bodies 
(Aizer et al., 2008; Alexandra Steffens et al., 2014). Not only do p-bodies move along actin 
cables, but yeast Dcp1, a core component of p-bodies, has been shown to directly interact 
with Myo2, a class V myosin motor, in vitro, with the same true for human and mouse 
homologs. The major mechanism underpinning of motility in yeast remains uncertain and 
previous studies indicate that both actin and microtubule cytoskeletons could be used for 
motility. 
To assess the interaction of yeast p-bodies with the actin cytoskeleton, the most prominent 
yeast actin structures, cortical actin patches (Young et al., 2004) were tagged with mNeon-
Green via the actin bundling protein Sac6. Cells were grown as described above and im-
ages were analysed for colocalisation through the cell cycle. Figure 29 shows micrographs 
of cells as they progress through the cell cycle. Manual analysis of micrographs showed 
association of p-bodies with actin patches during the latter stages of mitosis, identified by 
bud size of the analysed cells. While complete co-localisation was not observed there was 
a clear overlap of the fluorescent signals of p-bodies and actin patches that could indicate 
a physical interaction with the actin cytoskeleton during the budding process in yeast. Pre-
vious reports of p-bodies being inherited in budding yeast cells, and this process being 
dependent on myosin motor proteins, would support the idea that they are trafficked via 
the actin cytoskeleton. 
Contrary to the manual observation of micrographs, the Mander’s M2 coefficient shown in 
Figure 29, which represents the fraction of p-body signal overlapping with Sac6 signal, 
remained relatively constant throughout the cell cycle, with a slight increase in cells in G1. 
While manual observation relies upon a lower number of cells due to time taken on anal-
ysis, computerised colocalisation calculations do not suffer from this limitation, it is there-
fore likely that the slight overlap of p-bodies and actin patches observed in micrographs 
of late G2/M phase cells extends to the rest of the cell cycle. Reports in plants have shown 
that p-bodies are trafficked within interphase cells along the actin cytoskeleton (A. Steffens 
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et al., 2014) so this cell-cycle wide association may indicate that the same is true in budding 
yeast.  
5.2.2 Cop1, Anp1, Chc1 / Early, Mid, Late Golgi 
The Golgi apparatus is a major part of the protein distribution and maturation network 
within the cell. Given its major role in protein trafficking and the role of p-bodies in the 
regulation of protein production, a proximity between these 2 organelles could lead to 
more efficient management of protein production. In budding yeast, the Golgi apparatus 
Figure 30: Time Lapse Micrographs of Cop1-
mNeonGreen, early Golgi and Edc3-
mRuby2, marking processing bodies.Pro-
cessing bodies showed proximity rather than 
complete overlap with Cop1 tagged Early 
Golgi structures. There are clear sections of 
overlap between the processing body and 
Early Golgi signals although diffuse Cop1 
signal may have influenced automated 
analysis. This time-lapse shows a repre-
sentative set of images from a group of an-
alysed experiments used for manual obser-
vations, not automated quantification. Scale 
bar 5 μm. Mander’s M2 values were signifi-
cantly above control levels for all cell cycle 
stages as shown above. 
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is separated into early Golgi, Golgi and late Golgi compartments differentiated by their 
function and protein composition/coating of membranes (Suda & Nakano, 2012), which 
roughly correspond to the mammalian pre-Golgi, Golgi and trans-Golgi network TGN). In 
S. cerevisiae, cis-Golgi cisterna are generated at endoplasmic reticulum exit sites (ERESs) 
and mature into later Golgi stages. P-bodies have been shown to associate with ERESs in 
Drosophila (Wilhelm et al., 2005) in a complex associated with a particular subset of 
Figure 31: Time Lapse Micrographs of Anp1-
mNeonGreen, marking Golgi, and Edc3-
mRuby2, marking processing bodies.Pro-
cessing bodies showed a small degree of 
overlap with some Anp1 structures repre-
senting the Golgi. These overlaps appeared 
to diminish during budding p-bodies 
moved into the buds before distinct Golgi 
structures were visible. The diffuse mor-
phology of the Anp1 signal meant that   
bodies appeared to colocalise with some of 
the Golgi. This time-lapse shows a repre-
sentative set of images from a group of an-
alysed experiments used for manual obser-
vations, not automated quantification. 
Scale bar 5 μm. M2 quantification (shown 
above) was significant during both G1 and 
S phases, in line with manual observation 
of micrographs. 
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mRNAs. This association may imply a relationship between mRNA storage or release from 
p-bodies and the localised production of protein at ERESs, and possibly other sites. As well 
as the previously identified localisation the ERESs, p-bodies also contain a component, 
Scd6, that both regulates translation via eIF4G and represses the null mutation of clathrin 
heavy chain Chc1 (Rajyaguru et al., 2012). This dual involvement of a p-body component 
in both mRNA regulation and trafficking further supports a possible role for bodies within 
the protein trafficking network. 
Each stage of the Golgi network in budding yeast, as well as ER to Golgi vesicles, was 
visualised with a fluorescent fusion protein incorporating mNeonGreen and co-expressed 
Figure 32: Time Lapse Micrographs of Chc1-
mNeonGreen, marking late Golgi, and Edc3-
mRuby2. In most cases p-bodies did not ap-
pear to overlap with Chc1 (late Golgi) struc-
tures and show independent cytoplasmic 
foci. During Budding, processing bodies ap-
peared to localise in proximity to Clathrin 
structures at the bud tip, although this colo-
calisation was not always This time-lapse 
shows a representative set of images from a 
group of analysed experiments used for 
manual observations, not automated quan-
tification. Scale bar 5 μm. Quantification of 
overlap using M2 coefficients shown above 
supported the manual observations. 
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with the p-body marker protein Edc3-mRuby2. ER to Golgi vesicles were tagged with Sec13 
a COPII vesicle coat subunit. Early Golgi cisternae were identified by the presence of Cop1, 
a vesicle coating protein present in early Golgi membranes and vesicles but not in later 
Golgi membranes (Gomez-Navarro & Miller, 2016). The main Golgi regions were visualised 
by fusion to Anp1 (Chapman & Munro, 1994) a key protein in the secretory pathway. Finally, 
the yeast Late Golgi, equivalent to the TGN, was visualised using ChC1, the Clathrin heavy 
chain. 
Figure 33: – Time Lapse Micrographs of 
Sec13-mNeonGreen, marking ER-Golgi 
Vesicles, and Edc3-mRuby2, marking p-
bodies (left). P-body Foci showed overlap 
and proximity to Sec13 structures. 
Sec13/Edc3 overlap was particularly 
prominent around the nucleus indicating 
proximity and possible interaction with 
the ER. This time-lapse shows a repre-
sentative set of images from a group of 
analysed experiments used for manual 
observations, not automated quantifica-
tion. Scale bar 5 μm. Quantifications of 
M2 coefficients showed significant overlap 
in all stages of the cell cycle (above) 
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Visual analysis of micrographs was used to determine initial colocalisation for each of the 
tagged proteins, followed by computational co-localization analysis for quantification of 
co-localisation.  
Sec13 showed significant but not exclusive overlap with Edc3. Multiple Edc3 foci character-
istic of p-bodies were found to overlap with similar Sec13 foci on the same focal plane, 
although Sec13 coverage was more disperse. Edc3 foci were also found in areas with no 
Sec13 signal implying Sec13 is not a constituent component of p-bodies. Observation of 
Edc3 and Sec13 overlap was not limited to any specific cell cycle stage and was observed 
in nuclear periphery and arbitrary locations within the cell. Automated quantification sup-
ported the manual observations, with an M2 coefficient around 0.7 for all cell cycle posi-
tions, indicating a significant (p<0.001) degree of Edc3 overlap with Sec13. The M1 coeffi-
cient was consistently lower around 0.06, confirming the observation of micrographs that 
Sec13 localisation is independent of p-bodies, unsurprising given its known localisation.  
Examination of Cop1-mNeonGreen tagged cell micrographs showed some small areas of 
overlap between Edc3 foci and Cop1 signal, but no identical overlapping foci as with Sec13. 
Automated analysis showed an M2 coefficient of around 0.4, rising above 0.5 in G1, mean-
ing roughly 40% of all p-body signal overlapped with Cop1, slightly more during G1. The 
M1 coefficient showed a similar pattern, its highest proportion of overlap in G1, dropping 
to lower levels in S and G2/M stages. However, M1 was still significantly lower than M2 due 
to the dispersed nature of Cop1 localisation. 
Unlike with ER-Golgi and Early Golgi structures, p-bodies, visualised by Edc3-mRuby2, 
showed little overlap with the main Golgi body as visualised by Anp1-mNeonGreen fusion 
protein. Anp1 signal was diffuse with scattered foci of increased signal, with no clear overlap 
of Edc3 signal. Automated quantification showed similar results, with insignificant overlap 
shown via M1 coefficient and only a significant overlap shown via M2 coefficient during S 
phase, with insignificant overlap in G1 and G2/M. 
Late Golgi, visualised by the signal of Clathrin Heavy Chain, showed little overlap with p-
bodies. Examination of micrographs showed distinct Edc3 foci independent of Clathrin sig-
nal during all stages of the cell cycle. Automated quantification was contrary to manual 
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observation with M2 coefficients during S and G2/M over 0.5 with a lower overlap during 
G1. M1 followed the same pattern with a lower coefficient during G1, increasing in S and 
dropping back again in G2/M. The increased overlap during the latter stages of the cell 
cycle could be functional, or coincidental due to the fact that both Golgi and p-bodies are 
trafficked to the bud during asymmetric cell division of budding yeast cells (Suda & 
Nakano, 2012). The high degree of overlap in automated quantification could also be an 
artefact due to the diffuse localisation of Clathrin. 
The overall pattern of co-localisation, high at the ER-Golgi interface and early Golgi com-
partments, followed by decreased interaction with the main Golgi body and resurgence in 
the late Golgi points to a possible role interacting with the protein/vesicle trafficking system 
during glucose restrictive conditions. Interaction with the main Golgi body is likely limited 
due to the non-membranous structure of p-bodies, restricting their interaction to the ex-
posed membrane proteins of ER-Golgi and late Golgi Vesicles.  
5.2.3 Mitotag / Mitochondria 
P-bodies have been identified as sites of mRNA degradation due to their components, but 
they have also been implicated in RNA interference. In mammalian cell lines, mitochondrial 
inactivation leads to a decrease in RNA interference efficiency while p-bodies have been 
shown to associate with mitochondria in live cell imaging (Huang 2011). Although the RNAi 
machinery is not present in Saccharomyces cerevisiae, colocalisation of these organelles 
may still occur. To verify this interaction in budding yeast, mitochondria were tagged with 
mRuby2, by fusing this fluorescent protein with the mitochondrial import sequence from 
the yeast Tom70 protein. This construct was co-expressed with Edc3-mNeonGreen for 
colocalisation analysis. 
Manual observation of micrographs initially indicated positive co-localisation of p-bodies 
and mitochondria, with Edc3 foci appearing along the length of the mitochondria (Note 
that the structure of the mitochondria shown in Figure 34 are on a single imaging place, 
hence the lack of branching). The mitochondria of course extend beyond the p-body foci, 
so the M1 coefficient is predicted to be significantly lower than M2. Overlap of p-bodies 
was observed in all cell cycle stages with particular prominence at the bud neck and tip, 
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indicating a possible link in trafficking into the bud, consistent with previous studies show-
ing a link between mitochondria and the myosin motor protein Myo2 (Westermann, 2014), 
that has also been identified as a potential component of p-body inheritance (Chang et 
al., 2008). 
Consistent with the idea of shared trafficking apparatus between p-bodies and mitochon-
dria, automated co-localisation quantification showed both progressively increasing M1 
Figure 34: Time Lapse Micrographs of 
Edc3-mNeonGreen, marking processing 
bodies, and MitoTag-mRuby2, marking 
mitochondria (left). Processing bodies 
showed extensive overlap with the mito-
chondria as visualised with the Tom70 lo-
calisation peptide fusion. colocalisation to 
the bud neck and bud tip during budding 
was also observed that could imply a 
shared trafficking mechanism. This time-
lapse shows a representative set of images 
from a group of analysed experiments used 
for manual observations, not automated 
quantification. Scale bar 10 μm. Although 
significant localisation was also confirmed 
via Mander’s M2 co-efficient as shown 
above, the M2 values were lower than 
other membranous organelles. 
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and M2 coefficients, meaning p-body co-localisation with mitochondria increased to a 
maximum during G2/M, the stage at which the organelles would be trafficked into the bud. 
Interestingly the coefficients were not as high as some other organelles, namely early and 
late Golgi, although this could be due to the disperse nature localisation of these other 
organelles compared to the organised filamentous structure of the mitochondria. No cur-
rent evidence points towards the presence of p-bodies within the mitochondria, so the 
observed overlap likely indicates adjacency to mitochondrial membrane, rather than for-
mation within the mitochondria. 
5.2.4 Further organelle markers 
To represent a wider range of organelles and uncover any previously unreported localisa-
tion, mNeonGreen fusion proteins were created to tag the organelles. Together with the 
previous tags, this represents a comprehensive coverage of the cellular organelles that 
might interact with p-bodies.  
Peroxisomes, Lipid particles and the myosin contractile ring showed negligible co-localisa-
tion with p-bodies based on both manual and automated co-localisation studies, while the 
spindle pole fusion protein caused a growth abnormality making results unreliable. Inter-
estingly the three remaining fusion proteins did show a small degree of colocalisation, 
these were the nuclear periphery, nucleolus and endosome. 
Endosomes were identified by a fluorescent fusion to Vacuolar-sorting protein Snf7. Mi-
crographs showed some overlap with Edc3 close to the bud site and bud neck during 
budding, Quantification showed a small degree of colocalisation based on M2 coefficient 
that was highest in G1, decreased in S and increased again the G2/M, a pattern that was 
reflected in M1 coefficient. 
Micrographs showing the nucleolus, identified by the fusion protein of Nucleolar Protein 
Nop56, indicated no overlap of Edc3/p-bodies and the nucleolus consistent with previous 
observations indicating p-bodies are not present within the nucleus (J. Buchan, 2014). How-
ever, the quantification of co-localisation showed overlap in the M2 coefficient, which is 
unusual given the aforementioned lack of Edc3 in the nucleus and most likely due to over-
lap of fluorescence signals while the two organelles area in close proximity, possible during 
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cell division. Some p-body constituent proteins such as Dcp1 have previously been shown 
to shuttle between the cytoplasm and the nucleus (Haimovich et al., 2013), if Edc3 shared 
this shuttling activity, it could explain the co-localisation results, while still showing minimal 
overlap in manually assessed images. The signal for the nuclear periphery, which encom-
passes the nuclear envelope region of the endoplasmic reticulum as well the as nuclear 
export machinery, showed a similar level of overlap to that of the nucleolus. P-body signal 
was detected in this region at an increased level during the G2/M phase of the cell cycle 
which could again be caused by close proximity during cell division or could indicate a 
closer relationship during budding such as a shared mechanism of inheritance. 
The results of the colocalisation analyses are summarised in Figure 35. Although no indi-
vidual structure shows complete colocalisation with the p-body signal it is clear that p-
bodies do not exist in isolation from other cellular compartments. P-body signal showed 
overlap with the nuclear periphery, as expected given the p-body’s role in mRNA triage, 
Figure 35: Overview of processing body localisation (Mander’s M2 coefficients) for cellular 
compartments. 
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as well as previously unrecorded colocalisation, including the highest level found, with 
Sec13.  
5.3 Age-induced changes in processing body localisation 
The progression of replicative ageing in yeast has been shown to cause deterioration of 
multiple cellular pathways, eventually leading to senescence and cell death. One of the key 
findings so far, not just in yeast but in multiple organisms, is that dietary restriction appears 
to increase lifespan. In yeast this manifests itself as an increase in replicative lifespan (RLS) 
under conditions of reduced nutrients and can be studied in the lab using various methods 
to measure RLS. The formation of p-bodies is induced under the same conditions shown 
to increase RLS. Both dietary restriction induced lifespan extension and p-body induction 
are consequences in a global drop in translation. Given this shared regulatory mechanism, 
the progression of ageing may impact the dynamics of p-bodies, and p-body function 
may influence ageing. Understanding how age affects the localisation and interactions of 
p-bodies is therefore important to determine both how ageing affects p-body function, 
and how p-body formation due to low glucose conditions might be protective leading to 
cellular longevity. 
To study the localisation of p-bodies in advanced replicative age, single cells of Saccharo-
myces cerevisiae were constrained in a series of traps, in a microfluidic device. This device 
allowed the removal of daughter cells in media flow, while retaining the mother cells as 
they advance in age. Each marker strain was loaded into such a device and allowed to 
grow over a period of several days during which time the devices were imaged using an 
inverted fluorescence microscope. The cells were grown in synthetic complete media con-
taining 0.1% glucose, a media composition shown to induced p-body formation in yeast 
while not stopping cell growth. Phase contrast imaging was used to visualise the cells until 
they reached an age of 15± cell divisions, after which multicolour fluorescence imaging 
was used to visualise both organelle markers and the p-body constituent protein Edc3.  
The organelle markers used in this part of the study were identical to those used in the 
previous section. The colocalisation procedure used in this section of the study was iden-
tical to that used in the previous section. During aging of the mother yeast cells in the 
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microfluidic chip it was observed that the morphology of several organelle markers was 
altered with advanced replicative age. The main example of this change in morphology 
was that of the mitochondria which showed both an increase in size and a lesser degree 
of fragmentation.  Although this observation is not strictly relevant to the current study it 
may have influenced the quantification of the colocalisation of p-bodies with some orga-
nelles due to increased fragmentation.  
In cells of advanced replicative age there were some organelles which completely lost col-
ocalisation with p-bodies. These included the nuclear periphery, the endosome, lipid par-
ticle and the myosin ring. Of these both the nuclear periphery and the endosome showed 
an M2 coefficient of above 0.3 during at least one cell cycle point during normal growth. 
The loss of colocalisation in advanced replicative age could point to the loss of interaction 
between components of these organelles and p-bodies or could be due to an increase in 
p-body colocalisation elsewhere within the cell, given that some organelles showed a sub-
stantial increase in colocalisation the latter theory is the logical assumption. 
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5.3.1 Sac6 / Actin Patches 
P-bodies showed a decreased overlap with actin patches in cells of advanced replicative 
age. Micrographs of fluorescently tagged Edc3 and Sac6 showed little overlap on manual 
inspection, and automated quantification of colocalisation showed a 20% drop in M2 co-
efficient compared to young cells meaning insignificant colocalisation vs control during G1, 
and a 50% drop during S and G2/M. This could again be due to the sequestering of p-
bodies in specific locations during advanced replicative age. Given the observed break-
down of protein segregation in budding cells of advanced replicative age it could also be 
that p-bodies lose their link to the actin cytoskeleton during replicative ageing, which may 
also lead to a breakdown in their segregation. 
Figure 36: Micrograph of aged cell (top of 
channel) tagged with Sac6-mNeonGreen and 
Edc3-mRuby2.  Processing bodies showed little 
overlap with Sac6 in aged cells compared with 
young cells, although colocalisation was pre-
sent at the bud tip as observed previously. This 
time-lapse shows a representative set of im-
ages from a group of analysed experiments 
used for manual observations, not automated 
quantification. Scale bar 5 μm. Quantification  
(above) showed that G1 colocalisation was in-
significant compared to the control, whereas S 
and G2/M levels were still significant, 
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5.3.2 Cop1, Anp1, Chc1 / Early, Mid, Late Golgi 
The results for colocalisation of Golgi compartments varied between markers for different 
sections of the yeast Golgi stages. Localisation of p-bodies to the ER/Golgi vesicle marker 
Sec13 was reduced by 60% in G1 and S phases and by 90% in G2/M. G1 and G2/m phase 
colocalisation was insignificant compared to controls. Given the overlap of Sec13 signal 
with the ER, this drop in colocalisation could imply a reduced association of p-bodies with 
ERESs in aged cells. Micrographs of Sec13 and Edc3 tagged cells were similar in aged cells 
to those of young cells, in which P-bodies were clearly distinct in many cases but showed 
overlap with the ER signal in some cells. 
Figure 37: Micrographs of aged cells labelled with 
Sec13 mNeonGreen and Edc3-mRuby2-. Pro-
cessing bodies showed a similar overlap with ER-
Golgi vesicles in aged cells. Although the morphol-
ogy of the Sec13 signal became more diffuse, pro-
cessing bodies were still observed to overlap with 
distinct Sec13 structures around the nucleus. This 
time-lapse shows  representative set of images 
from a group of analysed experiments used for 
manual observations, not automated quantifica-
tion. Scale bar 5 μm. Quantification of 2 values 
Showed that G1 localisation was insignificant, as 
was G2/m localisation, only S phase M2 values 
were significant (shown above) 
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Localisation to the Early Golgi compartment, represented by Cop1, was also shown to be 
reduced during advanced replicative age but still significant compared to controls. M2 
coefficient dropped by 47, 66 and 34% for G1, S and G2/M phases respectively. Manual 
observation of micrographs showed little overlap of the p-body and Cop1 signals during 
any cell cycle stage. In contrast to the drop in colocalisation with Cop1, Edc3 showed no 
decrease in localisation with Anp1 in cells of advanced replicative age, although the local-
isation was low in young cells to begin with. In the G2/M phase, p-bodies showed an 
increased overlap with Anp1 signal, with an M2 coefficient of 0.18 compared to 0 overlap 
in young cells. This overlap during the latter stage of the cell cycle could again be due to 
a breakdown in p-body, or Golgi, trafficking in aged cells leading to dysregulated transport 
and an increase in random overlap of the signals. In micrographs of Anp1 tagged cells, p-
bodies were observed to overlap completely with some Anp1 tagged structures. Whether 
this overlap is due to an interaction between the 2 compartments or some shared 
Figure 38: Micrographs of aged cells labelled with 
Cop1-mNeonGreen and Edc3-mRuby2 No com-
plete overlap of processing bodies with Cop1 struc-
tures was observed in aged cells. This time-lapse 
shows a representative set of images from a group 
of analysed experiments used for manual obser-
vations, not automated quantification. Scale bar 5 
μm. M2 values were low but significant compared 
to controls as shown above. 
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localisation to a 3rd compartment is not known, and further investigation is required to 
identify these structures.  
Micrographs of Chc1 and Edc3 tagged cells were similar in old cells to those from young 
cells. Some overlap was seen between Chc1 structures and p-bodies and overlap of iden-
tically shaped structures was also observed. Quantification of colocalisation showed an 
increased M2 coefficient in both G1 and S phases (much larger in G1) but a decrease in 
G2/M phase cells. The structures observed in micrographs were similar to those observed 
in Anp1 tagged cells, spherical bodies, that overlapped completely with some foci of Edc3 
signal. 
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5.3.3 Pex3 / Peroxisomes 
Automated quantifications of colocalisation of Edc3 with the peroxisome marker Pex3 in-
creased in cells of advanced replicative age. M2 coefficient increased from 0 in al cell-cycle 
stages to 0.2, 0.65 and 0.43 in G1, S and G2/M respectively. Observation of micrographs 
showed some overlap in distinct foci of Edc3 and Pex3, although both also formed inde-
pendent non-overlapping structures. No previous interaction has been shown between p-
bodies and peroxisomes, but in plants, peroxisomes, p-bodies and Golgi bodies have been 
observed to use the same or similar mechanisms of intracellular transport (Hamada et al., 
2012) and all pause to interact with the ER. If there is a breakdown in this transport, or the 
Figure 39: Micrographs of Aged cells tagged with 
Pex3-mNeonGreen marking peroxisomes and 
Edc3-mRuby2 marking processing bodies. There 
was no clear overlap of processing bodies and 
peroxisomes in the aged cells at any point during 
the cell cycle. Both organelles appeared as inde-
pendent foci. This time-lapse shows a repre-
sentative set of images from a group of analysed 
experiments used for manual observations, not 
automated quantification. Scale bar 5 μm. M2 
throughout the cell cycle was significant as 
shown above. 
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release from pausing, in aged cells it could cause an accumulation of these organelles at 
pausing sites leading to a perceived increase in colocalisation.  
5.3.4 Mitotag/Mitochondria 
The colocalisation of p-bodies with mitochondria showed a large increase based on M2 
coefficient in aged cells. In micrographs, individual p-bodies clearly overlapped sections of 
the mitochondria throughout the cell cycle, although some p-bodies still remained inde-
pendent. The colocalisation of p-bodies and mitochondria was strongest during G2/M, as 
with young cells, although in aged cells there was a 100% increase in M2 indicating that 
the proportion of Edc3 overlapping Mitochondrial signal had doubled. Mitochondria have 
been shown to control the segregation of some protein aggregates in (Zhou et al., 2014) 
Figure 40: Micrographs of aged yeast cells tagged 
with MitoTag-mRuby2 and Edc3-mNeonGreen. 
Processing bodies show consistent overlap with 
mitochondria throughout the cell cycle in aged 
cells. Processing bodies were transported through 
the bud neck to the bud tip alongside mitochon-
dria implying a share transport mechanism. This 
time-lapse shows a representative set of images 
from a group of analysed experiments used for 
manual observations, not automated quantifica-
tion. Scale bar 5 μm. M2 values were significant 
compared to controls and higher than for all other 
organelles in aged cells. 
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budding yeast, although p-bodies were not investigated. If mitochondria play a role in p-
body segregation the increased localisation to mitochondria of p-bodies could be due to 
changes in this process. In non-inherited aggerates, such as HSp104 chaperones heat in-
duced aggregates, advanced replicative age leads to a decreased association with mito-
chondria and leakage of aggregates into the daughter cells. P-bodies display an inverse 
behaviour in young cells, in that they are inherited by daughter cells under conditions of 
glucose restriction. If this process is regulated by association with mitochondria it is possible 
that a breakdown in the regulation of association could lead to a failure of p-body inher-
itance as they remain associated with non-inherited mitochondrial regions. The localisation 
of p-bodies in aged cells is summarised in Figure 41. 
To summarise the results of the colocalisation studies, it was found that the localisation 
profile of p-bodies, as determined by the marker protein Edc3, was altered in cells of ad-
vanced replicative age, these changes are shown in Figure 42. P-bodies showed a de-
creased association with membranes of the endoplasmic reticulum and Golgi apparatus, 
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Figure 41: Summary of processing body localisation in aged cells. Figures are summarised 
as Madners’ M2 coefficients during each stage of the cell cycle. 
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particularly during the G2/M phase of the cell cycle in the case of ER-Golgi vesicles. This 
drop in colocalisation may indicate a loss of adhesion to, or co-trafficking with these mem-
branes during budding in aged cells, which is known to be present for some mRNA during 
young cell growth. Conversely p-bodies showed an increased association with the mito-
chondria in aged yeast cells, possibly indicating a shift in association to the mitochondrial 
membrane from the ER. The implications of this shift are unclear and require further ex-
ploration. The raw changes in Mander’s M2 values are summaries in figure 42.  
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Figure 42: Change in localisation of processing bodies during cellular ageing..Change in 
Manders M2 represents the change in overlap between the the processing body marker Edc3 
and the indicated orgranelle marker. 
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6 Inheritance and motility of Processing Bodies in 
Saccharomyces cerevisiae 
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6.1 Movement and inheritance of processing bodies in Saccharomyces 
cerevisiae  
While the potential roles of p-bodies in mRNA decay and storage have begun to be un-
covered, a third potential role that is yet to be considered has had very little attention. The 
transport of mRNA in yeast has been well studied and is known to rely on an mRNP com-
plex made up of the class V myosin motor protein Myo4 and the mRNA binding proteins 
She2 and She3 (Niessing et al., 2018). This complex shuttles a variety of mRNAs into the 
bud via the actin cytoskeleton for localised translation of proteins important in bud devel-
opment. This mRNP complex has also been implicated in the early transport of ER into the 
emerging bud and so its activities are not limited to the transport of mRNAs.  
In budding yeast, it has previously been shown that p-bodies, when induced under condi-
tions of glucose deprivation (0.1% glucose in synthetic complete medium), move between 
mother and daughter cells in a unidirectional manner (Garmendia-Torres et al., 2014) i.e 
bodies are transported to the daughter cells, and do not return to the mother. The mRNA 
transport proteins are required for this inheritance of p-bodies, and deletion mutants of 
Myo4, She2 and She3 all show a loss of unidirectional inheritance during budding. This 
evidence points towards an expanded definition of p-body function, in which not only 
mRNA degradation and storage occur in p-bodies, but transport of mRNA as well. The 
stress specific transport of certain mRNAs to the emerging daughter cell could confer a 
selective advantage by ensuring an optimised program of gene expression for growth in 
nutrient restrictive conditions. The same study that identified the inheritance of p-bodies 
also showed that daughter cells achieve a larger overall size before themselves budding, 
suggesting that at least as far as cell growth was concerned, inheriting a p-body is advan-
tageous. 
P bodies share many similarities with other mRNP and protein aggregates found within 
eukaryotic cells. Their assembly appears to depend highly on interactions between the low 
complexity domains of their constituent proteins, leading to a critical concentration at 
which liquid-liquid phase separation occurs creating the mebraneless granule (Molliex et 
al., 2015). This reliance on low complexity domains for reversible assembly makes the con-
stituent proteins of mRNP granules susceptible to mutations that could cause aberrant 
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aggregation, ultimately leading to a cell death. In humans, stress granules, p-body related 
mRNP granules, have been implicated in the pathology of aggregate-based neurodegen-
erative diseases, with many of the constituent proteins present as homologues in budding 
yeast, such as TIA-1 (Pub1) and Ataxin-2 (Pbp1)(Reineke & Lloyd, 2013). It has been sug-
gested that the continuous process of LLPS may lead to a build-up of misfolded proteins 
with disordered regions that eventually form aggregates of their own, and then self-ag-
gregate, ultimately forming pathological fibrils that cause cell damage, and that this pro-
cess is enhanced by mutations in the proteins involved. Although p-body proteins have 
not been shown to be present in human disease state cells in the same way as stress 
granule proteins, their formation is thought to follow the same process, and multiple p-
body proteins have been found to undergo LLPS in vitro (Schutz et al., 2017). Given the 
likely build-up of misfolded proteins associated with any mRNP granule such as a p-body, 
it would seem counter-intuitive to pass these granules on to a new daughter cell, where 
the ageing processes is theoretically reset upon budding.  
In the case of p-bodies, the evidence that they are inherited for a single generation is clear, 
although beyond that no data has been published. The general interphase movement of 
p-bodies has also been largely overlooked, with studies focusing on how cytoskeletal inhi-
bition affects formation and disassembly of the granules (Sweet et al., 2007). In this section, 
the movement of p-bodies in budding yeast, as well as the inheritance of p-bodies be-
tween generations was investigated to gain a greater understanding of how p-bodies carry 
out their possible function in mRNA transport. 
6.2 P bodies are mobile in S. cerevisiae and move in a directional manner. 
The limited previous studies of p-body motility, in human cells (Aizer & Shav-Tal, 2008) 
and yeast (Garmendia-Torres et al., 2014) have given little insight into how p-bodies might 
move around the cell in order to carry out their function. In principle, either mRNAs must 
be trafficked deliberately to p-bodies, or p-bodies must scan the likely cytoplasmic loca-
tions of mRNA (ER, Nuclear exit sites etc) to find and segregate their target mRNAs. In 
mammalian cells, p-bodies were observed (in a limited study) to remain in small cellular 
regions, without showing the larger scale directional movement indicative of transport 
along microtubules (Aizer et al., 2008). In yeast, the localisation of p-bodies to the site of 
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bud emergence, just before budding has been demonstrated, but the movement in the 
time periods outside the budding process was not studied in detail (Garmendia-Torres et 
al., 2014). The exception to this lack of detailed information comes from studies carried out 
in plants, specifically Arabidopsis Thaliana. In Arabidopsis, p-bodies have been shown to 
colocalise with and move in unison with myosin motor proteins, along distinct actin fila-
ments (Alexandra Steffens et al., 2014). This process was reliant on the p-body protein 
AtDCP1, which was shown to bind to both yeast and mammalian class V myosins, indicating 
a highly conserved interaction. The same study identified an interaction between yeast 
Dcp1 and the yeast class V myosin Myo2, a paralog of Myo4, the motor protein involved 
in mRNA transport. 
To investigate the nature of p-body movement in Saccharomyces cerevisiae, a brightly 
fluorescent protein, mNeonGreen, was fused to the yeast p-body component Edc3. The 
increased intensity and lower photobleaching of this protein allowed images to be cap-
tured at high time resolution using a spinning disk fluorescence confocal microscope to 
track movements of p-bodies in live cells. Images were captured every 100ms with the 
illuminating laser power set to maximum in order to capture the greatest possible detail. 
Using this technique, it was also possible to increase the capture speed, up to 70 frames 
Figure 43: Anisotropic movement 
of large processing bodies. Images 
were captured every 100 ms and 
bodies were tracked to quantify 
speed of movement. Blue lines rep-
resent the trajectory of the pro-
cessing body. Each left panel image 
is a 5µm square.  
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per second, but the loss of signal resulted in noisy images that contained little useful infor-
mation. 10 frames per second worked well as a compromise between speed of acquisition 
and signal-to-noise ratio. 
Under microscopic observation at 10 frames per second, p-bodies marked by Edc3 showed 
three main types of movement. Similar to the observations in mammalian cells, large p-
bodies showed anisotropic movement without directionality. These p-bodies remained 
confined to small areas of roughly 4 square microns. Figure 43 shows an example of this 
movement. 
A second class of p-bodies showed clear fast directional movement along linear pathways. 
These p-bodies were smaller, with a lower total fluorescence intensity, and therefore pro-
tein content. Both classes of p-body were present in single cells and the motile p-bodies 
often appeared to interact with the larger bodies, possibly exchanging material. 
Figure 44: Fast directional movement of pro-
cessing bodies. Images were captured every 100 
ms. Some processing bodies showed fast direc-
tional movement of up to 2.5 µm s-1. Trajectory 
of processing body movement is shown in yel-
low. Each left panel image is 7 µm tall. 
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Quantification of the speed of movement of these bodies showed an average speed of 2.5 
microns/second, consistent with previously observed movement of vesicles along actin fil-
aments facilitated by class V myosins. Although the speed of travel appears consistent with 
transport along actin filaments, the distance travelled was different to previously observed 
Figure 45 Colocalisation of actin filaments and processing bodies. Actin was visualised 
with Lifeact-mNeonGreen and processing bodies with Edc3-mRuby2. Each 3-frame sec-
tion is a 0.5-micron Z section, numbered 1 – 14 from the base of the section to the top. 
Arrows indicate sites of colocalisation. Scale bar indicated 5 microns. Processing bodies 
show qualitative overlap with the actin cytoskeleton throughout the cell, and not limited 
to the coritcal actin cytoskeleton. 
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trafficked cargoes. P body movements were shorter, often covering only 1 – 2 microns at 
a time, although imaging was performed in a single plane and so movement in the 3rd 
dimension could explain this shortened travel distance. While many p-bodies were ob-
served close to the bud neck in dividing cells, the short time frames of these image se-
quences (1-4 seconds) did not capture directional movement into the bud. Figure 44 shows 
an example of the directional movement observed in this class of p-body. 
Figure 46: Processing bodies undergo fusion events. Processing bodies appear to interact 
and undergo fusion events to create larger bodies with higher fluorescence signal. Left – 
tracks of 2 bodies converging on a single point. Right upper – complete tracks of both bodies. 
Right lower – Quantification of fluorescence signal for one track showing increased fluores-
cence upon merge of bodies. 
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Finally, a third class of bodies was observed to move quickly and directionally, often trav-
ersing the inside edge of the cell, perhaps interacting with cortical actin filaments or endo-
plasmic reticulum. These p-bodies were much smaller and dimmer and were only observed 
qualitatively and in time-lapse movies rather than single images, as their signal faded 
quickly due to the intensity of the imaging laser. Whether these p-bodies are in fact pre-
sent, and not an artefact of imaging noise may be questioned, as inspection of individual 
images was difficult due to the low signal to noise ratio. Improved imaging technology will 
be required to validate these observations.  
To determine if p-bodies were associated with actin filaments, not just actin patches as 
quantified in the previous chapter, the actin binding protein ABP-140 was tagged with 
mNeonGreen via genomic integration and co-expressed with Edc3-mRuby2. ABP-140 sig-
nal highlighted clear actin filaments within the cell with which p-bodies were seen to co-
localise, although only in certain circumstances. Larger p-bodies did not associate with 
actin filaments, consistent with their lack of movement, while smaller, dimmer foci more 
often appeared adjacent to, or overlapping with actin filaments, see Figure 45. 
6.2.1 Processing bodies undergo rapid fusion events 
While analysing images captured for the purpose of determining p-body movement, an 
interesting behaviour was observed. Individual p-bodies appear to move to, interact with 
and fuse with each other to form larger, higher protein content (based on fluorescence 
signal) granules. This fusing behaviour, as shown in Figure 46, is similar to a previously 
observed interaction between mammalian p-bodies and mammalian stress granules. It was 
reported that mammalian stress granules appear to “dock” with p-bodies, but not undergo 
fusion (J. R. Buchan et al., 2008). This observation that p-bodies can fuse into larger gran-
ules is consistent with their structure being the result of liquid-liquid phase separation, as 
fusion events are expected in such systems (Schutz et al., 2017). These fusion events hap-
pen at millisecond timescales, which may be why previous studies, using lower time reso-
lution imaging have failed to identify them in vivo. 
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6.3 P bodies are inherited through multiple generations during caloric re-
striction 
Previous work on the movement of p-bodies during mitosis identified a unidirectional traf-
ficking of individual p-bodies, dependent on the locasome of She2/She3/Myo4. In yeast 
this activity was observed in cells grown in restrictive glucose conditions of 0.1% glucose, 
which allows continued cell growth but also induces the formation of p-bodies 
(Garmendia-Torres et al., 2014). To verify this activity, p-bodies, labelled with Edc3-mNeon-
Green were imaged at 1-minute intervals over a 16-hour period, to enable the tracking of 
p-bodies during several cell divisions. 
In agreement with the previously mentioned study, p-bodies were observed moving from 
mother to daughter cells in a unidirectional manner as shown in Figure 48. To expand 
upon this observation, individual p-bodies were tracked beyond the initial inheritance, 
while still under conditions of glucose restriction. Individual p-bodies were observed to be 
inherited through multiple generations of yeast daughter cells, while the mother cells 
formed de novo p-bodies at some point between transfer of the existing p-body and exit 
of mitosis. Although the inheritance of a single p-body may not seem significant, as any 
mechanism for inheritance will likely act on the p-body if conditions are unchanged, it does 
reinforce the idea of an active function for the p-body in the stress response, beyond the 
segregation of existing mRNA. If the contents of the p-body were the functional compo-
nents, then disassembly of the body should take place upon inheritance to access these 
contents. It should also be noted that the p-body is essentially a protein aggregate, and in 
most cases such aggregates are actively retained rather than inherited due to their poten-
tial to aggregate further and cause cell damage. The inheritance of the p-body would 
therefore seem to be counter-intuitive, unless it has an active role in cell growth under 
glucose restrictive conditions.  
6.4 P-body inheritance depends on mRNA transport systems and Dcp1 
The inheritance of p-bodies in budding yeast has previously been shown to rely on the 
“locasome” complex that facilitates mRNA transport. The key components of the locasome 
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are the She2 and She3 mRNA binding proteins and the myosin V motor protein Myo4. 
Deletion mutants for any of these genes evince loss of p body inheritance and loss of 
targeted localisation to the bud neck in the time period before budding. A link between 
Figure 47: Multigenerational inheritance of processing bodies. Individual processing bodies 
were tracked across multiple generations of yeast cells. Images were captured every 10 
minutes for 16 hours and segmented to identify individual bodies. Individual bodies appear 
to be inherited through multiple generations without disassembly. Each Image is a 12 µm 
square. Column 1 shows the fluorescence signal channel of the time lapse capture, column 
2 shows image segmentation focused on a single processing body that is trafficked be-
tween multiple mother and daughter cells. 
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the locasome and p-body in yeast has not yet been validated, although several studies 
have linked a second myosin V protein Myo2 to the assembly of p-bodies (Chang et al., 
Figure 48: mRNA Transport mutants disrupt processing body inheritance. Deletions of 
any components of the locasome” complex required for mRNA transport in budding yeast 
results in a loss of inheritance of processing bodies. Processing bodies were tagged with 
Edc3-mRuby2. Images were captured every 10 minutes and processing bodies manually 
tracked. Scale bars represent 5 µm. 
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2008; Alexandra Steffens et al., 2014). In plants the link between movement along actin 
filaments appears to be the p-body component atDCP1. Yeast Dcp1 has been found to 
bind Myo2 in vitro. 
To test whether yeast Dcp1 might be the link between p-bodies and the locasome in bud-
ding yeast, the deletion mutants for the locasome complex published previously were rec-
reated and compared to a deletion of Dcp1. Importantly, during mitosis, p-bodies in the 
Dcp1 deletion strain show the same loss of inheritance seen in strains deleted for compo-
nents of the locasome. Whether this loss of activity is due to a loss of interaction between 
Dcp1 and the locasome is not clear, but it does suggest a potential link between p-bodies 
and actin filaments that has not previously been identified. The locasome deletion mutants 
showed a p-body inheritance of 10%, 18% and 5% for Myo4 Δ, She2Δ and She3Δ strains 
respectively (figure 48), while in the Dcp1Δ strain (figure 49), 8% of total p-bodies were 
inherited. Interestingly although p-bodies were inherited in wild type cells, there was only 
a slight change in total Edc3 signal inheritance across the mutant strains, indicating that at 
least for this protein, the maintenance of protein concentration in the daughter cells does 
not rely on inheritance of p-bodies. 
6.5 P body inheritance is maintained in replicatively aged cells. 
Replicative or chronological ageing can cause the breakdown of a number of cellular sys-
tems in yeast and other organisms. One such system breakdown is the control of 
Figure 49: Dcp1 is required for processing body inheritance. Processing bodies were tagged 
with Edc3-mRuby2 in a Dcp1Δ strain. Images were captured every 10 minutes. Scale bar 
represents 5 µm. 
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segregation of protein aggregates. In budding yeast, young mother cells preferentially re-
tain protein aggregates (Dillin et al., 2014) and cell of advanced replicative age progres-
sively lose this ability. To establish whether the inheritance of p-bodies is adversely affected 
by replicative age, cells tagged with Edc3-mNeonGreen were grown in microfluidic dissec-
tion devices to advanced replicative age. Cells were grown to the point of 20 replications 
(to within one or two generations depending on the age when captured in the device) and 
imaged over time to visualise the inheritance of p-bodies. Observations of these time 
lapses videos showed that in advanced replicative age, p-body numbers appear to in-
crease, but in the majority of cells, at least one of these p-body is inherited by the daughter 
cell. Figure 50 shows the most commonly observed behaviour in which at least one p-
bodies continues to be inherited by daughter cells.  
From these observations it appears that advanced replicative ageing does not inhibit the 
inheritance of p-bodies, indicating that this process may be more robustly controlled that 
the inheritance of protein aggregates. Alternatively, if p-bodies are trafficked while linked 
Figure 50: Processing bodies are inher-
ited in cells of advanced replicative 
age. Cells expressing Edc3-mNeon-
Green were grown in CliC2 microflu-
idic dissection devices in 0.1% glucose 
media. Images were captured every 5 
minutes after 24 hours of growth. The 
outlines represent individual cells, and 
red outline an individual p-body. P-
bodies continue to be inherited in cells 
that have undergone multiple bud-
ding events. This image shows the 12th 
bud of the mother cell, in which a pro-
cessing body is inherited by the 
daughter cell. 
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to an existing organelle, it could be that any active mechanism of inheritance does break 
down over time, but p-bodies continue to be inherited due to their continued association 
with this organelle. 
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7 Discussion 
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7.1 CliC2 microfluidic chips are suitable for analysis of processing bodies 
during replicative ageing 
As established in the introduction to this work, there appears to be a link between the 
mechanisms and signalling pathways involved in the response to environmental and cel-
lular stress and the progression of ageing. A possible link between these two processes 
has emerged in the form of cytoplasmic mRNP granules. Types of these granules are 
formed in response to cellular stresses such as caloric restriction, oxidative stress and in-
creased heat. mRNP granules have also been observed in cells affected by various neuro-
degenerative disease of ageing, with aberrant aggregation of their constituent proteins a 
possible cause of such diseases. Investigations of cellular components in human ageing 
and long-lived animal models is difficult due to the time frames involved and so model 
organisms are used in which lifespans are significantly shorter. One such ageing model is 
the replicative lifespan of the asymmetrically dividing budding yeast Saccharomyces cere-
visiae. 
Traditional studies of replicative ageing in yeast utilised physical microdissection in which 
microdissection needles manually move daughter cells from mothers on agar plates, al-
lowing continued growth of the mother cells. This was a laborious process that required 
refrigeration of cells for overnight periods potentially impacting analysis of the stress re-
sponse. More recently, microfluidic platforms have enabled this process to be scaled and 
integrated into live cell imaging experiments. As the conditions of cellular growth may 
influence the formation kinetics of p-bodies, any variation must be limited to eliminate bias 
during imaging experiments. Since there have been no previous studies of yeast p-bodies 
in replicative ageing, this study first evaluated microfluidic devices for their potential use in 
the study of p-bodies. Several factors were evaluated to assess the suitability for use in the 
study of p-bodies during replicative age. When compared with traditional methods of 
time-lapse imaging, in terms of p body formation and frequency, growth of yeast cells in 
the CliC 2 microfluidic chip showed both similar induction and frequency of p-bodies. The 
CliC 2 chip also showed a higher rate of retention when compared with the second tested 
chip, HYAA. Although the CliC 2 design still suffered from flaws regarding the trapping of 
yeast cells as demonstrated in chapter 3, it still presents a suitable method for the analysis 
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of p-bodies in advanced replicative age. This method represents a potentially powerful 
tool in the study of mRNP granules during ageing, of which there are currently limited 
models. Future work to refine the designs proposed in this study will improve both the 
retention and ability to strictly control environmental conditions in these devices.  
7.2 Subcellular Localisation and associations of processing bodies 
7.2.1 Processing bodies localise to ER and Golgi membranes during log phase growth, 
implications for function 
The various protein and mRNA components of p-bodies in budding yeast have been ex-
plored in multiple previous studies although the cellular localisation of these bodies has 
never been robustly investigated. This previous work has focused on which proteins are 
recruited to p-bodies, which are important to their formation and disassembly and the 
associated known roles of these proteins. What is lacking at present is an overview of how 
the p-body itself acts as an organelle and what its overall function is. Part of refining the 
understanding of the role of p-bodies is understanding how they behave in the context of 
other organelles and which organelles they interact with.  
P-bodies have been shown in some circumstances to localise to, or in proximity to, orga-
nelle membranes in yeast, specifically those of the endoplasmic reticulum (Huch et al., 
2016). Several p-body constituent proteins are also suspected to be membrane associated, 
as demonstrated by membrane flotation assays (Huch et al., 2016). The co-localisation 
analysis presented in this study identified three markers of the ER and Golgi Apparatus, 
Sec13, Cop1 and Chc1, representing portions of the ER and early Golgi membranes, as 
potential sites of p-body localisation. The high degree of localisation with these markers 
indicated that p-bodies spend significant time associated with ER membranes. This asso-
ciation supports the theory that ER membranes may be sites of p-body formation as pre-
viously suggested. Localisation of the constituent factors to ER membranes may act as a 
catalyst for protein aggregation by bringing together proteins containing low complexity 
regions in a confined space and limiting diffusion by attachment to membranes. Another 
possible reason for the association with organelle membranes is to facilitate the trafficking 
of p-bodies. P-bodies have been shown to be inherited in yeast, and mRNA inheritance 
has been shown to be possible in association with the endoplasmic reticulum (Fundakowski 
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et al., 2012). The association of p-bodies with endoplasmic reticulum may therefore indi-
cate a role for p-bodies in the transport of translationally repressed mRNPs. Maintaining 
an mRNP aggregate between generations during times of cellular stress may help to op-
timise gene expression in daughter cells by preventing expression of high copy number 
mRNA not required for maintenance during stress. A visual summary of the colocalisation 
results is presented in Figure 51. 
7.2.2 Replicative age causes a shift in p-body membrane association 
The progressive decline in the function of cellular systems over time is one of the main 
consequences of ageing in eukaryotic cells. The budding yeast Saccharomyces cerevisiae 
Figure 51: A visual summary of log phase processing body localisation. Actin patches (A), 
Early Golgi (B), Endosome (C), ER/Golgi vesicle (D), Golgi (E), Clathrin (F), Lipid Particle (G), 
Nucleolus (H), Nuclear Periphery (I), Peroxisome (J), Myosin ring (K), Mitochondria (L). 
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is an important model organism in the study of this age-related degeneration due to its 
easy of growth and asymmetrically cell division, allowing the segregation of components 
during cell division to be studied. Factors associated with ageing in budding yeast include 
asymmetric inheritance of damaged or aggregated proteins and extrachromosomal rDNA 
circles (ERCs) as well as increases in respiration and autophagy. Mitochondrial dysfunction 
has also been identified as increasing with replicative age in budding yeast (Fehrmann et 
al., 2013) which can lead to a number of damaging effects including the increased produc-
tion of reactive oxygen species (Breitenbach et al., 2011). Asymmetric inheritance of dys-
functional mitochondria is therefore important in maintaining daughter cell longevity by 
restricting damage to the mother. The colocalisation analysis in this study identified a pos-
sible link between the progression of ageing in budding yeast and the association of p-
bodies with mitochondria. 
P-bodies have previously been shown to interact with mitochondria in mammalian cells 
(Ernoult-Lange et al., 2012) although this interaction has not been observed in budding 
yeast. This study found that p-bodies associated with mitochondria during log-phase 
growth, but to a lesser extent than their association with the endoplasmic reticulum. Like 
the ER, mitochondria are trafficked between mother and daughter yeast cells by an ac-
tin/myosin mechanism (Westermann, 2014) and the co-localisation could be a result of 
shared trafficking pathways along actin filaments. Alternatively, mitochondria, like ER mem-
branes, may also be capable of co-trafficking with p-bodies. The observation that mito-
chondrial co-localisation with p bodies increases through the cell cycle to the point of 
cytokinesis would support the idea of shared trafficking for the purpose of inheritance and 
p bodies localised with mitochondria at the bud site and bud tip together. Association of 
p-bodies with the endoplasmic reticulum (ER-Golgi region) remained high throughout the 
cell cycle indicating that it is unlikely that mitochondria are the only inherited organelle to 
carry p-bodies during inheritance.  
The replicative ageing assays carried out in this work identified a shift in colocalisation 
associated with cells of advanced replicative age. Colocalisation with mitochondria was 
increased in these cells, although the pattern of increasing colocalisation through the cell 
cycle remained. None of the pathways known to be affected by replicative ageing in yeast 
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would explain this change in association between organelles. The segregation of other 
protein aggregates, including heat induced HSp104 chaperones protein aggregates, has 
been shown be controlled by mitochondrial attachments (Zhou et al., 2011). These attach-
ments appear to weaken with advanced replicative age resulting in greater inheritance of 
potentially damaging aggregates. Given that p-bodies are in fact preferentially inherited 
by daughter cells, rather than retained by mothers, the results of this study raise new ques-
tions about how mitochondrial attachments facilitate inheritance, as p-bodies show a con-
trasting behaviour to other protein aggregates in that they increase, rather than decrease 
their association with mitochondria during ageing. 
Given the breakdown in functional mitochondria inheritance with age and the apparent 
association of processing bodes with mitochondria, especially with advanced replicative 
age, it might be expected that the inheritance of p-bodies would break down in aged cells. 
In fact, this study found that p-bodies continue to be inherited into advanced replicative 
age of up to 20 generations. In these aged cells p-bodies are also more numerous and its 
was found that a minimum of one of these bodies was inherited on average. It could be 
that this lack of deterioration in inheritance is simply due to the higher frequency of p-
bodies within the cell allowing for greater probability of inheritance while attached less 
specifically to mitochondrial membranes. Whether or not the number of p-bodies inherited 
in cells of advanced replicative age has an effect on the lifespan or fitness of their progeny 
is yet to be seen and further experimentation will be required to determine this. 
7.3 Processing body transport on actin filaments 
mRNA transport is known to occur through a Myosin V dependent mechanism along actin 
filaments. A similar mechanism transports both cortical endoplasmic reticulum and mito-
chondria in budding yeast (Fundakowski et al., 2012). In plants the link between the actin 
cytoskeleton and p-bodies has been shown to be the decapping protein Dcp1 (A. Steffens 
et al., 2014), but limited data are available for yeast. This study uncovered new evidence of 
p-body transport along the yeast actin cytoskeleton. 
In yeast actin forms both filaments and cortical actin patches of bunched actin filaments 
involved in endocytosis. In this study p-bodies were observed to colocalise with and in 
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proximity to cortical actin patches in the bud and around the bud neck of dividing yeast 
cells. This observation alone does not necessarily indicate that p-bodies are trafficked as 
actin patches are not known to play a role in intracellular trafficking. P-bodies were also 
observed colocalising with actin filaments qualitatively, although the limitations of current 
fluorescent proteins meant that dual-colour imaging of yeast actin and p-bodies to confirm 
connected movement was not possible.  
Although dual colour imaging was not possible, fast single colour imaging of p-bodies was 
found to be possible. This imaging found that p-bodies exhibited a variety of movements. 
Over very short time spans, p-bodies were found to translocate across limited regions of 
the cytoplasm with speeds similar to those observed in myosin V (Myo4) mediated actin 
transport. This movement was directional and suggests that p-bodies are actively trans-
ported along actin filaments.  
P-bodies are inherited in yeast, in a process dependent on the mRNA “locasome” complex 
(Garmendia-Torres et al., 2014). This work found that this inheritance is not limited to a 
single generation, i.e. the p-body is not inherited and disassembled to access the compo-
nent mRNA and proteins. Instead a single p-body can be inherited through multiple gen-
erations when the inducing stress is maintained. Why a yeast cell would pass on this p-
body is not clear. Continued regulation of gene expression in the daughter cell is a possi-
bility, as the p-body may rapidly segregate non-essential mRNA and prioritise expression 
of genes vital for growth under the inducing stress conditions. Similarly, the body may act 
as a store of potentially valuable mRNA to be released upon release of stress. Alternatively, 
inheritance of p-bodies may confer an advantage through making essential decay factors 
available to daughter cells, reducing the burden on translation of these proteins. Given the 
evolution of this inheritance mechanism, whatever the reason for inheritance is, its benefit 
must outweigh the risk of inheriting an mRNP composed of multiple proteins with disor-
dered regions with the potential to form larger aggregates. 
This study also found a potential link between the actin cytoskeleton and p-bodies in the 
form of the decapping protein Dcp1. Deletion of Dcp1 mimics the effects of deletions of 
the mRNA “locasome” complex in terms of p-body inheritance causing asymmetrical 
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inheritance to be almost completely lost. As Dcp1 was previously shown to bind myosin 
motor proteins in plants, and in vitro to yeast myosins (A. Steffens et al., 2014), this new 
data suggests that Dcp1 could also be the link between p-bodies and movement along the 
actin cytoskeleton in Saccharomyces cerevisiae. Taken together this new data suggest that 
p-body can move along actin filaments in a process mediated by myosin motors. 
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8 Conclusions and future work 
The study of ageing in budding yeast has had a recent boost by the introduction of mi-
crofluidic dissection devices. In this study, available devices were evaluated for their poten-
tial use in the research of p-bodies that require strict control of environmental conditions 
for their induction and persistence. The Clic2 device was found to sufficiently reproduce 
the p-body numbers found in existing methodologies and was therefore used for further 
experimentation. The CliC2 device still had several limitations: retention of cells was limited, 
and cells were mostly lost before the onset of replicative age induced senescence. Opti-
misation and further testing of existing and new devices to improve cell retention while 
maintaining inducing conditions will allow the study of p-bodies further into the replicative 
lifespan of yeast cells. 
The results of this study identify several new potential avenues of research into the role of 
p-bodies although the question of what the functions=(s) of p-bodies are remains. The 
localisation of p-bodies at different stages of the cell cycle, summarised in Figure 51, iden-
tified a potential role of the mitochondria and endoplasmic reticulum in the trafficking of 
p-bodies in yeast during mitosis. This link can be explored through further live cell imaging 
experiments at increased time resolution, to image the inheritance of p-bodies and orga-
nelles simultaneously. During the course of this work attempts were made to capture this 
process by performing automated time-lapse imaging at varying time-resolution, to cap-
ture fast time-resolution images of inheritance without causing photodamage. These were 
ultimately unsuccessful, and optimisation of the imaging protocols may enable this process 
to be captured in the future.  
The component(s) of p-bodies that link them to the mitochondrial or endoplasmic reticu-
lum membranes remain unknown. This study supports Dcp1 as a potential link between p-
bodies and actin filaments, but whether Dcp1 acts directly by binding Myosin motors, as it 
has shown to be capable of, or binds other components linked to organelle membranes is 
unclear. Further biochemical characterisation of the interactions of Dcp1 will be required 
to fully elucidate its role in p-body trafficking. Mutation analysis of Dcp1 to determine the 
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regions required for p-body transport will further develop the understanding of this pro-
cess.  
The overall role of p-bodies in budding yeast remains unclear, while this study lends new 
evidence to a potential role in mRNA trafficking, functions in mRNA storage and decay 
remain possible. What is clear is that p-bodies are a significant part of the machinery for 
post-transcriptional control of gene expression. 
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Appendix 
Table of processing body regulators 
Table 1: Regulators of p-body assembly and disassembly in Saccharomyces cerevisiae 
NAM
E 
NAME DE-
SCRIPTION 
MOLECULAR FUNC-
TIONS 
BIOLOGICAL PROCESSES REFERENCE 
PKH1 Pkb-activat-
ing Kinase 
Homolog 
protein serine/thre-
onine kinase activity  
cell wall integrity MAPK cascade , endocy-
tosis , late endosome to vacuole transport 
via multivesicular body sorting pathway , 
peptidyl-serine phosphorylation , pep-
tidyl-threonine phosphorylation , positive 
regulation of cytoplasmic mRNA pro-
cessing body assembly   , positive regula-
tion of protein serine/threonine kinase ac-
tivity , regulation of nuclear-transcribed 
mRNA poly tail shortening  
Luo G, et al. 
(2011) 
PMID:211639
42 
TPK3 Takashi's 
Protein Ki-
nase 
cAMP-dependent 
protein kinase activ-
ity  
mitochondrion organization , negative 
regulation of cytoplasmic mRNA pro-
cessing body assembly   , negative regu-
lation of cytoplasmic translation , protein 
kinase A signalling , protein phosphoryla-
tion , Ras protein signal transduction  
Ramachan-
dran V, et al. 
(2011) 
PMID:219253
85 
PAT1 Protein As-
sociated 
with Topoi-
somerase II 
chromatin binding , 
mRNA binding , pro-
tein binding , RNA 
binding  
cytoplasmic mRNA processing body as-
sembly  , deadenylation-dependent 
decapping of nuclear-transcribed mRNA , 
formation of translation preinitiation com-
plex , negative regulation of translational 
initiation , regulation of translational initi-
ation  
Buchan JR, et 
al. (2008) 
PMID:189812
31 
BCY1 Bypass of 
CYclic-AMP 
requirement 
cAMP-dependent 
protein kinase inhib-
itor activity  
negative regulation of Ras protein signal 
transduction , positive regulation of ade-
nylate cyclase activity , positive regulation 
of transcription from RNA polymerase II 
promoter in response to glucose starva-
tion , positive regulation of transcription 
from RNA polymerase II promoter in re-
sponse to nitrogen starvation , protein 
Ramachan-
dran V, et al. 
(2011) 
PMID:219253
85 
Appendix 
 
162 
 
 
localization to bud neck , regulation of cy-
toplasmic mRNA processing body as-
sembly   
TPK2 Takashi's 
Protein Ki-
nase 
cAMP-dependent 
protein kinase activ-
ity , translation initia-
tion factor binding  
invasive growth in response to glucose 
limitation , negative regulation of cyto-
plasmic mRNA processing body assembly   
, negative regulation of cytoplasmic trans-
lation , protein kinase A signalling , protein 
phosphorylation , Ras protein signal trans-
duction  
Ramachan-
dran V, et al. 
(2011) 
PMID:219253
85 
PKC1 Protein Ki-
nase C 
protein kinase C ac-
tivity  
actin filament organization , autophagy of 
peroxisome , cellular bud neck septin ring 
organization , intracellular signal trans-
duction , positive regulation of cytoplas-
mic mRNA processing body assembly   , 
protein phosphorylation , regulation of 
fungal-type cell wall organization , regu-
lation of nuclear-transcribed mRNA poly 
tail shortening , signal transduction  
Luo G, et al. 
(2011) 
PMID:211639
42 
RAS2 homolo-
gous to RAS 
proto-onco-
gene 
GTP binding , 
GTPase activity  
activation of adenylate cyclase activity , 
ascospore formation , macroautophagy , 
positive regulation of adenylate cyclase 
activity , positive regulation of pseudohy-
phal growth , positive regulation of tran-
scription by galactose , protein localiza-
tion by the Cvt pathway , protein localiza-
tion to bud neck , regulation of cytoplas-
mic mRNA processing body as-sembly  , 
regulation of protein localization , replica-
tive cell aging  
Ramachan-
dran V, et al. 
(2011) 
PMID:219253
85 
CDC3
9 
Cell Division 
Cycle 
ATPase activator ac-
tivity  
negative regulation of cytoplasmic mRNA 
processing body assembly   , nuclear-
transcribed mRNA catabolic process, 
deadenylation-dependent decay , nu-
clear-transcribed mRNA poly tail shorten-
ing , positive regulation of transcription 
elongation from RNA polymerase II 
Mugler CF, et 
al. (2016) 
PMID:276920
63 
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promoter , pseudohyphal growth , regu-
lation of cell cycle , regulation of transcrip-
tion by RNA polymerase II , response to 
pheromone triggering conjugation with 
cellular fusion , transcription elongation 
from RNA polymerase II promoter  
CAF2
0 
Cap Associ-
ated Factor 
 
negative regulation of translation , posi-
tive regulation of cytoplasmic mRNA pro-
cessing body assembly    
Ka M, et al. 
(2008) 
PMID:1818215
9 
DHH1 DEAD box 
Helicase 
Homolog 
ATP-dependent 
RNA helicase activity 
, chromatin binding , 
mRNA binding , pro-
tein binding , trans-
lation regulator ac-
tivity, nucleic acid 
binding  
cytoplasmic mRNA processing body as-
sembly  , deadenylation-dependent 
decapping of nuclear-transcribed mRNA , 
negative regulation of translation , nega-
tive regulation of translational elongation 
, regulation of cytoplasmic mRNA pro-
cessing body as-sembly  , stress granule 
assembly  
Mugler CF, et 
al. (2016) 
PMID:276920
63 
SCD6 Suppressor 
of Clathrin 
Deficiency 
eukaryotic initiation 
factor 4G binding , 
mRNA binding , RNA 
binding  
cytoplasmic mRNA processing body as-
sembly  , negative regulation of transla-
tional initiation , stress granule assembly  
Rajyaguru P, 
et al. (2012) 
PMID:222846
80 
LSM4 Like SM U6 snRNA binding  cytoplasmic mRNA processing body as-
sembly  , mRNA splicing, via spliceosome 
, nuclear-transcribed mRNA catabolic 
process  
Decker CJ, et 
al. (2007) 
PMID:179843
20 
EDC3 Enhancer of 
mRNA 
DeCapping 
mRNA binding  cytoplasmic mRNA processing body as-
sembly  , deadenylation-independent 
decapping of nuclear-transcribed mRNA , 
positive regulation of nuclear-transcribed 
mRNA catabolic process, deadenylation-
dependent decay  
Decker CJ, et 
al. (2007) 
PMID:179843
20 
TPK1 Takashi's 
Protein Ki-
nase 
cAMP-dependent 
protein kinase activ-
ity  
negative regulation of cytoplasmic mRNA 
processing body assembly   , peptidyl-ser-
ine phosphorylation , protein kinase A sig-
nalling , protein phosphorylation , Ras 
protein signal transduction , regulation of 
Ramachan-
dran V, et al. 
(2011) 
PMID:219253
85 
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macroautophagy  
PKH2 Pkb-activat-
ing Kinase 
Homolog 
protein kinase activ-
ity , protein ser-
ine/threonine kinase 
activity  
cell wall integrity MAPK cascade , late en-
dosome to vacuole transport via mul-
tivesicular body sorting pathway , pep-
tidyl-serine phosphorylation , positive 
regulation of cytoplasmic mRNA pro-
cessing body assembly   , positive regula-
tion of protein serine/threonine kinase ac-
tivity , protein phosphorylation , regula-
tion of nuclear-transcribed mRNA poly tail 
shortening  
Luo G, et al. 
(2011) 
PMID:211639
42 
List of Yeast Strains used in this study 
Many yeast strains were made for this study, to evaluate specific primers and protein fu-
sions, below are the final strains used for the data presented in this study. 
MATING 
TYPE 
DESCRIPTION STUDY 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Chip Evaluation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Sac6:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Cop1:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Snf7:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Sec13:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Anp1:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Chc1:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Erg6:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Nop56:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Nic96:mNeon-
Green-HygMX 
Colocalisation 
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MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Pex3:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX Spc42:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX MYO1:mNeon-
Green-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby3-KanMX 
ABP140P:mNeonGreen-HygMX 
Colocalisation 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mNeonGreen-HygMX Dynamics, 
Inheritance 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby2-KanMX dcp1Δ::HygMX Inheritance 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby2-KanMX she2Δ::HygMX Inheritance 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby2-KanMX she3Δ::HygMX Inheritance 
MATA his3-d1 leu2-d0 met15-d0 ura3-d0 Edc3:mRuby2-KanMX myo4Δ::HygMX Inheritance 
MATA his3-d1 leu2-d0 met15-d0 ura3Δ::Mitotag:mRuby2 Edc3:mNeonGreen-
HygMX 
Colocalisation 
List of Bacterial strains used in this study 
Plasmids for yeast strain construction were stored in bacterial vectors prior to PCR and 
yeast transformation. The bacterial strains used for the final data in this study are listed 
below. 
STRAIN 
BACKGROUND 
PLASMID DESCRIPTION 
DH5Α E. COLI pFA6a-mNeon-
Green:hygMX6 
Plasmid with mNeonGreen and Hygromycin resistance 
marker 
TOP10 E. COLI pyomRuby2-KanMX Plasmid with yomRuby2 and Kanamycin resistance marker 
DH5Α E. COLI pUG6 (KanMX) Plasmid with Kanamycin resistance marker 
DH5Α E. COLI pFA6a-hphMX6 (HygMX) Plasmid with Hygromycin resistance marker 
TOP10 E. COLI pMitoTag Plasmid with Tom70 localisation signal fused to mRuby2 
and URA3 marker 
List of Primers for yeast integrations 
Yeast strains were constructed by homologous recombination, below is a list of primers 
used for the final strains in this study. 
DESCRIPTION 5' - 3' SEQUENCE 
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AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR ABP140P FUSION 
GTACCGCTGCTGGGTACAAGCTGTGTTTGAC-
GTTCCTCAAGGTGGTTCTGGTTCTATGGTGAGCAAGGGCGAGGA 
TTAAAGCGACAGATAATATTAAAATGATAGATAGTTTTGACGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR SAC6 FUSION 
AATTATTACTTTTATCGCTTCGTTAATGACTTT-
GAACAAAGGTGGTTCTGGTTCTGGTGG-
TATGGTGAGCAAGGGCGAGGA 
GAAAAAAAGTTCACAGGATATATGGCTTAATAAGTAGTTTCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR COP1 FUSION 
TAAGATCGGTGCACCTGCATCCGGATTAAGAATACGTG-
TAGGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
ATATAACTGTTAATTACATAGTCAGTTTTTTTTTTTCACTCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR SNF7 FUSION 
TGAAAAAGCATTAAGAGAACTACAAGCAGAAATGGGGCTT-
GGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
GACAACAAAAAAATAAAAACTATTAATTATGACTTAGCATCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR SEC13 FUSION 
TCTTGAGGGTAAATGG-
GAACCCGCTGGTGAAGTTCATCAGGGTGGTTCTGGTTCTGGTGG-
TATGGTGAGCAAGGGCGAGGA 
ACAAATCTTTAATTGTTATACGTTACTGTACATTATGCGTCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR ANP1 FUSION 
TCCTAAAGAAGTTCCATTAGACTTCGACCCTGATAGAAAC-
GGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
AGTTAAAGACCAAAGAATAGAGGTTTGATATTATTATCGGCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR CHC1 FUSION 
GCTGATGAACAGCGCGATGAACGTTCAACCCACAGGATTT-
GGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
TAAAAGTATATAAATTGAAAAGGCAGTTTCAATCATTTTACGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR ERG6 FUSION 
CGCCGAAACCCCCTCCCAAACTTCCCAAGAA-
GCAACTCAAGGTGGTTCTGGTTCTGGTGG-
TATGGTGAGCAAGGGCGAGGA 
ATGCAGTGAATTATAGTTTTTTCTTATTCTGATAGAAAATCGTTAG-
TATCGAATCGACAG 
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AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR NOP56 FUSION 
TAAAAAGGAAAAGAAGGATAAAAAGAA-
GAAAAGTAAGGATGGTGGTTCTGGTTCTGGTGG-
TATGGTGAGCAAGGGCGAGGA 
TAATAATATTTCTAAATATACAATATACAGCTTCCAAATCCGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR NIC96 FUSION 
GGAAACGTACAGCACTTTAATTAATATAGAC-
GTCTCTCTAGGTGGTTCTGGTTCTGGTGG-
TATGGTGAGCAAGGGCGAGGA 
GACTGAGGCTTTGTACAACGAAAGCCAAAATATTCGATGACGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR PEX3 FUSION 
CAGCAACTTTGGCGTCTCCAGCTCGTTTTCCTTCAA-
GCCTGGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
TGCAGGGTAATGTCATGTTACCTATTGCACACTTACTGTACGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR SPC42 FUSION 
TATGTCAGAAACATTCGCAACTCCCACTCCCAA-
TAATCGAGGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
CCGATAGCATTAATCCTTACTTATACGTCTATTCGTAGGACGTTAG-
TATCGAATCGACAG 
AMPLIFY MNEONGREEN-
HYGMX WITH HOMOLOGOUS 
ENDS FOR MYO1 FUSION 
AAATATTGATAGTAACAATGCACAGAGTAAAATTTTCAG-
TGGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
GTACCACCTTTAAGACTACTATCGAAGGATACGGGGTGAACGTTAG-
TATCGAATCGACAG 
AMPLIFY YOMRUBY2 + 
MARKER WITH HOMOLOGOUS 
ENDS FOR EDC3 FUSION 
TATACGTATGTATCCAGTTTAGGCTAAAGTAATTCTTGGTgcataggccac-
tagtggatctgatatcacc 
TGATCTTTTCGTCACTGACGGGTCCCTGCTATTAGATTTGATCGGTGAC-
GGTGCTGGTTTAATTAAC 
AMPLIFY MNEONGREEN + 
MARKER WITH HOMOLOGOUS 
ENDS FOR EDC3 FUSION 
TGATCTTTTCGTCACTGACGGGTCCCTGCTATTAGATTT-
GGGTGGTTCTGGTTCTGGTGGTATGGTGAGCAAGGGCGAGGA 
TATACGTATGTATCCAGTTTAGGCTAAAGTAATTCTTGGTgcataggccac-
tagtggatctgatatcacc 
AMPLIFY MITOTAG-MRUBY2 
CONSTRUCT WITH HOMOLO-
GOUS ENDS FOR URA3 LOCUS 
INTEGRATION 
CATATTTATGGTGAAGGATAAGTTTTGACCATCAAAGAAGCACTATA-
GAACGCGGCCGCC 
GGATAGTTCCTTTTTATAAAGGCCATGAAGCTTTTTCTTTCAC-
TATAGGGAGACCGGCAG 
TCTAAAACACAAAAAAACAAAAAAAATCCTATAACCAGTTCTCCCG-
CATGATATGGACATATTGTCGTTAGAACG 
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AMPLIFY A MARKER WITH HO-
MOLOGOUS ENDS TO REPLACE 
MYO4 
ATTTTCTGTCTAATTTTATAATTTTACTGACAGTAGCTAAGCCCTCTG-
TATGAGCGAGGAAGCGGAAGAGC 
AMPLIFY A MARKER WITH HO-
MOLOGOUS ENDS TO REPLACE 
SHE2 
GTAAACCCTCCTTAATTTTCCTTTTGCATAATACCAGACACTTAAAAAA-
TATGGACATATTGTCGTTAGAACG 
GATGCTGAAAATGAGTACGCCAGAATAAGAGCCGATCATCAGTGTTTT-
GATGAGCGAGGAAGCGGAAGAGC 
AMPLIFY A MARKER WITH HO-
MOLOGOUS ENDS TO REPLACE 
SHE3 
TTATTGATTTGTTGCCATGAGTAGCAGCAGTCTGAAGGGGTTAC-
CAAACGATATGGACATATTGTCGTTAGAACG 
AAGTGAAAAATATGGATTCGTGTCTATAAAACCTTA-
GAGGCATCTATTTATGAGCGAGGAAGCGGAAGAGC 
AMPLIFY A MARKER WITH HO-
MOLOGOUS ENDS TO REPLACE 
DCP1 
AGCAAGAAAGAAAAGAAAATTGACGAAAAAACAATAGAGAA-
TATGGACATATTGTCGTTAGAACG 
TCACTTGGGCATCTCACCTCTGTGCTCAAGCAAAAGAATCTGAGCGAG-
GAAGCGGAAGAGC 
ImageJ Analysis Macros 
Macro to select cell outlines manually 
1. dir1 = getDirectory("Choose Source Directory");   
2. dir2 = getDirectory("Choose Destination Directory");   
3. list = getFileList(dir1);   
4. setBatchMode(true);   
5. for (i = 0; i < list.length; i++) {   
6.     showProgress(i + 1, list.length);   
7.     filename = dir1 + list[i];   
8.     if (endsWith(filename, ".tif")) {   
9.         open(filename);   
10.         var name = File.name;   
11.         setBatchMode(false);   
12.         waitForUser("Select Cells", "Please select cells us-
ing ROIs and press t to add to the list");   
13.         setBatchMode(true);   
14.         roiManager("Save", dir2 + name + ".zip");   
15.         roiManager("Deselect");   
16.         roiManager("Delete");   
17.         run("Close All");   
18.     }   
19. }   
 
Macro to segment cells from phase contrast and manually fix 
1. setBatchMode(true);   
2. dir1 = getDirectory("Choose Image Directory");   
3. list = getFileList(dir1);   
4. for (i = 0; i < list.length; i++) {   
5.     showProgress(i + 1, list.length);   
6.     if (endsWith(list[i], "/")) {   
7.         subdir = dir1 + list[i];   
8.         name = File.getName(subdir);   
9.         sublist = getFileList(subdir);   
10.         for (j = 0; j < sublist.length; j++) {   
Appendix 
 
169 
 
 
11.             if (endsWith(sublist[j], "Merge/")) {   
12.                 subsubdir = subdir + sublist[j];   
13.                 name2 = File.getName(subsubdir);   
14.                 subsublist = getFileList(subsubdir);   
15.                 for (m = 0; m < subsublist.length; m++) {   
16.                     filename = subsubdir + subsublist[m];   
17.                     if (endsWith(filename, ".tif")) {   
18.                         open(filename);   
19.                         name3 = File.nameWithoutExtension;   
20.                         rename("image");   
21.                         run("Split Channels");   
22.                         selectWindow("C2-image");   
23.                         run("Despeckle", "stack");   
24.                         run("Smooth", "stack");   
25.                         run("Enhance Contrast...", "saturated=5 normalize pro-
cess_all");   
26.                         run("Auto Threshold", "method=Otsu white stack");   
27.                         run("Watershed", "stack");   
28.                         if (roiManager("count") > 0) {   
29.                             roiManager("Deselect");   
30.                             roiManager("Delete");   
31.                         }   
32.                         setBatchMode(false);   
33.                         waitForUser("Fix Errors manually then press OK");   
34.                         setTool("ROI Tool");   
35.                         waitForUser("Add ROI every 5 divisons");   
36.                         selectWindow("C1-image");   
37.                         roiManager("Save", dir1 + File.separa-
tor + name + File.separator + name2 + File.separator + "maskset.zip");   
38.                         if (roiManager("count") > 0) {   
39.                             roiManager("Deselect");   
40.                             roiManager("Delete");   
41.                         }   
42.                         selectWindow("C1-image");   
43.                         saveAs("TiFF", dir1 + File.separator + name + File.separa-
tor + name2 + File.separator + name3 + "Fluor");   
44.                         run("Close All");   
45.                     }   
46.                 }   
47.             }   
48.         }   
49.     }   
50. }   
 
Macro to crop image and mask files 
1. setBatchMode(true);   
2. dir1 = getDirectory("Choose Image Directory");   
3. dir2 = getDirectory("Choose Mask Directory");   
4. dir3 = getDirectory("Choose Save Directory");   
5. list = getFileList(dir1);   
6. for (i = 0; i < list.length; i++) {   
7.     showProgress(i + 1, list.length);   
8.     if (endsWith(list[i], "/")) {   
9.         subdir = dir1 + list[i];   
10.         subdir2 = dir2 + list[i];   
11.         name = File.getName(subdir);   
12.         name2 = File.getName(subdir2);   
13.         sublist = getFileList(subdir);   
14.         sublist2 = getFileList(subdir2);   
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15.         for (j = 0; j < sublist.length; j++) {   
16.             filename = subdir + sublist[j];   
17.             if (endsWith(filename, ".tif")) {   
18.                 open(filename);   
19.                 name2 = File.nameWithoutExtension;   
20.                 mask = subdir2 + name2 + "_mask_mask.tif";   
21.                 rename("image");   
22.                 open(mask);   
23.                 name3 = File.nameWithoutExtension;   
24.                 rename("mask");   
25.                 run("Analyze Particles...", "add");   
26.                 selectWindow("mask");   
27.                 close();   
28.                 selectWindow("image");   
29.                 run("Split Channels");   
30.                 selectWindow("C1-image");   
31.                 roiManager("Select", 0) run("Make Inverse");   
32.                 run("Colors...", "foreground=black background=black selection=yel-
low");   
33.                 run("Fill", "slice");   
34.                 selectWindow("C2-image");   
35.                 roiManager("Select", 0) run("Make Inverse");   
36.                 run("Colors...", "foreground=black background=black selection=yel-
low");   
37.                 run("Fill", "slice");   
38.                 run("Merge Channels...", "c1=C1-image c2=C2-image c4=C3-image cre-
ate");   
39.                 path = dir3 + name;   
40.                 File.makeDirectory(path);   
41.                 saveAs("TiFF", dir3 + File.separator + name + File.separa-
tor + name2);   
42.                 roiManager("Deselect");   
43.                 roiManager("Delete");   
44.                 run("Close All");   
45.             }   
46.         }   
47.     }   
48. }   
 
Macro to select individual cell masks for further analysis 
1. dir1 = getDirectory("Choose Source Directory");   
2. dir2 = getDirectory("Choose Mask Directory");   
3. list = getFileList(dir1);   
4. for (i = 0; i < list.length; i++) {   
5.     showProgress(i + 1, list.length);   
6.     if (endsWith(list[i], "/")) {   
7.         subdir = dir1 + list[i];   
8.         sublist = getFileList(subdir);   
9.         for (j = 0; j < sublist.length; j++) {   
10.             filename = subdir + sublist[j];   
11.             if (endsWith(filename, ".tif")) {   
12.                 open(filename);   
13.                 var name = File.nameWithoutExtension;   
14.                 rename("image");   
15.                 doWand(100, 100);   
16.                 setTool("wand");   
17.                 waitForUser("Select Cells");   
18.                 run("Analyze Particles...", "  show=Masks");   
19.                 selectWindow("image");   
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20.                 close();   
21.                 selectWindow("Mask of image");   
22.                 path = dir2 + list[i];   
23.                 File.makeDirectory(path);   
24.                 saveAs("TiFF", dir2 + list[i] + name + "_" + "mask" + "");   
25.                 run("Close All");   
26.             }   
27.         }   
28.     }   
29. };   
 
Macro to extract p body sizes and densities from masked cells 
1. // turn on batch processing   
2. setBatchMode(false);   
3. run("Set Measurements...", "area integrated redirect=None deci-
mal=3"); // ask for directories   
4. dir1 = getDirectory("Choose Image Directory");   
5. dir2 = getDirectory("Choose Mask Directory");   
6. dir3 = getDirectory("Choose Results Save Directory"); // extract file lists   
7. imagelist = getFileList(dir1);   
8. maskdirlist = getFileList(dir2); // start loop of images   
9. for (i = 0; i < imagelist.length; i++) {   
10.     showProgress(i + 1, imagelist.length); // set up subdirectories and get im-
age lists, get mask lists of the same   
11.     if (endsWith(imagelist[i], "/")) {   
12.         subdir = dir1 + imagelist[i];   
13.         maskdir = dir2 + imagelist[i];   
14.         sublist = getFileList(subdir);   
15.         masklist = getFileList(maskdir);   
16.         for (j = 0; j < sublist.length; j++) {   
17.             filename = subdir + sublist[j];   
18.             mask = maskdir + masklist[j]; //open file   
19.             run("Bio-Formats Importer", "open=filename color_mode=Default spec-
ify_range view=Hyperstack stack_or-
der=XYCZT c_begin=2 c_end=2 c_step=1 t_begin=1 t_end=1 t_step=1");   
20.             rename("image"); // process image for analysis   
21.             run("Enhance Contrast", "saturated=0.35");   
22.             run("Despeckle");   
23.             run("Smooth");   
24.             open(mask);   
25.             rename("mask");   
26.             selectWindow("mask");   
27.             if (roiManager("count") > 0) {   
28.                 roiManager("Deselect");   
29.                 roiManager("Delete");   
30.             }   
31.             run("Analyze Particles...", "add");   
32.             if (roiManager("count") > 0) {   
33.                 maskset = maskdir + "maskset " + i + ".zip";   
34.                 roiManager("Save", maskset);   
35.                 selectWindow("mask");   
36.                 close(); // cycle through ROIs   
37.                 n = roiManager("count");   
38.                 for (m = 0; m < n; m++) {   
39.                     roiManager("Deselect");   
40.                     roiManager("select", m);   
41.                     run("Measure");   
42.                     saveAs("Results", dir3 + "Cell " + i + "-" + m + " size");   
43.                     run("Clear Results");   
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44.                     selectWindow("image");   
45.                     run("Find Maxima...", "noise=50 output=[Single Points]");   
46.                     selectWindow("image Maxima");   
47.                     run("Watershed");   
48.                     if (roiManager("count") > 0) {   
49.                         roiManager("Deselect");   
50.                         roiManager("Delete");   
51.                     }   
52.                     run("Analyze Particles...", "add");   
53.                     selectWindow("image Maxima");   
54.                     close();   
55.                     dotset = maskdir + "dotset " + i + "-" + m + ".zip";   
56.                     if (roiManager("count") > 0) {   
57.                         roiManager("Save", dotset);   
58.                     } //record number of bodies per cell   
59.                     x = roiManager("count");   
60.                     print(x);   
61.                     selectWindow("Log");   
62.                     saveAs("Text", dir3 + "Body Count Cell " + i + "-" + m);   
63.                     print("\\Clear");   
64.                     if (x > 0) { // cycle through ROIs and meas-
ure p body size and intensity   
65.                         for (y = 0; y < x; y++) {   
66.                             roiManager("Deselect");   
67.                             selectWindow("image");   
68.                             roiManager("select", y);   
69.                             run("Enlarge...", "enlarge=8 pixel");   
70.                             run("Duplicate...", "title=image-1");   
71.                             selectWindow("image-1");   
72.                             run("Select None");   
73.                             run("Duplicate...", "title=image-2");   
74.                             selectWindow("image-2");   
75.                             run("8-bit");   
76.                             run("Auto Local Threshold", "method=Otsu radius=15 pa-
rameter_1=0 parameter_2=0 white");   
77.                             run("Invert LUT");   
78.                             if (roiManager("count") > 0) {   
79.                                 roiManager("Deselect");   
80.                                 roiManager("Delete");   
81.                             }   
82.                             saveAs("TiFF", dir3 + "Cell " + i + "-" + m + "-
" + y + "mask");   
83.                             rename("image-2");   
84.                             doWand(8, 8);   
85.                             roiManager("Add");   
86.                             selectWindow("image-2");   
87.                             close();   
88.                             selectWindow("image-1");   
89.                             roiManager("Select", 0);   
90.                             run("Measure");   
91.                             selectWindow("image-1");   
92.                             saveAs("TiFF", dir3 + "Cell " + i + "-" + m + "-
" + y);   
93.                             close();   
94.                             if (roiManager("count") > 0) {   
95.                                 roiManager("Deselect");   
96.                                 roiManager("Delete");   
97.                             }   
98.                             roiManager("Open", dotset);   
99.                         } // end of analyse single body loop – open next body   
100.                         saveAs("Results", dir3 + "Cell " + i + "-" + m);   
101.                         run("Clear Results");   
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102.                     } // end of analyse all bod-
ies in a cell loop – open next cell   
103.                     if (roiManager("count") > 0) {   
104.                         roiManager("Deselect");   
105.                         roiManager("Delete");   
106.                     }   
107.                     selectWindow("image");   
108.                     roiManager("Open", maskset);   
109.                 } // end of entire image loop, close im-
age and open next one   
110.             }   
111.             run("Close All");   
112.         } // goes to next image   
113.     } // goes to next folder   
114. } // end of script   
 
Buffer Compositions 
TAE Buffer 50X 
Composition: 
2.0 M Tris acetate 
0.05 M EDTA 
pH 8.2 – 8.4 (at 25°C) 
TAE Buffer 1X 
Composition: 
40 mM Tris acetate 
1 mM EDTA 
pH 8.2 – 8.4 (at 25°C) 
CCMB80 Buffer 
10 mM KOAc pH 7.0 (10 ml of a 1M stock/L) 
80 mM CaCl2.2H2O (11.8 g/L) 
20 mM MnCl2.4H2O (4.0 g/L) 
10 mM MgCl2.6H2O (2.0 g/L) 
10% glycerol (100 ml/L) 
adjust pH DOWN to 6.4 with 0.1N HCl if necessary, add dH20 to desired volume, sterile 
filter and store at 4°C 
SOB Medium  
0.5% (w/v) yeast extract 
2% (w/v) tryptone 
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10 mM NaCl 
2.5 mM KCl 
20 mM MgSO4 
Adjust to pH 7.5 prior to use with NaOH 
 
Yeast Synthetic Complete (SC) Medium 
 
 
Ammonium Sulphate 5 
  
Vitamins µg/l  Supplements mg/l 
 
Biotin 2 Adenine Sulphate 18 
Ca-Panthotenate 400 Alanine 76 
Folic Acid 2 Arginine 76 
Inositol 2000 Asparagine 76 
Nicotinic Acid 400 Aspartic Acid 76 
p-Aminobenzoic Acid 200 Cysteine 76 
Pyridoxine HCl 400 Glutamine 76 
Riboflavin 200 Glutamic Acid 76 
Thiamine HCl 400 Glycine 76 
Trace Elements µg/l 
 
Histidine 76 
Inositol 76 
Boric Acid 500 Isoleucine 76 
Copper Sulfate 40 Leucine 360 
Potassium Iodide 100 Lysine 76 
Ferric Chloride 200 Methionine 76 
Manganese Sulfate 
 
PABA 8 
Sodium Molybdate 200 Phenylalanine 76 
Zinc Sulfate 400 Proline 76 
Minerals g/l 
 
Serine 76 
Threonine 76 
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KH2PO4 1 Tryptophan 76 
Magnesium Sulphate.anh 0.5 Tyrosine 76 
Sodium Chloride 0.1 Uracil 76 
Calcium Chloride.anh 0.1 Valine 76 
Omit Amino acids for drop out medium. 
Low fluorescence medium 
As above SC medium, omitting Folic Acid and Roboflavin. 
YPD Yeast Media 
Reagent Amount to add (per 1 L final volume) 
 Liquid Agar plates 
Bacto agar -- 24 g 
Bacto peptone 20 g 20 g 
Yeast extract 10 g 10 g 
Water 950 mL 950 mL 
 
Autoclave and add sterile filtered glucose to 2%. 
YPD+G418 (for 1L) 
Same recipe as above. 
After autoclaving let cool until 55°C 
Add G418 to have a final concentration of 200mg/L 
(1 mL of 200mg/mL G418 in 1L of YPD) 
YPAD Yeast Media 
Bacto-peptone, 20 g 
Bacto-yeast extract, 10 g 
glucose, 20 g 
Adenine sulfate, 40 mg 
Bacto-agar, 20 g 
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Distilled H2O, to 1000 ml 
Autoclave  
Yeast transformation Stocks 
Stocks: 
10x LiAc = 1M LiAc pH 7.5 
10x TE = 0.1M Tris, 0.01M EDTA pH 7.5 
50% PEG 
Salmon sperm (carrier DNA) 
For chromosomal integration - prepare fresh: 
LiAc/TE (in sterile tube) 
1 ml LiAc 
1 ml TE 
8 ml d[H20] 
40% PEG/LiAc/TE (in sterile tube) 
0.5 ml LiAc 
0.5  ml TE 
4 ml 50% PEG 
Yeast Lysis Buffer 
200 mM LiOAc/1% SDS 
 
